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Abstract
The present study clIlIlI1ined the life historie, of individuals In Western
Arntrnlin with a d)ngnosis of Angelman or Prader-Willi syndrome. Angclman and
Prnder_Willi syndrome, are phCflotypically diverse disorders both of which result
from the failure of imprinting at the chrlSqll-q13 locus. In most cases, loss of
the maternal imprint from the region lead!; to Angelman syndrome, while lack oh
patem"1 pattern results in Prnder-WilIi syndrome. Betwoon 4-14% of Angelman
cases have a mUlll tlon in a single genc, UBE3A.

Subjects fnr the study were identified from the Disability Services
Commission of West cm Auslmlia. Dntn on Ihes. individuals were oblllined from
Ihe eliCflt files held by Ihe Commission, and supplcmenttuy datn were added by
linkage to n number of daln5cts via the Western Australian Dam Linkage Unit.
The information was Ihcn compiled into a database to provide informalion to
physicians, families, and carers on the life histories and ageing patterns of people
with either disorder.
Fifty-six of Ihc 90 s ubjects identified had a diagnosis of Prodcr_Willi
syndrome.

Ten of Ihe individuals clinically dingnosed with Prndcr-Willi

syndrome wen: analysed separately (Pruder-Willi-likc), as they had return"" a
normal mcthylDllon test Md therefore were unlikely to have the disorder. This lell
a group of 46 individuals in the Pruder_Willi cohort, and 34 pc,",ons with
Angelmou syndrome.

Nine individuals were deceased by the time of dntn

collection.
Both disorders are now diagnosed at an earlier "ge thou WIlS CIlmmon ten
years ago, allhough there was still some degree of delay in diagnosing AngcImou
syndrome when compared to Prndcr-WilU syndrome. In addition, the majority of
recent diagnoses were confirmed b y genetic Icsling, as opposed 10 the lack of
genetic verification for earlier cases.
The clinical presentation of both syndromes was gCflernlly similar to the
eKpected profiles. lbroughout their lives, individlUlls with Angclmou syndrome
eKhib ited most of the major clinical features; nowever epilepsy llSunlly did not
appear until after the age of three years.

Conversely, the Proder-Willi cOSes

lended to presenl different churnctmstics nl vnrious ages. During Infancy, feeding

m

difficulties and hypotonia were almost universal, but these symptoms became less
rommon in later life. By age three to four years most of the Prnder.WiIli children
had an insntiable appctilc, leading to obesity unless the diet was strictly
controlled. Some features, such lIS hypogonadism, were present from hinh, but in
females it was not always obvious until puberty. There were some diagnostic
clinical criteria which were unreported for many cases, c.g., microcephaly or
prognathia in Angelman syndrome, and hyperphagia Or the chllllleteristic fneies in
Proder-WilIi syndrome.
For many suhjects either no genetie test had been requested, or klll)'otypc
or banding tests only WeIC undertaken, many of which were uninformative. The
incideJlcc of uniparental disomy in Prndcr-WilIi syndrome was around half that
expeded, although the rate for Angelman syndrome was within the expected
moge.

On overuge, individuals with Angelman syndrome had been admitted t o a
hospital on aine occasions, Md those with Pradcr-Willi syndrome on seven
occasions.

Denwl work Md respimtory disorders well) �le main reasons for

hospital admission for

both

groups of patients.

However, significantly more

AngclmM syIldrome patients were admitted with epilepsy than Prnder.Willi
enses, Md treatment for undescended testes was needed only hy those with
Prader-WilIi syIldromc.
InteUox:tual function ranged from normal to profoundlydisnhled, with 88%
of the Angelman group within the modcrnte-scvere categories, Md 72% ofPrnder.
WiUi cases with a mild-moderule disability.

There were many fewer than

expectedPrndcr-Willi patients with an IQ>70 (9% vs 40%). But sin"" Disability
Services Commission does

not ncccpt individuals with an IQ>70, case

IlStcrtainment was effectively biased to ClIcl�de such people. This may explain
the low rat� of uniparental disomy in the Pmder.Willi group, since such cases
have a less severe phenotype than those with any other disruption of c1tr15qll.
q13.
In many cases the Disability Services Commission files contained only
limited infonnation on the clini",,1 nod behaviourul presentation of these
individuals. Oflen this was due t o a lock of conwct with the Commission, for any
of a number of possible reasons, c.g� dislWlce from services, reduced need for

"

services, or migmtion into or out of Westem AUsInIlia. The clinical criLcrla for
bolh S)'IIdromes have only been published wilhin Ihe l!lSt 10·]2 yeam, which
meant that reporting of some characteristics was lacking !IS th. relevance of these
fealures WIIS unknown prior to lhose publications.
Previous reports on ageing in people with lntellcctual disability have
indicated that many of their ageing issuC5 mirror those in the geneml population,
e.g.• visual or henring impalnnent, loss of mobility, and meDllI1 health disorders.
Since the oldest member of the study group WlIS aged 48 yeam, it was nOl possible
to produce a comprehensive picture of the age·associated morbidity typical of
eilher disorder. However. the study does provide 8 valuable compnmtivc baseline
for ongoing investigations into bolh syndromes.
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I.

INTRODUCTION

1.1

The aigaifleao(e o!tbls project
The World Health Organization hns Cillled for re=h into practices that

succesjfully promote longevity nnd healthy ageing in persons with intellectual
disability (ID) (Hogg el 0/., 2001). In terms of life expectancy, the population
promes of both developed nnd developing countries ditTer greIIUy from those of
one hundred years ago. For example, the median agc in Australia io 1901 was
22.6 years, but by

L999

It had risen 10 34.9 years (Australinn Bureau ofSlnti,tic!,

2000), because of the increasing ratio of older people 10 those middle-aged and
younger. People with ;n!eUechlaI disabilities arc also living significantly longer
thnn in the past (Eymnn Cl a/., ]981; lanicki et 0/., 1999; Binles cl 0/., 2002).
Those with mild ID have approximately the SilIIIe mean life eKpeclallcy as the
general population, olthouglt severe ID decrcnses life expec\aJ1cy by as much ll5
20% (Patjo el a/., 2000; Patja el al., 2001: BinI"" et al., 2002: Sutherland.1 0/.,
2002).
The Intemot/onal P/a" of Action on Ageing (United Nations, 199B)
suggested thol da'" relaling 10 older people were criticnl far the ""ccessful
development of processe, and policies mimed at improving the langevity and
quality af life af an ageing pop1llation.

There

arc

a number af identified

predictors of chronic disease that lead to m limi"'tion of funClional abilities in the
older population, including poverty, being female, having a lower cducnlion level,
and redm:ed aocess to health services (Walsh, 2002). These predictors apply
equally to those with!D, espct:ially as members afthe ID population oflen fall
into two o r more af those categaries (Holland, 2000). However, onc of the ,"ain
difficulties io the provision of heaIthcnre for people with ID is the communication
barrlcr thst often CKis!5 between the patient and the dootor, and the difficulty
experiem:ed by an individual with !D in recognIsIng worrying symptoms or
conveyIng relevant Information to the physician (Evenhuis, 1991; Luru;ky

&

Rciss, 1998: lanicki ct al., 1999; Hogg, 2001). On average, indIviduals with!D
have leSOl access to preventotive health
lifestyles, and

an:

Cil1C

prognuns, have morc sedenlaly

le,s likcly to complain af ill-health, althaugb those with

mild/modernte ID CIlI\ and do make Independent healthcarc decisions (Allan,
1997),

1.2

ami Pntde...Willlsyodrome

The Datu..., orAngelmao syodrome

Angelmnn syndrome (AS; M!M 105830) and Pradcr.WiIIi syndrome
(PWS; MIM 176270) !Ire specifie ohromosomal disorders IGCated in the q l !-q13
region of

15,

chromosome

They both involve abnormalities of genomic

imprinting, i.e., the process by which genetic material is differentially
according to ils parental origin. Angelman
imprint is absent

from

syndrome occurs when

expressed

the maternal

the region, while Prader·Willi syndrome results from

absen�e ofth. paternal imprint. Imprinting is One of the mechllnisms involved i n
epigenetics, i,e., chnnges I n g e n e activity UllIt occur without variation o f the
underlying DNA sequence (Riddihough & Penn;si, 2001; Wu & Morris, 2001). It
is thought that epigenetic processes, such as DNA methylation and RNA·
mediated silencing, evolved in port as defence mecl1anisms against pnmsitic DNA,
trnnsposon damage or virus invasion (Falls el ai" 1999; M.1zke el al., 2001;
Bestor, 2003). CIlm:ntly there

are 47

humnn genes listed in the Imprinted Gene

Cntnlogue, with a relatively eVen distribution between malemal and

expression

(Monson ., al., 2001; Moriso", 2004).

paterna!

However, as the roles and

actions of the estimated 25,000·27,000 genes in the human geno me arc funher
clarified, the number of imprinted genes may be
(NHGRl, 2004). To date, most of the

expceted

to rise accordingly

known imprinted genes

arc involved in

either pro-- or post·n.tni growth and development (Moher el 01., 2003a).
Although the two syndrome, are similar in
mcchnnis,""

they

differ

terms of

significantly in clinical

their basic genetic

presenlalion.

AngelmllD

syndrome OCC nrs in I per 10,000·20,000 births (Hou et al., 1998; Slromme, 2000).
The disease pbenot)IpC is chlll<lcter;,ed by

jerky gait, and seizure,.

sC\lere ID, limited speech, an \IllSbJ.ble

While AS WlIS fllSl clinically dC$oribed by Aogelmao i n

1965, the underlying genetic defect WlIS not rccogaised until the l.te 1980s, with a
consenSllS opinion on the clinical criteria for dillgl10sis of the syndrome published
in 1995 (WilIiamsetal., 1995).
Prader.Willi syndrome has n sImilar p....nlence
..
rote to AS ofbetwccn 1
per 10,000·25,000 births (Slrommc, 2000; Wbinington et 0/., 2001; Smith et al.,

,

2003). The phenotyplc characteristics include mild \0 severe ID, short stature,
hypogonadIsm, an insatiable appetite and resultant obesity.

It was originally

described in 1956, a n d clinical diagnostic criteria wen: developed in 1993 (Prader

et al., 1956; Holm et al., 1993).

As with Angclman S)IlIdrome, Ibe genetic basi,

was WIly elucidated in Ibe I.te 1980s.
There is considerable phenotypic heterogeneity among people with each
S}'I1drome, possibly related to the nature of the underlying defect. The relatively
recent description and diagnosis o f l b e syndromes mcnns thot information on their
clinionl progression is still very limited, and th.re may

be

many older,

Institutionalised individuals who have remoined undiagnosed throughout their
adult life. In "ddilion, little infoneDlion is ovoil"ble on the relationship

between

the disease phenotype and the specific genetic anomaly, or on the medical and
health obstacles faced by people with either S)IlIdromc in adulthood.

This

knowledge is of prirnary importance in improving our underslar)ding oflbe nature
and progression of the di�rdCl'S.

It is olso needed for oppmpriotc family

cnunselling and health care services, and ICI incn:ase basic knowledge of Ibe
influence of imprinting in the chr15qll-q13 region on the ovemU fimction of the
human genome.

1.3

Tbe purposeoflhc .Iudy
The presenl

project aimed t o establish a dodlC8lCd database of people in

Western Australia (WA) di.gnosed with AS or PWS. The PWJl(lse wllS to allow
estimotes of the population prevalence of each di,order to
compllrisons dmwn

between individllllls within each group.

be

made, and

The dalabll5e also CDn

b: used lIS a resource for further research into the syndromes and the ageing ofthc
study cohort.
Descriptions of the sUlVivai and mortnlity patterns of people with AS and
PWS arc recorded, together with hospital morbidity histories, so that infomllltion
on the lif""",urse and sUlVival of people with AS IllId PWS CIIIl be provided 10
flll1lilies, clinicillll s

an� genelie wunsellors.

Infonnalion of this nature will aid

Individuals and their families in predicting future health needs and i n plWllling
appropriate inlervl.Tltio",. As the life eKpectancy of people with ID has increased,
Ibe age of their plltCnlal carers has similarly extendod. This re,ulu In families
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facing a range o f probJems, includIng diminishing he�lth of the ageing c�,"" the
possibility of a sudden end to the carin�. relationship due to InCllpacity or death of
the Cllrer, and fewer options for employment ilI\d/orsocial activity forthe middle
aged or older ID indIvidual (Holland, 2000; Bigby %

/., 2002). More frequcnUy,

ammgcmcnts for gtlardianshlp for adults with ID may be necessmy when parents
are no longer ovoilable to fulfil this role, in a manner slmillll' 10 the increase in
guardiill\ships for adults with dementia that hO!; occurred in Japan since 1980
(Mizuno & Nanba. 2003).

Detailed information on the lifc-courses of poop le with AS and PWS hO!;
been ""nated and analysed. This project is onc of the frn;! in Australia to
investigate health IUld ageing issues pertnining 10 AS ilI\d PWS in a defined
population, and the data can be expanded by the continued future collection of
informalion o n these individuats.

1.4
1.

R""""n:b'lu",,11008
Whal arc the prevalen"" mtes of AS and PWS in Western Australia?

2.

What life-time momid!ti.. W'C COmmOn and/or .pecific to each syndrome?

3.

What ageing issues are relevanl l o people diagnosed with each syndrome?
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2.

REVIEW OF LITERATURE

2.1

The human genome

2.1.1

Overview
The information collected as pari of the Human Genome Project (HGP)

has hnd a major imJl4c\ On previously held views of the genctic code. it was
fonnerly believed that each ge ne encoded a specific protein, Md therefore the

h umM

genome would conmin more thnn 70,000 genes (the smnllest estimated

number of human proleins). However, to dale the HGP has identified only some
25,OOO-27,()()O gencs, indicating much greater complexity in terms of gene
interactions and Vllfiations of expression

than were previously believed (National

Human Genome Rosel!rCh Institute, 2004). On avcmge, each human gene

can

produce three different proteins, simply by changes in the initiating sites for
transcription and to the splicing points (Pennisi, 2001). Almost 50% of the human
haploid genome, approximately 3 billion base pairs, is composed of repent
sequences.

it is not yet known if these atCa5 perform a particulllf function,

perhaps as regulators of gene expression. According \0 th e director of National

Human Genome Research Institute (Collias er 01., 2003), the alms of the HOP
now include:

J.

Identification oran stnJctural and functional componcnts (genes or

regulators) encoded in the genome;
2.

Investigation ufthe structure of the preleln pathways and genetic
interactions within the genome, Md establishment of the role of each
component in the phenotype;

3.

ldentifieation of the range of heritable variation found within the human

genome, espccinlly the more common variants, e.g., single nucleotide
polymorphisms (SNPs), smoll deletions, and insertions.

The role of individual genes In the productiun oh specific phenotype Is
complicated by the very lorge number of SNPs, which may add many small
e[feets to a single phenotype. Alternate mutations or mutations at different sites

en the same gene can result in different disorders. For Instance, n disruption of
the dystrophln gene at one point leads to Oucheone muscular dystrophy while a

,

similar mutalion at a different point results in the clinically less severe Becker

muscular dystrophy (Gilohrist el 01., 2000). In nddition, the expression pat1cm5 of
vnrl""t alleles can be Dffected

by a

wide range of faclors, e.g., environmental

internctions, s10cbastic events, IIlld intergenetic interactions (Hartm"" cl al.,

2001).
In S<.lme cases, a nllmber of diffo:rent genes can produce a phcnolypically
identicnl disorder, suoh as 8utasomal dominDl1t polycyslic kidney di=
(Gilchrisl el al., 2000), Md dife
f rent forms of imprinting foilurewithin chrlSql l
q13 can result in PWS or AS.

Continued progress on the delineation of these

interactions by the HGP ""d similar organisations will increase knowledge in
these 1Il"CIIS, Md provide expllll1ations for the variations in phenotype between
individuals with t h e same syndrome, but differcntgenotypc" It is 01.0 envisaged

that detailed knowledge of the difef rences between genotypes will allow precision
matching of med i cations 10 act optimallY for th"t individWlI, e.g., a specific
epilepsy drug which will be effective for tr..ting individuals with Angelman
syndrome caused by

0 deletion (Prows & Prows, 20(14).

21.2

Genomk imprintillg

2.1.2.1

Normaloffem oflmprlllllng
The process of im prinling is thoughl to involve the differential methylation

ofCpG isla n d s «:yto.sinefguonlne-rich region!! of DNA) in genes located close to

the imprinting centre. Gene-rich segments of the genome tend I(} have higher
concentrations of CpG isl""ds than areas with a lower gene density (Pen n l !! ll

21l(1).

If methylation occurs within a promoter region of a gene where

tnmscripticn is initiated, then transcription ofth� particulor gene is blm:ked. This
form of silencing is evident in

imprinted genes, during X-chromosome

illllctivntion, ""d when parnsitic or l1lII1'posable sene elements are silenced (Falls

0101., 1999;Jones &TDkai, 2001; Pork & KurodD,21l01; Best(}r, 2003).
11 has been hypothesised that genomic imprinting is a ",Iution to the
conflict of interest thot is presumed to exist between the pDlemnl and motcmal

genomes, in which the paternal role I. to incn:asc the fitness of progeny,

irrespective of matemal cosl.

In contrnst, the maternal objective is to lImit

offspring fitness by an amounl sumc;enllo prevent overuseofm"ternal re!!ourocs

,

while continuing 10 mrnnlnin relnl health (Haig & Wharton, 2003). The miK\ure
nf pntemally and maternally imprintod genes found throughout the genome is thus
likely to represent a compromise between the two po�itioru, especially lIS most
known imprinted genes affect pro- or posmatnl growth (Falls el al., 1999; Haig &
Wharton, 2{!o3; Milher et al., 2003a).
Methylation has beon shoWII to alter the interactions between proteins and
DNA. These interactions

can

lead 10 chMgos in chromatin S\nJcture and 10 an

increase or decrease in the rate of transcription, which is sometimes linkod t o
cancerous growth patterns (Beliruky el al., 1998; Morison el al., 2001; Martincz
Delgndu el al., 2002). For example, a tumour suppressor gene (pJ6) is inacti�ated
by hypcrmelhylation of the promoter region in a number of tumour types,
.
including lung cancers and squ.nmous cell carcinomas. The degree of methylation
within the region increases as the IC'lcl of abnolTl1lllity of the cells increases,
indicative of a po..ible link between methylation of the promoter, 10.. of
expression, and development ofthe carcinoma (BeHnsky el al., 199B).
Hypermethylation of hlstones, especially histone3 on Lys9 (H3L9), has
been linked to the formation of stably-silenced chromatin regions on the maternal
chromosome
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a t the Pmder-Willi syndrome Imprinting centre (PWS-IC).

Conversely, the methylDlion o f h lstone3 Lys4 (H3L4) has been associatod wlth
the paternal chromosome IS in the same area. (Xin 01 al., 200t; Lau el al., 20M).
The chromatin modifieations which result from thIs selective histone methylation

are

proposed epigenetic markers, as the chMges persist throughout development

and are parent-specific (Xin et al., 200!; Rougeulle el al., 2003; Lac eta/., 2004).
In addition, noelylated histones have bcen Identified on the unmethylatod Md
active patcrnul CpG island of the

SNURF-SNRPN (SNRPN

upstream reading

frame-small nuc!eolar ribonucleoprotein N) region, wheJ"ellS the inactive maternal
copy is net associatod with ncetylation (S.iloh & WOOD, 2000). The silenced
wlth

a DNA

methyltmnsferasc inhibitor which induces hypomethylation of the

SNURF_

genes

have been

SNRPN CpG

experimentally

reactivated by treatment

island. However, i t ls not knoWII if this !eChn!que could be used

therapeullcally 10 help alleviale the symptoms of those with imprinting disorders
(Sailoh & WadD, 2000).
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The epigenetic imprint markers that idenlifY the pDl'Cnt of origin are erased
during early gamelogenesis,and thon reset with the new pm:nt-of-origin mark at
0, before meiosis

U (Talla el a/., 1998; Keljenn cl a/.,2000; Fellluson-Smlth &.

SUrnni, 2001; Coxe/a/., 2002; Kclly & TlllS ler, 20M). In mnle mice an imprinted
gene, H/9, w hich produces n fetal liver mRNA, has been shown to

be funy

methylated on the male strand by day 15.5 post-coitus, i.e., lhe pDlcrnal imprint is
fully es(nblished by the ealr y spem!ntocyte s(nge of gametogenesis, before lbe
complction of meiosis [ (Lucifcro el al., 2(02). Similarly, in hum"" males the

HJ9 imprint is acqu ired by the spermatogonia slage of gametogenesis (Kelly &.
Trnsler,2(04).
Likewise, in Ule female mOUSe a nlIIge of imprinted genes have been
,bO\\1l to undelllO methylation at a variety ef times and speeds. Most of the loci
investigated by Lucifao el al. (2004), i.e., SlV'pn, insulin-like growth factor 2
rcceptor (Igf2r), paternaily e�p=d gene

3 (Peg3),

and mesoderm-s pecific

lmIlscript CMes,), arc completely methylated by 25 doys postpartum, nlthough Ule
process occurs 11\ different stages of oogenosis for each gene (Lucifcro e/ al.,
2002; Lucifcro el al., 2004). In h u mans, mDlemal methylation ofth. SNURF

SNRl'N exon

I n onnally

is fuUy esmblished during late ovulation or aner

fertilillBtion (EJ-Maarri el al., 2001). The chromosomes iu a female mouse also
gain methyla!ion asynchronously, i.e., the mntcmally-contributed strand of Snrpn
ucquircs t h e imprint earlier in d evel opm ent than the pDlemal strand.

Thi.

discrepancy between the timing of methylation indicates that some form of

re«lgni!ion process i. available in primordial germ cells which fo rms a means of
differentiating betwccn !h. origins of eaoh chromo.ome, even in !he absence of
hypermcthylation (Davis et al., 2000; Keljean e/ al., 2000; Kelly & Trusler,
2004).

Selective oct:tylation of histones mny be such a means of identification,

although there may also be other epigenetic changes yet to be identified (S aitoh &.
WadB,2000).
2.1.2.2

Fal/�re a/Imprinting
Loss of effective imprinting can be due to:

1.

Deletion o f a portion ofeither the pntcmal Or maternal chromosome which

includes the rel ev an! gen e/so

•

2.

Unip=1II 1 diromy (UPD), i.e., tile inh.ritam:e nftwo chromosom� from
onc pllI'enl Drld nonc from the other. This may

be

Dll isodiSll my (two

identical chromosomes), or a hcterodlsomy (two different chromosomes).
The effect of UPO on gene ellpression can VIII}' greatly, depending on the
nannal role of ,,"ch nllele at thot 1""u5. For genes !hot are not imprinted,

UPD has usually no effect on expression, nlthough there are = where a
recessive allele is 'unmasked' due to the present. nrtwo copies from one

p!lnm� iDstowi of one from each pnn:nt (Hitch in. & Moorc, 2002). Any
imprinted gCllc which is hypenncthyJoted On both alleles due to UPD will
not be expressed (nulIisomy), but it would

be

CKPectcd that imprinted

genes whlch ore non-methylated on both nll.!es will both
leading to a diploid overdose effect (Smith, 1996).

be expressed,

In situ"lions where

there is phenotypic variation betwoxn UPD and deletion patients, it i s
possible thot the difference results from 0 gene dosage effect.

3.

Mutatlon by deletion or substitullon within the imprinting centre (IC) that
leads to disruption of the imprinting process and hence silencing of the
imprinted gCJIels On both chromosomes (Jiang et al., 1999; Clayton-Smith,
2001).
Methylation u s\llll1y acts to silence the relevant gene, thereby limiting ilS

expression to the al1o1e from the other parent. The importnnce of the contribution
of both parents to nonnal development is shown by the production of modified
mouse embryos. Androgenetic embryos, conlllinlng paternal genes only, suffer
from reduced folllI growth and exhibit a Ven" high growth rate for the extra
embryonic tissues (plnccnta and amnion). Parthenogenetic embryos, with only n
maternal gene ccntribution, show normal follll growth but gICally reduced extra
embryonic growth. Neither type of embryo is viable t o term (Falls el al., 1999).
The delay In resetling the epigenetic marker on specific chromosome

.<lrnnds, (Section

2.1.2.1), may help to Cltplain the recently reported Increase in the

risk of imprinting disorders found in cbildren conceived by inlracytoplasmie
spermatozoa injection (lCS!) Or other assisted reproductive technologies (ART).

It is possible that the oooytc may fnil 10 complete its nonnal post-fertilisation
maturntion, which includes the resetting of the epigenetic mnrlt, when undergoing
the laboratory processes involved in leSl or other type. of ART (Fcrguson-Smith
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& SUmni, 201!l, Coxel al., 2002, DeBaun el al., 2003, Orstavik el al., 2003). In
addllion, defe.:;:tivc Hl9 methylatlon hllS been shown to be lIS,\ociatcd with
abnonnal spermalogenesis aud a consequent low sperm <:ount (Ml1I"ques el al.,
201l4), which may DI"" have implications for the long-term outcomes of =isled
reproduction techniques.
A

report on the safety of lesl found no abnormal methylation effects in

infants conceived by this method, although the !;ample site was quite small (n �
92), ond subscqucntanalysis ofsperm smnpl,,s (n � 90) collected for ICSI showed

no imprinting abnorm.alities (Manning el a/., 2000, Manning el 01., 2001). A
Danish investigation into the outcomes of ART hnd concluded that the slight

increase in perinatal mortality and congcnitnl malformations was most likely due
to the effects of multiple births (WestcrgWlrd el al., 1999).

More recently,

however, infanlS <:onceivcd by ART in Western Austmlia have been shoWII to be
twice os likely to suffer from a major birth defect as natunllly conceived infants,

and to have

tower birth weights (Hanscn cl 0/., 2002), nnd simill1l"ly conceived

infants in Finland hnve higher rDtes ofeongenilal heart malformation (Koivurova
d al., 2002). Both sets ofresulls were significant even after controlling for the
effects of mUltiple births, which ore more commOn in ART conceptions, and there

are specific morbidity problems associated with such birtlts (Sutcliffe, 2002).

A

subsequent review of the literature on leS! indicated an increased risk of
congenital and genetic abnormalities, although the authors concluded that the
Imoreose could

be ",Iated

III the

underlying cause of inferli1ity in the parents

(Retzloff & Homslein, 2003).
Assisted "'prodUctive technology may also alTcct the incidence of

imprinted

disorom.

Both Angelman syndrome and Becl;with-Wledemann

S)'lldrome (BWS, MIM 130550) havo been reported to occur2-6 times more often

than expected in children conccived by in-vitro fertilisation (IVF) or ICSt
(Hnnscn el al., 2002: DeBaun

.1 01., 2003, Gicqucl el 01., 2003,

Gosden el al.,

2003, Orstavik el al., 2003: Halliday el aI., 2004). BWS is an ovcrgrowth
S)'lldrome chllnlcterued by macroglossia (palllOlogical and congenital enlargement
ofthe tongue), pro- Or postnatal overgrowth, and abdominnI wall defects (paulsen
& Ferguson_Smith, 2001). Almost half of all BWS cases have

been associated

with nbnonnnl imprinting of the KCNQJOT gen. at clIrllpl5. This leads to

10

demethylation of the

KvDMRI

region of the gene and subsequent biallene

expression ofinsulin·like growth factor !I (lGFII), whioh appears to contribute to
abnormal developme!lt of the hypothalamic·pituitwy·ndrenal axis and subsequent
growth accelemtion (Cole, 1998; Gicquel et al., 2003; Mnber et �I., 2003b).
Despite an eAAaustive selll'Cb ofonlice dntabascs, there aplXl!lt \0 be uo published
reports ofPWS in artifieia!Iy-coneeived cbiI�n, which may be due to the fully
functional patern.l imprint by the time fertlllsation lakes place, in IlOntrast to the
sub-fimctional malCrnal imprint (Geuns et al., 2003).

In

addition to Angelman, Bockwith·Wiedcmann

and

Prnder-Willi

s}'lIliromes, transient neonatal diabetes (TND; M1M 601410) and SlIvcr-RusselI
syndrome (SRS; MIM 180860) hove been identified us imprinting disorders.
Paternal uniparental disomy of chromosome 6 (UPD6) has been linked with the
development of TNO, IIIId two imprinted genes are known 10 be located in the
eltr6q24 region. These arc inferred to bave some effect on the diseru;e phenotype
(Arima �t al., 2001). Similarly, maternal UPD7 is implicated in 7·10% of SRS
casus. In Silver-RusseIl syndrome beth pre· and postnatal growth retardation are
presen� seemingly caused by either under-cxpression of p.temal growth.
promoting genes, or over-expression of motemol growth·inhibitors.

There are

also a rnnge of dysmorpbie feature.s associated witlt the SY,ldrome (Hitehins &
Moore, 2002).
2.J.2.3

The role ofImprinting/ailure in the development o/PWS andAS
Angelmoo ond Pmder·WiIIi syndromes differ phcnotypically, altltough

they both result from failure of imprinting or gene mutation within the same
region of chrI5qll-q13.

In genel1ll, if the affected chromosome is maternally

derived tIlen Angelmnn syndrome occurs, wberens Pmder-Willi syndrome results
if the paternal cbromosome is altered. Usually there Is nO obvious gender bias in
either syndrome, olthough more boys thnn girls are identified with PWS before
adolescence, possibly due to tile more subtle pbenotypic changes in prepubescent
Sirls (Smith et al., 2003).
Genetic testing for PWS or AS commonly begins with methylation
analysis.

There are " number of sites within the chrlSqll·ql3 region tIlat are

hypcnnethylnted on the maternal chromosome, e.g., 5'SNRPN, NDN, ZNF127,

"

8Ild PW71, and wme which are prefen:ntially methylated on the paternal strand,
e.g., u ID, YL48E and SNURFISNRPNintron 7. Ofthesc loci, fSNRPNh..., bce:\
recommended ..., the most accurate ond reliable site for the assessment of
hypermethylation and it h..., been adopted for prenatal diagnosis (Kubota el al.,
\996: Glcnn elal., 2000: GeullS el al., 2003). SNRPNis expressed from only one
olle!. by the 4...,.U, i.e., pro-implantation, stage of embryonic development
(Huntriss et al., 1998). The other hypcnnethylation sites (NDN, ZNF127, PW71,
uID, YU8Eand SNURFISNRPN intron 1) have been found to be less infonllotive
than 5'SNRPN, and to give highcr rates of incorrect diagnoses (GeullS et al.,
2003). Comprehensive methylation Molysis of both PWS Md AS cases with M
imprinting defect showed that u variety of loci were affected, with methylation
ahnormal on both chromosom� S\rnr,ds (Runle el al., 200Ia).
The presence ofa single band on methylation testing indicates uniparcntrJ
methylation, Md the size of the bond identifies which parental pattern is prcsen�
I.e., 4.2kb for the mntemol band and

0.9kb for the paternal at fSNRPN (Kubota el

01., 1996). The chonges in methylation may re due to deletion, UPD or an le
defcc� therefore further testing is neccssury to delemlinc which of these specific
mechanisms is present

(Wi!llams

el al., \99&). The discovery of two bands

(biparcntol methylation) is sufficient to exclude the diagnosis of PWS in most
cases, but not \0 exclude AS (Buchholz el aI., 1998: Fridman elaf., 2000b: Glenn
el al., 2000). Biparental methylation in AS can re an indication ofu single gene
(E6-AP ubiquitin-plotein ligl!l;e: UBE3A) mutation (Mal5uum et 01., 1997:
Monela er al., 1999a), but there also is a proportion of clinlcaIiy-diagnosed

AS

patients with no eUITeJI!ly identifiable genetic defect.
2.2

AageIman-'Yudrome

1.2.1

History and hat:kground

Angelmll!l syndrome w..., first described in 1965. The pbenotypo

was

cbll!llcleriscd as a combination of SC'Iere lcaming disability, seizures with a
specific electroencepbalogram (EEG) pattern, absent s�ch, jeJky alalllc
mevements, and a happy sociable disposition (Angelman, 1965). ConsellSus
diagnostic criteria, listed in Table 2.1 (p.l3), were subsequently published in 1995
(Williamselol., 1995).

Table2.1

Diagnostic criteria for Angelman syndrolDe

Coruistenl (100%)
Functionally SCVere developmental delay
Speech impainnen� nO or minimal use of words

Movement Or b.l""ce di.5o,der, 115ually ataxia of gait andlor tremulous movement
of limbs
Behavioural uniquencs�: any combination of frequent laughter/smiling; apparent
happy

demeanour; easily excitElble pcl'SOnality, often with hEll1d-flapping

movements; hypennotoric behaviour; short attention spon
Freqaent (>80%)

Delayed, disproportionate growth in head circumference, usually resulting in
microcephaly (absolute or relative) by age 2 years
Seilllres, oruet llSually <3 years ofIlJlc
Abnonn.l EEG, ehoracterlslic pattern with large amplitude slow-spike waves
(usually 2-3Is), facilitated by eye dosure
Assoclaled (2l1-li0%)
Flat <xx:iput; occipital groove
Protruding tongue

Tongue thrusting; suck/swallowing disordcrs
Fceding problems during infancy
Prognathia; wide mouth, wide-spaced teeth

Frequenl drooling; excessive chewing/mouthing behaviours
Strabismus

Hypopigmented skin, light hair ""d eye colour (compared to famny), seen only in
deletion cases
Hype,,"ctive lower limb deep tendon reflexes
Uplifted, flexed ann position especially during ambulation
Increased sensitivity to heat
Sloop disturbance
Attraction tolfascinotion with water

Adapl�dfrom IYilliamsel al. (J99J)

The diagnosis of AS is usually based on clin;cnl findings, and it
confinned in

is nOW

80_85% ofcases by cytogene�c or DNA testing (Loan "I al., 1999a).

The flfS! diagnostic tests for AS were introduced in 1937 (Clayton-Smith & Laan,

2003).

Since that time, e!Torts have focused on

further elucidating the genetic

mecbanism underlying AS, and many dCSCIiplions of the variant phenotype and
life-course orthe syndrome hove been produced.

22.2

Th�Angelman syndromephMOtype

2.2.2.1

Developmental characterisllcs
AngelmDII syndrome palients have been reported to be phenotypically

normal

during

the prenatal

and

perinatal perioos, will,

no diagnostic

clmrncteristics in the newborn infant (Cassidy & SchwllriZ, 1998). Howev.r, 63%
ofthe deletion patients seen by Smith (1996) showed hYPolOnia at birth, and even
more (71%) had experienced fceding difficulties during infancy. D.....!opmental
delay is generally manifest by 6_12 months ofage, when a delay in Independent
sitting becomes ....ident (Willioms cl al., i995; Cossidy & SehwllriZ, 1998:

Lean

Cl al., 19998). Sitting is normally accomplished at around one year of age, and
walking may be delayed until !be eighth year (Smi!b el al., 1996; Ln:m e/ aI.,
1999a). Males tend 10 ""hieve molor milestones al an earlier age than females
(Leitner& Smith, 1996), al!bough the two non-ambuJ""1 individuals from a group
of 1 1 patients s••n by Sandmmm e/ al. (I997) were both male. Walking olien
becomes more dimcult with increasing age, with as many as 42% of patients
becoming wheelchair_bound in adul!bood due 10 a range of problems including
obesity, an unwillingness to exercise, DIId scoliosis (Clayton-Smith, 2eOI).
Delayed or absent speech is onc of the cardinal features of AS.

Few

patients ever learn to speak Md any who do generally a"'luire only a vcry limited
vocabulary, although comprehension oflanguage is usually reasonable (Andersen

el al., 2001). Small amounts of gestural or signed language may be learned
(Wi11iwru; el al., 1995: Cassidy & Schwartz, 1998; L""" el al., 1999a).
vocab�lary

A

of 4-10 words was used by halfoftl-.e UBE3,{ mutation palients Cn �

14) studied by Monela Md co-workers (199�). These patients showed a higher
level ofcomprebension and non_ve,b�l communication than is normal for people
with

AS.

Clayton-Smith

(2001)

also reported

improved

non-verbal

communication skills in a group of older patients (n D 28: ages 16-40 years), due
to the improved coneentrntion span frequently found in older AS individuals.
ID is present in all people with AS and is usually within the ScVere 10
profound range, i.e., with measured IQ levels and an adaptive behaviour
lISSessment of I.ss IbM 40 points (Smi!b el al., 1996; Clnyton_Smith & Lnnn,
2003; Beckung

cl 01.,

2004).

On averuse, patients with 1UI imprinting centre

14

disorder have been found to have less severe ID thM those with AS caused by
other Genetic mcchanisms (Glllos.len_Kaesbach et al., 1999).
2.2.2.2

PlrysIcal characteristics

Thcjcrky, ntnxic movements nssoeialed with AS

are

appnn:nl III an early

nge and continue into Inter life. When walking,the arms are commonly raised and
held at o distancc from the body, with flCKed wrists and elbows. HMd-flapping is
also often involved, and the legs are generally kepI stiff {Smith et al., 1996: LaM
el al., 19990: Bcckun� et al., 201)4). Scoliosis develops in Dll estimated 40-70%

ofaffected individuals (Lnan el al., 1996: SDlldannIn el al., 1997: Clayton-Smith,
200 I), !I/1d tan contribute to a loss ofmobility as the palients oge ('�Jnyton-Smith
&

Lann, 2003). Surgery for scoliosis has been performed on some p'tients, ollen

with good results, and the o""",lion is quite well tolerated by most Individuals
(Lassie et al., 2001). Hypertonicity (high muscle tone) of"'e lim')!, generally
found in conjunction with truncal hypotonia (low mnscle lone), cu 1000d lojoint
contractures and 0 stooping posture lIS patients become older, and it may have a
demmentnl effcct on mobility (Cassidy & Schwnrtz, 1998; Clayton_Smith, 2001;
Clayton_Smith & Loan, 2003).
During the f!/"SI rew years of life AS patients often devetop a distinc�vcly
shoped head, commonly either b/llchyccphaly (0 disproportionately wide head) or
microcephaly(small head size) (Smith el al., 1996; SMdanum el aI., 1997; Lnan
el al., 19990). Facial fentures that may OCCur include a long mouth with widely

spaced teeth, flat occiput, mnndibular prognathia with

a

poinled chin, nnd a

protruding tongue. These chllrllclerist;cs tend to become more pronounced with
advMcing ogc (LIUIIl el al., 19990: Claylon-Smith & Lnan, 2003).
Between 15-32% of adult AS patients become obese, although true
hyperphagia, as found in PWS, isran: (Smith 01 al., 1996; Clayton-Smith l!:. l.aan,
2003). ObesIty

can

lend to ocsoph�SOllI n:flux, and also contribute to loss of

mobility. It is common for AS individuals to show hYJlOPigmr.ntation, i.e� with 0
lighter skin, eye and hair colour than th.ir unaffccted siblings (Loan el 01., 1999n;
Lassie et 01., 2001). However the halt may darken with age, as is common ill the
general populntion (SandMWTI et al., 1997). Older AS paticn!!:U" ofien found to
suffer from strabismus (37.57%), IUld keratoconns (TVa) (LaM el 01., 1996;
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SnnWmam el af., 1997). There is no evIdence ofabnonnal genital development in
AS =s, unlike the hypoplnsia found in PWS, Md puberty occursatthe eJt]ll>Cled
age 8lld proceeds in a nonnal f,,-,hion (Williams el 0/., 1998: Clayton-Smith &
Laan,2003). Females with sevcre ID mny, however, have difficulty dealing with
menstruation DIld many ore prescribed conlrnceptives to control menstrual
bleeding.
2.2.2.3

Behavjoural aspecls

Angelman syndrome was once tenned the 'bappy puppet syndrome',
because of the chllrncleristic gait (Section 2.2.2.2) nnd behavioural troits of
patients (L.nn et 0/., 1999a). innppropriatc smiling or laughter, a happy socIable
disposition, short ottention

span, and W1 easily excitable pcl"SOnnlity ore

present in

most individuals with AS (WilliDIl1s rl al., 1995: Smith el al., 1996; Lnan el al.,
1999a). Even babies bave been noticed loughing during the first fcw weeks ofHfe
nnd this fonn of laughter genemlly continues throughout life, nlbeit at reduced
frequencies (S8lldanDIl1 cl a/., 1997: Clnyton-Smith & LIl.IIlI, 2003). Hypemctivity
nnd excitability are less common in older individuals with AS, who have a betler
conceIltration span thDII YO\Ulger patients (Lnan el 0/., 1996; Clayton-Smith,
2001). A significnnt proportion of AS cases su(fer from sleep disturbances, with
either a reduced need for slccp or abnormal sleep/wake eydes. These abnormal
sleeping habits oflcn improve with age (Smith cl 0/., 1996; SandanDIl1 el 0/., 1997;
Willlams cl 0/., 1998: Ohta cl al., 1999n; Clayton-Smith, 2001: Clayton-Smith &
Lnan,2003).

Many AS patients ore reported to have a foscillation for water, reflective
surfaces, and balloons (Williams el 01., 1995; Clayton-Smith & Lann, 2003),
although the signIficance ofthis behaviour is unknown.
2.2.2.4

Neur% gjcalj/ndlngs
Seizures life present in npproximately 80% ofAS cases during childhood,

with OllBet nonnaUy within the first few years of life. The scizUftS W1l often
difficult to <:entrol, especiaUy in patients where the causative abnonnality
involves the deletion of genetic material (Leilner & Smith, 1996; Smith el al.,
1996: MinDssian " 01., 1998; Clayton_Smith & Laan, 2003). Some studies have
reported a decrease in seizmc frequency during adolescence, but with mMy
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individuals cxperj�"cjng a return oflbe seizures in adulthood (Lean er al., 1996;
SDIldllIHlIII el al., 1997: Clayton_Smith, 2001). By com)lill"ison, other researchers
have descrlbed 11 sllSlalncd decreo.se in seizure frequency 1010 adulthood (Bunlinx
ellll., 1995).
Almost all AS palients have an abnonnal EEG profile, even in the absence
of,.,izure activity (Sandaomn el al., 1997; Smith e/ 111., 1997; MinOlS,ill1l el Il/.,
1998; GUlcsscn-Kocsbnch .101., 1999; Clayton-Smith & Laan, 2003; Valente e/
0/., 2003). A number of specific patterns have bccn identified which may 00
present 01 different limes in the 5aIIle individual.

Many AS children ,how

persistent high amplitude 4-6Hz ,low-wave brain octivity which is nOl llSsocinted
with drowsiness (1IIe delta paltern), although this will often disappear in later life
(Mntsumolo e/ al., 1992; MinElSSi!lIl e/ 01., 1998; Lean el al•• 1999n; LWlII ", al.,
1999b; ValcnlC c/ al., 2003). In older AS patients, prolonged runs oftriphnsic 23Hz rhythm, primarily over the frontal region, have been found

to be more

COmmOn (Loan e/ al., 1996), and spikes ns,oeiated with 304Hz waves across the
posterior area have also becn idenlificd (ClaylOn·Smith & LlI3I1, 2003; Valenlc e/
al., 2003).

2.2.3

Genetic basis ofAngdman syndrome

Table 2.2

Categories ofAogelmnD and Prader-'h,lli syndrome by
genolype

Type ofmecbaDllim

Persoosn(fectcd (%)

MetbylaUoD

Rccurnmce

70-74

Abnonn..1

Very low

�7

24-28

Abnonnlll

Very low

Imprinting centre
(IC) defects

�1O

1-3

Abnonnnl

Significant

UBEJA gene

4-0

.,

Normal

Significant

Unknown

10-20

<I

Nonnnl

...

Deletion
Uniparental disomy

(Ul'D)

AS

PWS

65-75

Adap/edjromJiange/al. (1999)

"

As shown in Table 2.2

(r.

17), the genetic basis of AS has been sub

divided into four main m""honisD�, described below. However, there is also a
signifiCllnt proportion of cases in which no specific aetiology has been dermed,

Md some of these may be eonfu:,ed with n rnnge of mimicking conditions, such as
Rett syndrome or LClUlox..(lnstDut syndrome.

2 U.J

De/Cl/an
Tnble 2.2 (p. 17) indicates that the most coll',mon cause of AS is a--lMb

deletion in the chrlSql l-ql3 region ofthe malemally-derived chromosome, found

in 6S-75% of AS cases (Jiang el a/., 1999).

In oddition 10 this large-scale

deletion, there is a small group ofIndividuals with unbalanced tnmsl()CDtions and
smaller deletions In chrlSql l-qI3.

The deletions

are detooted either by

high

resolution banding, or by fluorescence in-situ hybridisation (FISH) after

n

unipnrentnl methylation pooem husbeen Identified (Williamsel u/" 1998).
The region ofchromosome IS CQmmonly deleted in AS isshown in Figure

2.1 (p 20).

It involves two centromeric break_points (BPl & BP2), and one

!elomeric break point (BP3), with approximately SOOkb between BPl and BP2
(Butler el 0/., 2004). The deletions are thought to result from unequal crossing

over between either complete or truncated CQpies oftheHERC2 gene, which fonn
one set of low-copy repeats at the tclomerie end of the region, and another set at
the ccntromcric end (Ca.rrozzo elol., 1997; Ji el 01., 1999; Mnnn & BnrIOlomei,
1999). The Herc2 gene in the mouse hus no repents, bUI mutntions in this gene
lead 10 a rnnge of defects, i.e., neuromuscular, =retory vesicle and spenn

acrosome defects, andjuvenile lethality (Ji e/o/., 1999).
A recent study found thol a heterozygous inversion between BP2 and BP3

wru; relatively commOn (67%) in the mothers of AS patients with a BP2-BP3
deletion, but a similar inversion was not present in the mothers oflndividuals with
BP1-BP3 deletions or with UPD (Gimelli cl 0/., 2003). It is SUll&ested that the
Bn-BP] inversion, which is present in around 9% of the general population,
cou ld predispo;e to breakage at these specific points. However, lIS the risk of
recum:noe for AS deletions is less than 1% (Jinng el 0/., 1999), the pcnctrancc of
the increased risk of chromosome breakage is likely to be very low at 0.1_0.2%

(Glme11i e/ 0/., 2003).

\.

Figure 2.1 The AS/PWS region of chr15qll-q13
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The common telomeric breakpoint and two centromeric breakpoints are depicted as vertical jagged lines and are separated by 4Mb (distances not to
scale). The imprinting centre (IC) is bipartite, with the cis element required for maternal-to-paternal switching shown as a blue oval overlapping the
SNRPN promoter (deletions in this region cause PWS). The more upstream element of the IC required for switching from paternal-to-maternal is
shown as a pink oval (deletions in this region cause AS). Genes or transcripts known to be paternally expressed are blue, and maternally expressed
transcripts or genes are shown as pink. Transcripts that are not imprinted, or those for which the imprinting status is unknown are not given any
colour. Transcription direction, if known, is indicated by arrows.
Adapted from Jiang et al. (1999) and Meguro et al. (2001)

1.1.3.1

UnlparenJaJd/somy (UPD)
Paternal UPO accounts forbetweeD 2%and 7% ofAS cases (Glenn el aI.,

1997: llang el al., 1999: Lossie el al., 2001; WilIillII\S el al., 2001). The pr<:SCJIOC
of two paternal and no malernw copies of chromosome 15 is oRen a result of
monosomy rescue, i.e., llIe inherilanoc of one paternal chromosome 15 and no
malemnl copy (due

10

n malernal meiolio error), followed by po:<t-zygotic

doubling of the paternal chromosome to correct the IOto] chromo,ome number.
This reS\llts in identi""l pnternal chromosomes (isodisomy) (Robinson el al.,

2000).

UPO may wso result from meiotic non-disjunctioD

spennatoge"esis, leading

10

a trisomIc conceptu,.

during

Loss of the maternal

chromosome 1S (trisomy rescue) then leaves only two different paternally-derived

chromosomes (hetcrodlsomy) (GyRodimou el al., 1999).
A parcntal tmnsloClltioD Or other

structural

rearrng
n emenl within

chrl5q I 1-q13 increase, the likelihood ofrccurrence, due 10 the higher probability

of 0 non-di,junction event (Smith .1 al., 1997; Robinson el al., 2000).
Microsntellitc annlysis ofthe probruld and parents, using markers from outside the
PWSlAS area, will differentiate between UPD and a deletion. That is, if markers
from both parents

arc

pr<:senl, the patient h", a deletion, if not, then UPD is

indicated (Willi""" el 0/., 1998; liang el a/., ]999). The type ofdisomy can also
be di:<tingui'hed In this manner, e.g., if only one type of allele from the father is

found atcaciJ marker, then i,odi,omy is indicated.

1.1.3.3

ImprlnJing<:enJ/"/! (le) defects

As shown in Figure 2.1 (p. 20), the imprinting centre spans the section of
chrISqll-q13 centromeric ofllle S/I'RPN gene (Farber et al., 1999). There are
two components of the le in the cbrlSq] 1-q13 "'gion, with the more upstream
component, the AS smallest region of overlap (AS-SRO), approxim.tely 900bp in
size. This element Is involved in changing the imprint from palernw to maternnl.
Any mutation or delelion that offects this element will lead

to

a malernwly

inherited chromo.<ome llIat has patcrnw marking, and so will nCI as 0 paterna!
chromosome (Sailoh et 0/., 1996; Farber et Ill., 1999; Ohta el 01., 19990).

Imprinting mutations, caused either by the deletion of 011 or part of the le, or
some other mutation, are found in 2-10% of AS cao:es (Rougeulle & lalande,
"

1998: liang el aI., 1999: Lossie cl a/., 2001: Willimn! el a/., 2001: Duitlng et a/.,
2003).
The pres<:nce of an abnormal methylation pattern and biparental
inheritance ofmicrosntellite markers within the PWSfAS region is indicative ofan

le abnormality (JiDJIg e/ aI.,

1999). Almost halfofindividuols with an IC defect

have hud no mutation identified, and It has been suggested thot these defects are
abnormal epigenetic state.!, or epimulatio"s. It also h!lS

been hypothesised that

epimutations arise from spontaneous events during the fertilisation proce,.
(Buiting et al., 2000: Builing .1 aI., 2003).
2.1.3.4

UBEJAgcno
The UBEJA gene has been described as the 'AS gene', and point

mutalions within the gene on the mnlemat chromosome hove been found in 4-14%
of AS potients (Kishlno

.1 aI.,

1997: Jiong el al., 1999: umie el al., 2001:

WlIIiwns el al., 2001). The UBEJA gcne is located downstre.lm ofthe IC and the

SNRPNgelle (Figure 2.1, p.20), and the gene product is a ubiquitin·protein ligase
(E6-AP), which is involved in the degradation ofo nmge ofproteins (Jiang el al.,
1999). In UBEJA patients Ille methylation pattern within Ille PWSIAS region is
normal, i.e., biparenlol, and the ,,"alysis of microsatellites also shows biparental
inheritance. Testing for UBEJA mutations is indicnted whenever there is an AS
pilellotypc, including an abnormal EEG, with normal methylation and biparental
chromosomal inheritance lIS evIdenced by genetic testing (Lnnn el 11/., 1999b).
The IlliIjority of UBEJA mUllltions nrisc d� nova (Matsuum etal., t997), although
there is some evidence for somatic mosaicism of UBE3A mutations in
phenotypicn1]y normal carriers (Moncla et 01.,

(9990).

In vnrious cells of the body, such lIS !ymphocytes, fibmblnsts and cells
from the kidney and heart, UBE3A is expressed from both Ille maternal and the
paternol nIJelcs, although the imprint marker is still present and Ille paternal
expression is reduced compared 10 (hat of the motemal allele (Vu & HolTman,
1997; Herling el al., 2002). However, in parts of the central nervous system nod
Ille brain, especially Ille hippocampal nod Purkinje neurons, UBEJA
only by the maternal

copy

is expressed

(Albrccht et al., 1997; Rougeulle el a/., 1997;

Rougeullecl al., 1998: Ruugculle& Lnlandc, 1998: Mann &. BlU1o!ome� 1999).
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Two altemative UBEJA RNA transcripts have boon identified. One, the
UBE3A sen.., transcrip� was expressed biallcHcally in glial cells in the embryonic
brain, but from only the materna l chromosome in neurons. The other Mtisensc
transcript (UBE3A-ATS) was only expressed from the poternol chromosome, and

only in neurons (Yamasaki er al., 2003). As sholm in Figure 2.1 (p. 20), the
UBE3A-AlS eX!eIJds downstream from the imprinting centre, through the

SNURF-SNRPN Md IPW loci, and ovorlops UBE3A (Runtc er Ill., 2001b;
Rougeulle &. Heard, 2002). There are two alternate splice ""nfigurations of the
UBE3A-ATS, both of which appear to function as suppressors ofthe expression of
UBE3A from the paternal chromosome (Chamberlain &. Brannan, 2001; Landers
el Ill., 2004).

As yet the role played by UBE3A and UBElA_ATS in the

development of the AS phenotype has not been detcnnincd.

It is, howC'l.r,

nnticipated that as more gene products and the interactions between them

nre

identified, the infonnotion mode available will improve understanding ofthe role

of UBE3A in the aetiology orAS.

2.2.3.5

Unknown
In npproximately 10-20"10 of clini<:ally dlagnosod AS patients [fable 2.2),

none of the above genetic abnormalities have been identified using current

laboratory t\l\:hniques. For this reason, cases with biparental methylation and no
identifioble UBEJA mutation nre classoo lIS 'Unknown'. It bas been suggested by
WilIiams and co-workers (2001) that some of these cases m ay DCtually be
dilTerent disorders that mimic the AS phenotype. Possible candidate disorders in

thi, category are Reil syndrome, a-thalasSilemia retardation syndrome (ATR-X),
nuti'm spectrum disorders, any one ofa variety of chromosomal defects, Lcnnox

Oastaut S)IIIdrome, Gurrierl S)IIIdrome, and general dC'leiopmental dol.y
(Williams �I al., 2001; Clayton-Smith &. Loan, 2003).
There is also the possibility that mutations in other, as yet unidentified,

genes which form part of the ubiquitin pathway could lead to either the non
expression of UBEJA or blockage of the pathway at some other point, and thus

result in theAS pbcnotype (Lossle 0111/., 2001; Clay ton·Smith &. Lann, 2003). In
addition, there may be genes within chrlSqll-q13, unconnected to the ubiquitin
pathway, that affect the AS phenotype. One such candidate gene is ATPlOC,
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mapped to 230kb distal of UBEJA (Figure 2.1, p 20), which produces an
aminophospbolipid·transporting ATPase, and is preferentiolly expressed from Ibe
maternnl cbmmoscme in the brain (Hening el al., 2001: Mcguro ct w., 2001).
ATPJOCmay be Implicated in chromosome IS-associatcd aulism, and it may also
influCllce Ibedevelopment ofAS, as Ibe gcne product is postulaled to be involved
in

cell signalling (Herzing el al.,

2001).

However,

in

;lIlmans no e�idence of

mullllion wilbin Ibis gene has yetbc<:n produced (Claylon-Smilb & lnan, 2003).
MOSllicism hilS been identified in some AS palients.

On investigation wilb

FISH, n ca.e of clinically typical AS wilb biparenrnl melbylatIon WIlB

found 10

hove .omatic mosaicism for a deletion ofchrISqll-q13 (Tekin el al., 2000).

It is

possible that funber cases of mOSllicism may remain unidentified because of n
lack ofFlSHlesling afierthediscovery ofa bipnrenllll melbyl.tion pattern.

2.2.4

Genolypdphe1lotyJUl correlations
The phenotype of AS may vary according

mechanism.

deleteriollB

to

phenotypes, while

do!etion

the underlying genetic

le defect

In general, patients wilb UPD or an

have Ibe least

= are Ibe most ..verely

affected

(lossle et al., 2001).
Aogelman syndrome individuals wilb chr1Sql l-q\3 doletions have been
shown to hove lower body mass indice., earlier oruet ofBeizures, and more ..Vere
epilepsy Ihan Ibose wilb UBE3A mUllllions, followed by Ibose wilb UPD and [C
defects (Smilb et

al.,

1997; Minassian el al., 1998;

[999; Moncloet 01., 1999b; Ohta et aI., 1999n).
more severo seizure

Gmessen_Koesbnch et w.,

It nllB been hypolbesised thol lbc

activity found in deletion cases may be due to Ibe loss oflbe

GABRBJ gene which is situated downstream to UBE3A (Figure 2.1, p. 20).

DeletIon cOSe. are al.o more likely to walk �I a 1.ler age than indivldunls wilb
UPD, 1-8 years for delelioa vS <3 years for UPD, allbough Ibe number ofUPD

patients sampled hllBbeen small (Smilb el01., 1996; Smith elal., 1997).
Microcephaly is le�s common in UPD

DIld UBEJA

polients thDII in

deletion cases (Smllb el al., 1996; Smilb el al., 1997; Monel" et al., 1999a;
Moncla et

al.,

1999b). UPD or IC palicnts are more

vocabulary IbDII tho.e wilb

deletioru, UBEJA

likely to achieve a larger

abnurmalitIes, or wilb AS of

unknown ''<lliology (Moncla e/ al., 19990; Monela cl al., 1999b; FridmDII Cl al.,
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2000a; Lossie e/ al., 2001). le patients are more liable to be hypotonic and/or
obese, and to have a mild/moderate intellectual disability. They are less utaxie,

less prone to epilepsy, and have a nomml head circumference (GiUessen_
Kaesbach e/ aI., 1999).

The nge at dingnosis d()Os not seem to be greatly affected by the
underlying genetic mechanism of AS. Deletion patients have been reported with a
mean age at diagnosis of8.8 years, and UPD cases nt6.6 years, a non-significant
difference (Smith et aI., 1996; Smith el al., (997). Other studies confinn that
then:: is no substantlDl discrepMcy in the ages at dingnosis between delction and
non-deIelion patients (Monela el al� 1999b).

It Is thought that loss of the maternal allele of the P gene from the
tclomerie end of chrl5qll-q13 (Figure 2.1), coupled with the presence of a

mutation in the remaining paternal allele, Is responsible for the lock of hair, eye
and skin colouration found mainly in deletion cases. Mutation in the P gene has
been shown to lead to oculoeutancous albinism type 2 (OCA2), an antosomal

recessive disorder in which melanin production in the skin, h.ir and eyes is
defective (li••
llg e/ al., 1999: Snitoh et al., 2000).

UPD patients with

hypopigmentation may have had n palemDl recessive aUele 'unmasked' when it is
present in both isochromosomes.
[n deletion CIlSes it has been suggested that haplo-insumciency, i.e�

deficient gene expression by the lone allele, of any non-imprinted genes in the

PWSlAS region could magnify the effects ofthe lossofcxpression of UBE3A. In
turn, this would lend to the more seVere clinical mEUlifesl.lltion observed in these
=s. Simil.,.]y, the extnl dosage ofp.ltemally expressed genes found in UPD

and le eases may ameliorate the effecta of the loss of UBElA expressIon on the
disease phenotype (Lossie e/ al., 2001). However, there is no obvious renson why
le p.ltients, who have two paternal-type thromosomcs, have PWS-likc fcature,
(obesity and hypotonia) when these Imits occor in PWS patients who have no
paternally mO/ked thromosome ]S (GIll�.ssen-Kne,bao:hel al., 1999).

An even milder phenotype than that generally described for AS pntients
has been reported in n sincle AS CIlSC with UPD, and an additional small
supernumerary marker (SMC) chromosome IS. This patient showed less ataxia

than more typical eases, better communication skIlls, milder seizure activity

(confined to infnncy), and nononl pigmentation (Thomp"'" & Bolton, 2003), The
SMC may have contained genes that were nol present in an active form On the
chromosomes, thus supplying the products absent In those with the classical AS
phenotype.
2.3

Prader-WlIIill)'Jldrome

2.3.1

His/ory andhacAground
This disorder Was first described by P/'IIder, Lnbhart and WilIi in 1956.

Symptoms common to all palients were learning disability and behaviour
problems, hyparphngin and obesity, nnd delayed sexual development (Stale &
Dykens,2000). The genelic basis ofPWS was c1nrified in the late 1980., with
consensus diagnostic criteria published by Holm and othen In 1993.
A mod.1 for PWS has been proposed which represents PWS as a
starvation syndrome, ",ther than one of ove....a
., ting as i. commonly accepted
(Hollnod er ai" 2003). The thOOI)' supposes that the body falsely perceives a state
of starvation when th<: hypothalElIllic pnthwnys thot signal saliety are disrupted.
This lead!i to a similar drop in metabolic lUte nnd gonodotropin release to that
appnrent in !,"ople suffering from nnoroxia nervosa. At the sume lime, n high rate
of ghrclIn secretion ClIllSes desensitisation of the growth hormone secrctol)'
response, suppressing growth hOl1l1one production.

It is likely thal mutations in any genes within the PWS region that disrupt
the functIon ofthe hypotholornus could nccount for the main features ofPWS, i.e.,
ove�ting, growth deficiency, and hypogonadism (HolInnd er al., 2003). In fllC�
a number ofgenes offeeting the development of the paraventricular nucleus in the
hypothalamus have been Identlfied. These include NDN on chromosome t5 and

SlMJ

on chromosome 6, which are both Imprinted genes (NlchoUs, 2000;

Michaud, 2001; Michnud et al., 2001).

As yet there hllS been no positive link

between any specific gencls and the development ofthe PWS phenotype.

2.3.2

The Proder-WllII syndrotmphenotype
Tnble 2.3 (p. 28) lists the PWS diagnostIc criteri... which are divided into

eight major nod 11 minor clements. Most ofthe major clinical signs Il/'C present to
v8I)'ing degrees otall "!les, wherens many ofthe minor criteria an: found only in
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older patients (Holm el 01., 1993).

Lnle identification of the disorder was

common in the past, with 36% of the = studied by Grcenswng (1987)
diagllosed after 16 yelll'S of ugc. However, these IDle diaglloses wc� generally
made prior to the publication ofclinical eri!cria and the development ofdiagnosUc
JabornlOry tests for the syndrome, so thot in general the age at diagnosis is now
decreasing. A number of studies have recruIted only ehildren with genetically
confurned PWS, indIcative of diagllosis prior to adolesCCIl<:e (Lindgren el 0/.,
1998; Houlfa el al., 2000; Wigren & Heimnnn, 2001; Trifiro et al., 2003).

lkve/apme1l/a/ characleris/lcs

2.3.2.1

Young PWS patients usually cxbibil poor suckling abilities, fceding
difficullies, and developmental delay.

Webb Cl 01. (2002) reported 100%

occurn
re ce ofthesc three crileria in their PWS subjects. Developmenta! motor
delay is evidenced by the lalc;r average ElSe ofsiuing unsupported (12 monlhB) and
of walking (24-29 months), although nol all cases are similarly delayed in their
developmenl (Gillessen-Kaesbacll el 01., 1995; Cassidy

&

Schwartz, 1998).

Speech acquisition is also somewhat belated, often inlu the third year of life
(GilIcssen-Knesbach el al., 1995; Clayton_Smith, 2001; Wllliams e/ at., 2001),
and speech articulation defects, found in 19-90% of patients, are common
throughout life (GilIcssen-Kacsbooh el at., 1995; Webb e/ at., 2002; Whiltiugton

el al., 2002).
Mild 10 moderole ID occurs in the majority of cases, wIth assoc:ialed
learning difficullies (Holm el al., 1993; Eiafeld el al., 1999; Fridman c/ al.,
2000b).

Approximately 27-40"10 of PWS cases function at Iow average or

borderline inlclligence JeveI" and 1-19% of ratients

nre severely

intellectually

disabled (Cassidy & Schwartz, 1998; Einfeld el al., 1999; Slnte &. Dyken!, 2000:
Clayton-Smith, 2001; Clarke et al., 2002). Across nIl IQ groups, PWS patients
are found 10 pcrfonn ocademically below the expeclcd level. for their inlcl1!gcncc
rating (Dcscheemaeker e/ al., 2002).
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Diagnoslic "riteM ror Prader·WIW syndrome
(scoreorS points needed)
Major criteria (1 pt .mcll)
Neonntnl and infar,dle hypotonia, wilh poor suckling, improving wllh age
Feeding problcms in infancy
Excessive or rapid weight gain bctween' ] and 6 ycars ofoge: centml obesity in
the absence ofintervention
Characteristic fociol fcab,":, with norrow face, almond-shaped eyes, small moulh
wilh Ihin upper lip, down-turned corners of the mouth, micrognolhia (3 or more
featun:s required to scorn)
Hypogonadism: hypogonadism, Or delayooor incomplete gonadal maturation
Globol developmentnl deloy <6 years; mild-moderate ID in cIder per.;ons
Hyperphagia/food obsession
Deletion at ISql l-q13, maternal discmy or imprinting centre ,,"omnly

Minor criteria (1/2 pt eacb)
Decreasoo felnl mcvemen� infantile lethargy or weak cry
Characteristic behaviour problems _ temper tantrums, violent outbursts; obsessive
behaviour, tendency to be argumentative, appositional, rigid, manipulative,
possessive and stubborn; pe=vemtion (stereotypical actions): lying and stealing
(S or more realures needed to scorn)
Sleep disturbance or sleep apnoea
Short stnture forgenetic background, in the absence ofgrowth honnone lhempy
Hypopigmentation - fair hair and skin compared to fomily
Small hands or reet fcr height age
Narrow hands with straight nlnar border

Eye obnonnalities
Thick viscous saliva
Speech articulation defects
Skin p!cking
Snpportlve nod logs (Dot scored)
High pain threshold
Decreased vomiting
Tempemture instability in infancy, Or altered tempemture sensitivity in older
children and adults
Scoliosis and/or kyphosis
Early adrenarche
Osteoporosis
Unusual skill withjigsaw p�les
Noma! neuromuscular studies
Adaptedfrom Holm et 01. (1993)

"

2.3.2.2

Phy£ical ciwraclerlslic£

The poor suckling and fceding difficulties found In most PWS Infants
(Section 2.3.2.1) are u result of the muscu11l1' hYJl!ltonia gentrally asSOl'iated with
this syndrome (Gillessen-Kaesbach el al., 1995: Fridman el al., 2000b: Webb ot
al., 2002:

Trifrro el al., 2003). HypotonIa in PWS is normally observed in

infancy, but some adults continue to suffer frem low muscle IOnc throughout their
lives. Eating ability improves with uge and pronounced weight gain between the
uges of [2 months and 6 years is a common chlU'llcteristic of people with PWS.
Without intervention, excessive weight gain is one ofthe major diagnostic criteria
(Hohnetal.,

1993).

MIlIIY PWS patients, children and adults alike, have an unusually low
resting metabolic ratc which appears to be related to the obnorma] fat mass to lean
moss mtio found in the disorder (Carrel cl al., 2002). Young underweight PWS
patients hove a greater proportion of body fat thllIl healthy children at W1y
p'lrticullll' body mass index (HMI), and this is 01,0 apparent in older, obese PWS
children (Brnmbilla e/ al., ]997: Eiholzcr ct al., ]999). In fact, the ratio of lean
body mass to fat mass is lower in PWS cases of aU ages than in both obese
controls IlIld normal weight controls.
The unusual oody composition In patients with PWS can be improved with
growth hormone th�rapy, which decreases the percentage of body fat SlId
increases that oflean body moss, thus resulting in an ineTCllSed resting mClabolic
rate (Davies el 01., 1998; Lindgrcn et al., 1998: Lindgren & Ritun, 1999: Myers
Cl al.,

1999: Carrel el al., 20D2: Hoyby. et al., 2003; Paterson & Donoldson,

2003). The combination ofhypotoni.. low metabolic rate and lack ofactivity, 011
of which arc associated with PWS, mny help to explain the apparent low caloric
requirement of patients. Extremely re,trictive diets have been found necessary to
control weight goin in many PWS patients (Hoffman el al., 1992: Cossidy &
Schwartz, 1998: Gold'tone el al., 2002).
The obesity that gencrrJly results from uncontrolled eating

can

significantly inc=e morbidity and mortnIity mtes in PWS paticuts (State

&

Dykens, 2000: Clayton-Smith, 2001). However, with effective weight control,
patients with PWS can survive inln thuir gib decade (GreenSWDg, 1987; Cnrpenter,
1994). Among the morbidities associated with excess weight DIe limited mobility,
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cardi"'pulmonory disease, leg ulcers, and diabetes mellilus, any Or all of which
can lead

to

increllSoo hospitnlisation and earlier deo.lh (Grcenswng, 1981;

Goldberg el a/., 2002: Hoybyc cla/., 2002). Diabetes was fonnerly thought to be
p=nt as a major health risk for PWS cases, bowever, there have been more
re""nl reports which suggest thal the preYulen"" ofdiabeles in PWS mny nOI be as
bigb as previously belleved (Greenowas, 1987; Goldberg c/ of., 2002: Hoybye el
0/.,2002).
Most PWS palients are reduced in stalure when compared to relatives.
This Is thought to be primarily due to the absence of 11 nuturally-occurring
pubenal growth spurt, although birth weightsand lengths hayebeen n:ported \0 be
lower in PWS

cases

than in healthy infants (Gillessen-Kncsbach el a/., 1995:

Cassidy cl of., 2000: Slate & Dykens, 2000). Growth hormone (GH) treatment
hllS been used to inc","",e the growth velocities of PWS children, with partial
success (Dov!.s cl a/., ]998: Lindgrcn el 0/., ]998: Lindgrcn & RlIzen, 1999:
Mycrs el a/., 1999: Carrel el a/., 2002). This therapy

CM

also minimise Ibe

de....lopment ofthech!lnlcteristic facies, improve respiratory Dlld musele fUoction,
and reduce depressive symptoms, especially in individuals over 1 1 years of age
(Lindgren elof., 1999: Myers el al., 1999: Whitman el 0/., 2002). In addition,
children younger than 1 1 year.; \end to show less deterioration of hehaviour after
treatment ibM is expected ofPWS patients (Whitman elal., 2002).
Specific facia] features arc often present in individuals with PWS. These
fOlllUres include dolioccpbaly (a relatively long head), almond-shaped eyes, small
bifrontal diwnetcT, a thin upper lip in 0 smoll mouth, and/or down_turned corners
oflb. mouth (Laumncc .1 0/., 1�81; Holm.1 a/., i993). Howtver, one study
found thal only 49% ofPWS cases had the characteristic facies, making this onc
ofthe least sensitive major criteria for the disnrder (Gunay-Aygun e/ al., 2001).

[n Itnly, 57% ofPWS ncanal.shad thrc:c ormore ofthe cr.miofanial features, with
a further 28% ofcam showing two features (Trifiro el 0/., 2003).
Genitnl hypoplasia and/or delayed or incomplete gonadal matumtion

nrc

commonly found in PWS palients. Male cases frequently exhibit undcsxndcd
testes

and/or a small penis (Grecnswae, 1987: Wcbh el 01., 2002: Trifiro el 0/.,

2003). The presence of these highly vi"ible signs of hypogonadism in moles
fncllitates dingnos;; in childhood, unlike fem.les who often lack visible signs of

genil.Eli hypoplasia (Smith er al., 2003; Trifiroel 01" 2003). Primary nmenorrhoea
is the most commOn sign ofhypogonodism in remoles, with 60% ofWOmen never
reaching menarche. Individuals ofboth gender generally undergo delayed and
incomplctc secondary sexual development (Crioo elal., 2003).
In \\'(lmen with some history of menses, Ule majority report delayed or
irregular periods (Greensw'g, 1987). There have been several pope.. r"""rtmg
fertility In female PWS cases. although only two of the five mother.; had an
nnequivocal genetic diagnosis (Hockey el al., 1987; Akefeldtel al., 1999; Schulze
elal., 2001). Ofthese two women. onC hod a maternal UPDand her child showed
no nbnormality, due to the transmission of a nonual maternally-imprinted
chromosome from the mother (Akefe1dt el al.• 1999). The other individual was a
deletion case who save hirth to DD infant with AIlgelman syndrome, because the
deletion was inherited 00 the motemal chromosome (Schulzc elal.• 2001).
Strabismus occurs in 58-75% of PWS cases (Gillessen_Kae,baoh ef al.,
1995; Cassldy & Schll'llrtz, ]998; Cassidy el al.• 2000; Whitlington elal., 2002).
Hypopigmenl.Eltion also is found in m3JIY PWS patients, especially those with the
COmmOn deletion in chrl5ql ]-q13 (Gillessen-K.esbach

., al.,

]995; C!l5Sidy &

Schwam, 1998; Cassidy elal., 2000). In similar fashion L lbe AS deletion., the
PWS deletion also includes the P gene (Figure 2.1, p. 20), associated with the
pigmenl.Eltioo ofhair, skin 1lJld eyes. A single mi,sense mul.Eltion in theP gene on
the m.tema! chromosome in a PWS patient thus affects the functionality of the
gene product DIld results in DCAl (Lee el al., (994).
Scoliosis has been found in 34-75% ofPWS cases entering adulthood, and
its progress appears to be unresponsive to OH therapy (Lourance el al.• 1981;
Cussidyel al., 2000; Cnm:1 el al., 2002). In addition, o,teopoenio or o<teopolOsis
oetllfS in 75% ofadults with PWS, possibly as a result ofhypogonadism which is
o known risk faclor forost""polOsis (Hoyhye elal., 2002). It has been established
that bone mineral density (BMD) tends to be lower in PWS patients than in age
and BMI-matched obese individuals (Brambilln el al., 1997). Although initial
studies reported no chEUlge in BMD after one year ofGB therapy, an improvement
has been achieved In PWS children after a 4-ycar course of GH treatment
(Lindgren tlal., ] 998; Carrel el ai., 2002). The widespread incidence ofscoliosis

oodfor os\Coporosis in PWS contributes to the reduced

mobll!ly found in m.'IIy

adults with the syndrome.

A number ofth. ciJlI/'llcteristic features ofPWS arc thousht to result from
the intemJplion of correct hypotha]amic function. Growth hormone production is

regu]ated from the hypothalmnus, lIS

is the satiety signa]

which appears III be

dysfunctional in PWS p.ltlenlS with hyperphagia. It has been hypothesised that
the complU'lltivc lack ofl= body tissue, which ilsclfrelates to GH deficiency, is
associated with the development of many of the features of PWS, i.e., the
proscnce ofhypotonia, low resting melabolic rate, poor fcoding in tnfWlCY, Md the

law calo;ic requirement that appears to be typical ofPWS patients (Brambilla el
a/., 1997; MorIin el al., 1998). Further research into the effects of OH therapy
should aid understanding ofthe role played by the hypothalamus in the production
efth. PWS phenotype.
1.3.1.3

Behm>iouralaspec/s
A]though hypotonia, low metabolic rate

""d inactivity oil

contribute to

obesity in PWS, ultimately the weisht gain is caused by hyperphagia, i.e�

compulsive

eating

and food obsession, which

is present in most PWS patients

(Einfc]d el al., 1999; FridmM el al., 2000b; Gnnoy-Aygun cl a/., 200];

Russcll &

Oliver, 2003). Foodand other [css paiotable materials, such as dog food or food
scraps, oflcn need to be locked out ofreo.ch in no effort to control patients' eating
urges (Lnlll"lc
ll1 eel 0/.,

]981).

Tests of the eating behaviourofPWS pntienlS compaled to those ofobcse

and norma] weight subjects have revealed that PWS individuals tend to eat for a
longer timc thnn either ofthe other two groups nod with no diminution ofeating
1lIte, probably due to a

rook of satiety response.

The rote offood comumption

exhibited by the PWS individuals was lessvaried,with no difference between the
IlIte of eating at the beginning ofthe session

nod the rate at the end of the session.

It therefore appear.; that PWS individllllls do not exparicnce the snme intensity of
hunger signals as control subjects

(Undgnm 01 al.,

2000).

Simil.rly,

PWS

subjects are likely to cboose a larger qunolity of food, regardless of their
preference rating for thnt food, even when the lalger quantity comes only after a
limc-<lelay (Joscph el al., 2002).

These results support the theory that PWS

"

patients suffer from lack of satiation rnther than hungerpe� se (Holland �I al.,
2003).
A Food-Related Problems Questionnaire (FRPQ) hllS been developed in

the U.K. which can help

10

ehnrncterise ,,"oh individual's responses to food

(Russcll & OHVCf, 2003). The three mnin

nrCIIS

covcred are preoccupation with

food, impairment of satiety, nnd composite negative behaviours (i.e., taking
nndlor storing food, the eating ofincdiblc items, Md inappropriate respon� when
food is not occ:essible). When the FRPQ is used there is slgnifiCDllt variability in

the rerolling scores between individuals with PWS, which may help thernpists to
provide appropriate programs to alleviate the specific behaviour patterns of each
person (Russell & Oliv�r, 2@3).

The range or minor criteria often seen in PWS subjects is listed in Table
2.3 (p. 28), and include, both biologicn] Md behav;ourol troits (GreensWllg, 1987;
Holm e/ al., 1993; Einfcld e/ 01., 1999; Fridman cl al., 2000b; Webb cl aI., 2002;
Whillington cl aI., 2002). Daytime sleepiness is reported in many PWS enses, and
this is genernlly unaffected by weight loss. However, both sleep opnoea und
obstructed breathing are onen relleved when body weight is reduced (Gillessen
Knesbach el al., 1995; Hanis & Alien, 1996). Skin picking is common in
individll.llls with PWS, often commencing before the oge of 7 years.

The

behaviour mny be episodic, i.e., occurring once or twice a year, or it may be more
frequent.

In either case the behaviour nsually persists throughout life.

Complicntions such lIS cutaneous infections mny occur, and similar behaviours,
e.g., hair or clothes picking, are oncn found in conjunction with skin picking
(Wigren & Heimann, 2001).
PWS patients, csJ=ially those with UPD Md/Or with modcralC to severe
ID, are prone to the development of psychoses Md other mental disturl!aJlccs in
adulthood (Clarl<e el al., 1998; Verho.vcn el al., 1998; Boor ./ a/., 2002;

Dcscheemackcr e/ al., 2002; Verhooven cl al., 2003b, 2003a). Psychotic episodes
tend to be preceded by a specific event, c.g� loss or the threat of loss, a change in
life situation, or the introduction oh strict diet regime (Vogels er al., 2004). It
has been suggested that there moy be a mnlCmnlly CKplCSsed gene within
chrlSqll-ql3 that results in a gene dosage eITeet when present in two ReliVe

copies, as is found in UPD. There is, however, no identified gene in the region

which tall be prediclcd

to

affect the bmin chemistry sufficiently to Induce

psychosis (Smith, 1996).

pws·/ikephenotype

2.3.2.4

In the U.K.,

PWS-lik� patients with no genetic <:onfilT11ltion
l
of

the

syndrome were lISSesSed and comporcd to those with a genetic diagnosis of PWS
(Wcbb el al., 2002).

The results showed that most oCthe minor criteria ofPWS

andsome ofthe major eriteria were present in slmilEIT proportions in both groups.
Hypotonia at birth, feeding difficulties in infElllCy, and genital hypopia5i" were all
more frequent in true PWS than in thosewith a PWS-likc phenotype. This would
suggest that these criteria are ofgreatest application in diffel'e!ltinting PWS from
other disorders associated with

develcpmenl:l! delay,

hyperphagia, and obesity

(Webb el al., 2(02).

M�r/allty In Prmler-Wil/i syndrome

2.3.2.5

The m.in causes of mortality in 8 series of PWS cases varied with age at
deall! (Sehrander·Slumpel
13),

six

el al., 2004). In the younger oge sroup «

children died

from

ncute

hypoventilation. two from gostrointestinal

rospimtory

problems

infections,

S yoars, n
three

�

from

associated with fever, one

from a parapharyngcal abscess, Md onc from accidental cnuses. None of these
disorders

are

normally associated will! obesity, as would be expected at the

younger ages where typically there is no huge increase In weight. Among the
group of 14 subject. aBed nine years or older,

Individuals Were

the

causes of death for four

respiratory complaints, four had cardiac disenscs, three had

gastrointcstinal disorders, and onc each were due to carcinoma, a stroke and spinal
myelitis. There is a credible link between obesity and some of these causes of
death, notably Cllrdiac complaints and stroke, as PWS cases in this age gronp are

very likely to be overweight (Palcrson & Donaldson, 2003: Schrander.Stumpel el
al., 2004).
2.3.3

Gonl!l/c baslsfor Prader-WIIIIsyndrome

2.3.3.1

DeletiDn

The

vast majority of PWS cases show an abnonnnl methylation

when tested (Fridman el

al.,

pattern

2000b: Glenn el al., 2000; HMe! & Wevrkk, 2001b).

As is the = with AS, the major mulntion associated with PWS Is 11 deletion in
chrISqll-13, although in PWS the affected chromosome Is Inherited from the
father (Tablc 2.2, p. 17). Between 70-74% of PWS subjects have the - 4 Mb
deletion which shares the common break points (Figure 2.1, p. 20) wllh the
deletion thllt cauSe,j AS (GilIessen-Kaesbach d al., 19%; G!enn el a/., 1997;
Cassidy el al., 2000).

At !east seven cases of somatic mosaicism for PWS

deletion have been recorded in the literature (Matzoc 'l al., 1998), and there may
be difficulty in identifying these cases, as the methylation pattern often appcllfS to

be biparental. FISHtes!ing is most elTective at identifying somatic mosaicism. as

wcll as more common deletions.
2.3.3.2

Uniparental d/somy
Mat.mIIl UPD!5 accounts for24-28% ofPWS = compared to 2-7% of

AS subjects (Table 2.2. p. 17). reHecling the greater likelihood ofnondisjunetion
during oogenesis than spermatogenesis (Gleon el al., 1997; Cassidy & Schwartz,
1998; Cassidy el a/., 2000). The increased parental age lISSOCiated with matemal
UPD could be related to the fact that older women

ore

more prone ta defects af

oogenesis than younger females (Gillcsscn-Koosbach el al., 1995; Fridman el 0/.,
2000b). Almost a quarter cfthe maternal UPD cases investigated by Robinson el
al. (2000) were shown to result from post-zygotic rescue ofa trisomic conceptus.
resulting in heterodisomy.
A similar case with mutemn! heterodisomic UPDIS was also fouod to
hove 11 SMC IS. The phenotype WIIS typical of PWS, with the addition ofearly
onset Type I diabetes (Horelina el al., 2004). Mosaic trisomy 15, in conjunction
with makmal UPDI5, has been reported to produce a severeversion ofPWS with
an incrensed risk of congenital heart disease. Incomplete trisomic rescue is the
mechanism that ha<; been proposed in explanation oflhis phenomenon (Olanderel
a/.,2000).

2.3.3.3

Imprinting centre de/ecls
le abnormalities are present in 1-5% of PWS, including most of the

families within which there have been two or more "lTected individuals.
DeIelion" in the IC, which

occur

in 14% of PWS

cases

with IC defccts, hove a

recurrence risk ofs()%, making correct identification ofthe genotype an important
34

genetic counselling 1001 (Sailoh el al., 1997: Cnssidy & SchwDrlz, 1998:
Rougeulle et Lalande, 1998: Builing el al., 2000: Buiting el al., 2(03). The PWS
section oflbe le is localed just upstream ofSNRPN (Figure 2.1, p. 20), and any

disruption ofIbe le eliminates rescUing of the imprint from matemol to palcmnl
in Ibe male germ-line (Snitoh el al., 1997: Buiting el al., 2000). The PWS-SRO

has been narrowed to a 4.3kb section ofchromosome which contains both SNURF
Md the promoter region for the SNRPN gene (Saitoh el al., 1996: Ohta el al.,
1999b).
2.3.3.4

Single gone dc/eels
As shown in Figure 2.1 (po 20). then: nn: seve/lll genes in the chr15q]].

ql 3 region thot ore solely expressed from the paternal gene in some tissues, and
SNRPN, JPW, MAGEL2 (NDNLI), NDN and ZNFJ27 (olso known os MKRN3)
have all been considered as candidate genes for PWS (Snitoh dol., ]997: ClISSidy
& Schwnrlz, 1998: Cossidy el

01., 2000: Lee .1 al., 2000: Hanel

& Wcvrick,

200]b).
There is some evidence that CIlmplete transcription ofSNRPNwill prevent
development of the PWS phenotype (Kuslich cl al., 1999).

Experimental

treabnent of SNRPN with 5-IWI·dcoxyeytidinc, an inhibitor of methylation, has
resulted in reactivation of expression from the previously silent allele (Falmer
Smentck& Francke, 200]). However, the dcmethylation wos not accompanied by

acetylation of the H3 and H4 histones in the region, contrnry to the findings of
other wOIkers who hove successfully reactivatod the nllele (S"itoh & Wad.,

2000). Asyc� reactivatIon ofSNRPNhM not bcen tested In vivo for suitability as
a thc/IIpeutic measure to alleviate the PWS phenotype.
Th� SNURF-SNRPN locus

i.o; compl.", and

III

least four functions

are

em:oded within this area, including part of the PWS imprinting centre whieh is
overlapped

by SNURF.

ExoM 4-10 of SNRPN encode a core spliceosomal

protein (SmN) that hosan active function in brain ti.o;suc involving mRNA splicing

(Gray cl aI., 1999). In addition, there arc a number of altemotive splice sites
within SNURF-SNRPN, including many within the nnneeding exons lOa-20
(Wirth elnl., 2001). The alternate 3' transcripts produced fromthese sites moy be
the soun:e ofother proteins, such lIS th.t producod by the HDII·8S snoRNA (smat!

3S

nucleolDl RNA) gene cluster, the HBIl-438A snoRNA gene, IUId theJPWcene (de
loo Santos el al., 2000; Gallagher el al., 2002). Fnrther elucidation of the roles of
these different transcripts will be ofpotential interest to researcher.; ofPWS.
The 2.2kb sillgle""on gene NDN encodes a protein, NECDIN, from the
MAGE family (Figure 2.1,

p. 20). This protein is in�olved in the regulation of

cell proliferation, ond it can bind to a number ofdifferenl transcription factors. It

is imprinted in humDll.S ond mice, with the mmemol ollel. lelativcly
hypermethylated in all lissues, and highly methylated in the blllin (!..au et al.,
2004). The result is that NDN is prefercntially expressed from the paternal allo1e,
with high levels ofnctl�ity in the developing hypothalamus, which is llSsocioted
with a number of phcnotypic features of PWS, e.g., hyperphDgia and lack of
growth honnonc (Sutdiffe el 01., 1997; Lee
Knepper, 2001).

&

Wevrick, 2000; Nicholls

&

Disruption of necdin production in mice leads to the

dcvclopmlmt of reduced

number.; of oxytocin-producing cells in the

pamventricUlar nucleus of the hypothalamus, a region that contains

0

critical

regulator of appetite (Michuud, 2001).
In a similar f..,hion, MAGEL2 is monoallelically expressed from the

]IIIternol chromosome in tissues of the central nervous system (Hnccnccio Cl al.,
1999). During development, high levels of exprcSiion

are

found in sites thut

include the hypoLhalnmus, the first branchial arch and tongue, the gcoillll

tuhereule, the limb buds, and the otic vesicle. Characteristics of PWS that arc
connected to these

areas

of exprcsslon include, hyperphagia Md shor! stnture

(hypothaJamus), lIItlculntion defects IUld thick salivo (tongue), hypogonadism
(genilal tuberoule), small hands and feet (limb buds), and eye abnormalities (olic
vesicle) (Lee elal., 1000).
ZNFI27 encodes . zinc-finger protein which may have a function as a
ribonucleoprotein, IUld is cxpressed only from the paternal Dllele. Figure 2.1
shows thal ZNF127 overlaps a second gene (ZNFI2AS) which is transcribed from
the antisensc strand, producing a dilTerent protein albeit of unknown func!!on
(Jong cl al., t999).
None ofthe mollSC models that possess only a single, patcrnally_inherited
Snrpn, Ipw or Zfpl27 gene have shown an identifiable PWS phenotype.
However, Ndn-deficlent strnins hove givlm variable results; one showing no
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abnormal phenotype, the other exhibiting a failure to thrive and a lethal
respiratory cefcct (Hanoi & Wevrick, 2001 a; Michaud, 2001). Since no speciilc
gene ha>; been positivdy identified as the cause ofPWS" i1 is inferred that PWS is
,
a contiguous r.,cne disorder, Le., there Is more than onc gene arreming the
syndrom� phenotype (Nichol1s& Knepper, 2001).

2.3.3.5
A smal! minority of patie,lls with the PWS phenotype lack ."y of these
three major forms ofchrlSql l-q13 defecl. In infancy, PWS shares some feature�
with Down syndrome, trisomy 18, !lIld hypothyroidism. Simil!lfly, a number of
different syndromes, e.g., Sot03, Wilson_Thmer, Cohen, and Bnrdet-Biedel, lIS
well !IS hyperinsulinism and growth hormone deficiency, all have similar
phenotypes to PWS as it manifesls in older children (Nolan, 2003; Delme &
Mlchaud, 2004). Many of the PWS diagnostic criteria, i,e� neonnlnl hypotonia,
infantile fceding difficulties, obesity after 2 years old, nod facial dysmorphism,
arc also pre,;ent in persons with a deletion of the paternal allele of the SIMI gene

at chr6qI6.2 (Falvro el 01.. 2002).

The

SlMJ

gene hllS been linked to the

development of lhe parnventricular nucleus of the h)'pothalamus, nod mouse
studies indicate tlw.1 haploinsufficiency of the gene leads to the PWS-Iikc
phenotypo (Miehaud Cl (11., 2001; Delm. & Michaud, 2004). In addition, certain
X-chromosome abnormDlities, e,g., Klinefelter's syndrome, Fragile-X, nod
supemumerury X-rnmker chromosomes, also show some of the choractmistics of
PWS (Monaghan el (1/" 1998; Stratakis, 1998; Delme & Michaud, 2004).
Individuals with a PWS-likc plu:notype ."d normal methylation patterns should
therefore be elllliltl ncd carefully for any ofthcse mimicking conditions.
The presence of a moternal interstitial duplication of chr15qll-ql3 has
been linked to a separate phenotype which shor.s some features widl both PWS
and AS.

Indlvldllllls with these dUplications have developmental delay,

intellectual hnodicap, speech delay, and some autism-like chamcteristics. MElIlY
are prone

to

seizures, display unprovoked laughter, make involuntary hond

movements, and arC hypotonic.

Growth retardation and hypogonadism are,

however, not features of this phenotype (Repollo �I al., 1998; Thorn", �I (1/.,
1999). Thesc choracteristIcs arc similar to those exhibited by individuals with
SMCl5 (Webb elw., 1998),

Gl!IIotypdphenotype corre/QtJlms

2,1.4

It was believed that there were nO phenotypic differences between PWS
patients with chrlSqll-q13 deletions and those with upn and IC defects
(Greenswag, 1937). However, the mean birth weights and birth lengths ofinfants
with adeletion moy be larger than ofthose with UPO (Gunay-Aygun etal., 1997),
eVen though preVious re;earch had indicated larger birth weights for non-dcletion
cases and similar birth lengths (Gillessen_Kacsboch et al., 1995). As the lalter
study included both upn and IC patients, the conclusionsdrawn from the two sets
of results were not necessarily contradictory. In fact, no significant differences
have been identified between the standard deviations of measurements of height,
weight or body mass lndeK in PWS patients diagnosed with the three different
types ofPWS defect, deletions, UPOand lC (Haulfuet 01.. 2000).
Compared to pattents whh a deletion, especially femules, the mean age at
diagnosis is significantly higher for individuals with UPO. This probably reflects
the milder phenotype oJlcn reported for upn patients compounded by the
difficulty ofrecognising femule genital hypoplasia prior to pubeny (Cassidyel al.,
1991: Gun"Y.Aygun clal., 1997: Cassldy & Schl'o'lllU, 1998). Speech nrticulation
defects are olso more commOn in PWS cases resuiting from. ddetion (Cassidy cl
al., 1997; Webb el 01., 2002).

Two of the physical features of PWS that are mOre common in deletion
patients

are

an increased frequency of the 'typical' fadal features, and of

bypopigmentntion (Gillcssen-Kae,b.ch el al., 1995; Cas,idy & Schwnrtz, 1998).
Individuuls with a deletion are more likely to present withbYl"'rphagia at an early
age and excessive skin picking. They also exhibit n higher pain threshold than
non-deletion cases (Cas,ldy el al., 1997; Cassidy & Schwnnz, 1998; Fridmilll el

al., 2000b; Webb el al., 2002). Many PWS individual, with " delClion arc
purported to sbow superior spatial skills, e.g., in solvingjigsaw pU7Zles, however
these reports bave been largely confined to adults (Cossidy elal., 1991; Cossidy &
Schwartz, 1998; Webb el a/., 2002).
Patients with " deletion between BPI and BP] have been descnbed as
having greater difficulty In control1lng their compUlsions, whether regarding foad
intake, dully routines, or obsessive tendencies, than those with a BP2-BP]
deletion. This observation has been interpreted as suggesting the presence of a

gene in the region between BPI nnd BP2 whioh exerts some effecton compulsive
behaviour:s (Butler et al., 2004), although no such gene hos been identified.
Maternal UPO increases the probability of psychotic episodes in
adulthood, with heterodisomy elevating the risk to a greater degree than
isodisomy (Clarke et al., 1998: Vernoeven el al., 1998: Boer et al., 2002;
Descheemackerel al., 2002; Verhoevcn elal., 2003b, 20030). The reason for this
finding is unclear, although the hypothalamic dysfunction associated with the
PWS phenotype hns been linked to the development of bebnviourul and
psychopathologic.1 abnonnalitics (Vcrhoevcn el al., ]998; Vcrhoevcn el al.,
20030). ]fthis prove� to bethecase, theromny be ogene (or genes) that arlvem:ly
affect the development of the hypothalamu" or a pathway that affects mentnl
health.

However, eKpression would only be observed when there were two

different functional allele"� insleod of the single functional gene found in non·
affected people, or in the CllSe of the total lack. of functionality found in PWS
cases with a deletion or on

ICdefect, i.c., a gene dosage effect

�ummary

2.5

The dise..e phenotypes of AS and PWS vary ccnsidernbly, both between
and within the two disorders.

The variety of physical and behavioural

characteristies commonly found in individuals with AS or PWS may be attributed
10 the differences between the specific underlying genotypes. There bos been only

limited informallon available as to the effects of ageing on either disease
phenotype or on the common morbidilie, fneed hy people with AS or PWS.
There will, however, be some health Issues that

are

universal

la

many ageing

people, enoompassing the wider ID populace and tho� with PWS or AS,
including visual or bearing impairment, restricled mobility, ond co-morbiditles
associated with obesity. In nddition,thcrc arc some conditions, commonly found
in people with ID, thal are likely tu be frequent among those with AS nod PWS,
e.s., high rates of respiratory diseases, seizure activity, psychiatric disorders and
dementia.

The existence of morbiditles specific

10

either PWS or AS ha.';,

however, been R matter for conjecture.
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METHODOLOGY

3.1.

The data sources
The Disability Serviccs Commission (DSC) ha!. been Tespon.sible for

providing services to Western Australians with ID .ir,c<: 1953. Any individual
refemd 10 DSC during the IIlSt 50 years h.... nIl oleclronic record stored in the
client database, which until June 2003 contained diognostic nnd demographic
informalimt on over 15,000 persons. Clients

are

referred to DSC for initial

assesm
s ent from a variety of sources around the stale, including hospitals,
specialist physicians and general pmctilionets. Referrals also may be made by
fllIllily members on behnlf ofpeopJe will! inteUectuBl lu!l1dioap.
Historically. clients hove been offered regular appointments with DSC
physicians who provide an assessment ofnced and oITer advice about disability
reloted services.

In addition to the DSC client database, paper records are kepi on

each e1icn� including information on medical, ollied health care, w:commooat;on,
und psychologicnl assessments, and geneml correspondence relating

10

each

client's hcalth care needs.
Demographic data recorded electronically at DSC Include se", dote of
birth, contact

details, type of residence (e.g., complete residential care, group

home or family home), lIl!lIillll status, employmentsllltus and ethnici!), (Appendix

I). Diagnostic variable! that are coded include the clinical dingnosis, level of
severity of ID, and additional co-morbidities such lIS congenital malfonnations,
SCnlDI)' disabilities, and any DSsociated physiCllI disability. lnfonnotion is also
included ifo genetic aetiology

is suspected, and whether any psychiatric condition

exists (Appendix 11). This IlISt field tends to be limited in its interpretation and
only indicates whether a person has 0 behaviouml, ncurotic or p,;ycitotic

component to their presenllltion.
The electronic Wld paper records for individuals are sometimes incomplete
due to varied contact ofthe client with DSC-based health care workers Md the
age ofthe client. The quality ofdata collection has also been otrcded by changes
in infonnation col1ectlon prnctices since the inception of the database (Megahey,
1996).
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3.2

Record linkage

3.2.1

Oven,iew of the Data Linkage Unit
In addition to analysis of the DSC electronic and paper records, health

information for each AS and PWS case was obtained by record Iink.age to the core
datasets held in the Western Australian (WA) Data Linkage Unit.

The Data

Linkage Unit was established in 1995 and is supported by the Health Information
Centre in the Department of Health, the Centre for Health Services Research at
the Unjversity of Western Australia, the Telethon Institute for Child Health
Research, and the Centre for Health Informatics at Curtin University of
Technology (Figure 3.1).

Figure 3.1 Truncated structure of the data-linkage system in Western
Australia

Core data sets

Commonwealth Data
Systems

Hirth
Registrations
1974-2003

Busselton Surveys
1966-1987

Hospital
Morbidity Data System
1970-2003

Road lnjury
1987-200)

Deaths
Registry
1969-2003

Red Cross Blood
Transfusion Service
1995-2002

Mental Health
Information System
1966-2003
Cancer Registry
1981-2003
Midwives Notifications
1980-2003

Research databases

Other State data systems

Disability Services
Commission
1953-2003

WA Electoral Roll 1988-2003
Silver Chain 1993-2002

WA Data Linkage System structure as ofMay, 2003
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The method "",ployed fur record Ilnkol1e involve" the probnbilistic
matohing IlIld clerical reviews ofhealth records from the six con: dntasels listed in

Table 3.1, using vital information such as names, addresses and daleS of birth
(Holman ., al., 1999). There an: three basic Sleps 10 the process of linknge.

Records that !mve 0 potential n:lntioru;hip are filSl col1ected into 0 block, IUld in

the second SInge they are m&tched to determine ifthey an: likely to be rel.ted.

the third singe, the matched records an: linked

In

for W1wy s l s of the information

pertaining \0 o:nch individual (Holrrum el al., 1999). During the post ten years, the

Data Linkage Unit has relined the system of linking the various health database"
in WA, and the process is estimated to be at least 99% DCCumtc.

Toble3.1 Time-.paD ot....,otd.'l trom tbe sb core datasets orlbe Data

Uokage Uoit

Mental Health Information System

1966·present

Cancer Registry

19a1-present

Midwives' Notifications

1980-present

Adaplodfrr;m Holmonel al. (1999)

Th� core dQlas�1!i

3.2.2

As pnr\ ofa wider project on ID, wl clients registered at DSC since 19SZ
were linked to four of the core damsels (Hospital

Morbidity Data System

(HMDS), Ikath Registry. Menlol Health Informalion System (MH1S) IlIld Cancer
Registry)

10 obtain infonn.!!on

on health history. Extroction of the data from

these datascts was completed in 2002.

1.2.2.1

The H(JSpll�1 Morbid/I)! DaJa Sy$lem
The Hospital Morbidity Data SySle (HMDS) has
�

been

aclive in WA

since 1970 10 monitor IlIld record moTe thari. 12 million episodes ofacule can: in
,,
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public ond privnte hospital!, and free-standing day hospitals throughout the Stote.
Information on the principal reason for admission ond 11 variety of co-morbiditics
is sto� in the HMDS.

The HMDS contains up to

21

diagnostic IIlId I I

procedure codes for each admission, ond it is this information th"t w"-' used to
identifY physical morbidity among the AS IIlId PWS clients. Diagnoses Il1C stored
according to the coding sysk:ms of the Intem.tional Classification of Disease
manuals, !ermed ICD·8, lCD-9 and lCD·]O codes (World Health Organization,

]967; World Health Otgnnis&tion, 1977-\97B; World Health Orgllllization, 1992·
cl994). To fll.Cilita\e onalysis, records were updated from the earlier systems to
their equivalent in the ICD·lO coding system.
1.2.2.2

The DemJu &gir,ry
lbe Deaths Registry provide. infona.tion on the dole, place Md cause of

death of individuals whose death WIIS regIstered in WA since \969. The dol.!! for
the Deaths RegislIy were obtained directly from the Office of the Registror
Geneml, Md in the study the Deaths RcglslIy was used to supply additional
infornllltion on mortnlity nmong the members ofth. study group.
1.2.2.1

The Menial Heallh In/annallon Syslem
The Mental Health Information System (MHIS) contains records of an

contacts for WA residents with the Mental Health Service since July

1966.

The

System consists of !Wo separate datnbases - inpatients and outpatients. The
inpatient data cover nU acut. public nnd private hospitnl admissions due to menta!
health conditions, IIlId all admissions to designated psychiatric hospitnls,
authorised psychiatric hospitals, residential progrums and units, and psychiatric
host.ls and nu-sing homes. The outpatient datn encompass all public p,ychiatric
outpatient ond community mental health �rvices in WA.
The data stored 00 the MHIS thnl were used in the present study include
the specific JlSYchintric diagnosis, the type of ndmission or ,ervice used ond the
length of stay (inpatients) or length of use of,crvi"". (oulpntlcnts).

As with the

HMDS, the data are stored in 0 mixture of ICD coding systems editions, which
were updated 10 the ICD·IO rormat prior to analysis.

3.2.2.4

The Cancer NIJI!ficallons Reg/slry
The CDnccr Notificotions Registry 0115 been in existence since 198] und

holds a list of a]] cases ofcnrcinoma diagnosed in WA from that lime. Owing to
the relatively recentestahlisomcnt "fthis datnsct there weresome members ofthe
study group woose results Were nol recorded by the Cuncer Registry.
3.1.3

Supplementary datuse!

For the current project the databose at the Genetic Services of Western
AustraI1a (GSWA) Was also sourced durinS 2003-2004. GSWA provides genetic
hoalth services to individuals with genetic disorders or those at risk of carrying
genetic disorders, und their families. A referrnl from a Medical Practitioner Is
needed to book a consultation a\ GSWA, although the initial impetus for
investigation may come from un individual or couple if they have rcnson to be
concerned about hereditmy disorders.
A range of diagnostic, <:<.lunseUing, and prediclive services are availnble
through GSWA for those affected by, or ot risk of, genetic and congenita]
disorders. Details of the specific molecular Md/or cytogenetic tests conducted,
Md the results ofthose tests, ore maintained on the GSWA database.
3.3

Daln collect!on protocol
The casus were initially Identified by the selection from the DSC database

of all individuals with 0 clinical diagnosis of AngelmWl syndrome (Heber cude;
6759) or Prader-Willi syndrome (Heber cnde; 6715) (Hober, 1959). The poper
files Were ordered from the Records Department ofDSC. with a maximum oflen
filesordercd 0\ Wly given time. Tne files wcereviewed Wld details ofthe clinical
presentation of the coses were <:<.lnfinned. All of the data ,,){!rnction procedures
werecondueted within the DSC prcmises in west Perth.
The profonna used to "'<:<.lId the infonnation cxln\c\ed from Ihe paper files
is reproduced in Appendix Ill. It included provision for recording the presence or
absence of ciinicol sigru, especially those included in the diagnostic criteria for
eoch syndrome, as well as demogrnphic data, dewiJs of any genetic

tests

<:<.lnducted, fW1lily history, and data on illnessormedIcal condilions.
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The types ofdata included in the DSC files v.uied from cnsc to case, but
on the whole there Was a great dcal of consistency. EveI)' file contained basic
data II.'i outlined previously (Section 3.1). In addition. most parents had provided
information on fnmily background. ante· and postnatal hl!;tory, and the
developmental history of their offspring (Appendix IV), and the referrals were
accompanied by a Client Referral form Md a Clinicnl Information form
(Appendices V & VI). It is usual for DSC physioiWL'l to conduct an initial
physical c){llfIIination, followed by periodic updates where possible. The results
of these cxnminations were recorded in the patient's file (Appendix VII). The
l'C);ults and detoils of DSC specialist services, such as speech thempy,
physiothelllPY, hwing tests or optical te!;tins were also included in the client
files. As the individual continued to use DSC services, more <lnta were odded.
including rel"'rts from non·DSC servIce providers.., nvallable.
A database of extructed information pertaining to each individual was
created in the Statisticnl Package for the S()Cial Sciences (SPSS) version 1 1 .5 for
Windows. The list of variobles included In the datob= Is contoincd in Appendix
Vlll. MMY ofthese variables were taken directly from the proform.. with oth""
being added ... further dolo were collected. Any clinical data which

were

not

specifically mentioned in the files were recorded either as unknown or 'no data'
within the datasel.
Snppl�JOentruy information Was merged from the four other COre State
SOu","s as d�'Scribed above: Hospital Morbidity Data System, Dcaths Registry,
Mental Health Information System. and Cancer Registry. ... well .., the aenetic
Services WA database. As can be scen from Table 3.1 Cp. 43), some ofthe data
sets

have been in existence for a shorter time than tile DSC !'I:cords, which meant

that in cortain c= limited amounts of infommtion were available in tile other
datnbascs. The Hospitnl Morbidity databnsc. for instance, only commenced in

1970 and so 18 of the study group had no recorded hospitnl ndmiBSions between
their year ofbirth and tile estnblishment ofthe dotob.sc.

3.4

Data analysis
The study was population·based, cslng comparisons between the two

groups of patients. The data wcre analysed in a quantitntive manner, using the

Statistical Package for the Social Sciences (SPSS) version 11.5 for Windows.
Given the relatively low prevalence of AS and PWS, quite limited numbers of
subjects were available for study. This was particularly the case for deceased
subjects (AS, n '" 2; PWS, n " 6; PWS.like, n '"

\) and for this reuson mortality

and survival mtes Wcre not calculated.
The project was primarily descriptive in its outputs, analogoll.S to
international studies addressing similar research questions, and hence most ofth.
findingsare presented in the fonn ofsummruy statistics.

3.S

The study population
The American Association of Mental Retardation

(AAMR)

criteria for

intellectual disability shown in Table 3.2 are used by DSC to dclcqlinc client
eligibility for rogistmtion and sclVices (Grossman, 1983).

Table3.2

LcvcloHnlellcdual ruactlou lIS iudicated by IQ muge

T,�

IQmnge

Low nveragelbordcrlinc disability

71·84

AAMRCodc

Mild intellectual disability

55·70

3 1 7.0

ModC!llte intellectual disability

40·54

318.0

SC'lcre intellectu"1 disnbility

25·39

318.1

Profound intellectual disnbility

<25

318.2

Unspecified

318.3

Arlaplcdfrom Grossman (1983)
The specific criteria of ncccptancc for DSC rogistmlion include sub-
averoge intellectual functioning (i.e., IQ<10) that has an onset before IB years of
age, and evidence of significanl imp�innent (i.e., 2SD below the mean) as
measured by un Adoptive Behaviour Assessment. Adaptive ,km, !IN asscssmllllts
of learning, personal indepcndence, und soc!allsation skills, as Op(lfOpriote to no
individual's age and cultuml background (Grossmnn, 1983). In pl1lCtice, persons
with an IQ>70 but with significantly limited adaptive beIw�iollT skills arc

"

sometimes included in the DSC registIation process, due to their demonstrated
level ofoverall disability.

k; outlined in Section �.3, all individuals WWI a Hebcr diagnosis ofeither
Angelman syndrome (n

,.

35)

or

Prnder-WiIIi syIldrome (n ,. 59) from the

Disability Services Commission were selected for the study (total. n .. 94). After
reviewing the patient files, it was appan:nt that two of these CllSes had been
Incorrectly l.belled asPWS (Heber 6715). In another two cases the diagnosis had
been changed; one from AS to Lenno)(-Gaslaut spectrum, n type of epileptic
disorder, the other from PWS to Stein-Lcventhal syndrome, defined Il5 polycystic
ovaries, obesity. hirsutism and llIIIenorrhoea (MJM 1&4100). These four cases
were therefore Cltcluded from the analysis, reducing the !!llnl study sample 10 90
subjects.

An additional three

people were identified from the GSWA dalnbase as

hnving AS or PWS, although they had never been registered as clients of DSC.
Sinee no further informalion was available on these individuals, nonc was
included in the cohort. A JlCI1lon identified from GSWA records with nbnormal
methylation ofehrl5qll"'l13 had B male child registered at DSC, with a genetic
diagnosis ofi>WS. This child was already included in the study group.
Within the PWS group, a set of ten individunls who had normnl
methylation patterns were annlysed sepnratcly (referred to as the 'PWS-like'
group), since biparonlat met�ylation hllS been considered as sufficienl reason to
exclude PWS as n diagnosis in >98% ofeases (Buchholz cl al., 1998: Fridman �I
al� 2000b: Gleon �I 01.. 2000). Hence there was 0 strong possibility that most of
these people had some other as yet unidentified genetic abnonnality.

The

exclusion of these ten individuals left a central (lI'Oup of 80 cases for whom a
specific genetic I\llomaly had been identified, or who had

B

robust clinical

diagnosis ofAS or PWS.
3.6

Etbloal lssuCll and approval

Ethical approval for the project was given by the Edith Cowan UnivWlity
Ethics Committee. The Disability Services Commission of Western AustIalia
(DSC) Ethics Committec also gave permission for use ofthe DSC client dalabase
to conduct the reselU'l:h, and specifically gmnted permission for the project to be

undenaken On DSC premises. The study was epidemiological in nature and
analyses were conducted on a group Jevel. Individuals were not identified in any
d!lCllDlents or reports. Subjects and their fumilies were not contacted for the
research, and

115

previously noted, nO client files were removed from DSC

premises.
Ethical approvnl for the linkage of cHenIs to thc four DaIll Linkage Unit
core datnbases was received from both DSC IUld the WA Confidentiality ofHcaltb
Infonnation Committee at the Depllrtment ofHealth, which is responsible for the
maintenance and linkages of these e1ttcmal datnbases. All DSC cases (n

�

15,000) were linked to obtain this edditional infonnntion, since it was expecled
that not all AS and PWS diagnoses would be specifically entered into the DSC
database, or conversely that they had heen retrospectively diagnosed during their
contact witlt DSC. As stipulated under the lerms imposed by the Confidenliality
of Health Infonnation Committee, !he data linkage was undcnakeD by the
personnel responsible for record linkage within the WA Data Linkage Unit. The
datascts conlllinoo within the Dntn Record Linkage Project

are

avnllable for

rcsenrch purposes. They are a highly effective, proven 1001 for h""lth infonnntlon
retrieval and nnnlysis, and are almost unique worldwide in the broadth and depth
ofcoverage offered.
The general and medicnl files for each DSC client were kept in SecUIC
storage on DSC premises when not in use, and were Recessed only by !he
candidlllc and her supervisors.

Aller datn linkage and eJ(lroction, subjects

contained in the database Were identified by an unique number, which was used
for all recording of information relcvanl l0 the client, in�ludi"g medical detnils
elClrooted from tile DSC filcs. Electronic infonnation Was proleCled by passwords
and unique numbers, and any hard copies were kept in secure stornge

at

the

Cenlre for Human Genetics, Edith Cowan University.
The completed dlItabose will be held on a password'protected computer at
the Centre for Human Genetics, and it is envisaged tha� subject to ethics
approval, the infonnalion will be made avaUable to Medical Practilioners, carers
and service providers for individuals with eilber syndrome. Genemlly, Ibe data
will be available in !he form ofsnmmaries, allbough reports will be prepared for

specific interested agencies,

such as DSC. In oddition, Drlicie!! will be prepared

and submitted for pnblication in specialist academicjonrnals.

.1

"
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4.

RESULTS OFTHE STIIDY
prom.. oUhuludy cohort

4.1

As shOWII in Toble 4.1, 34 of the 90 individuals seleded for study (19
females and IS males) had a diognllSis ofAS, 46 (23 femol." and 23 males) had a
diagnosis ofPWS, and there were SC'/en males and three femoles in the PWS-Jikc
group lotolling 10 enses. On. oflbe PWS enses was of Indigenous Austrulian
deSl'ent, but none of the AS or PWS.lik. cases. The ages at the censor dale
(30.06.20!}3) or oge

01

death ranged from 10 months 10 4& years 4 months. All

members ofthe AS group Were nged six years or older, but nine individuals with
PWS were less than six years ofage. The birth yearn for the palients in both the
AS and PWS.lik. groups ranged between 1957 and 1998, whereas the PWS group
were born belween 1954 and 2002 (Figure 4.1, p. 52). Nine oflbe 90 subj�cts (2
AS, 6 PWS, I PWS·likc) were dc=d by the cenSOr date.
Tablc4.1

Cbaradcrulk. of Ihe .tudy ""hart(0 � 90)
AS

PWS

PWS-like

Tolal

34

46

"

'"

Mole

15 (44)

23 (50)

7(70)

45 (50.0)

Female

45 (50.0)

Diagnosis:
(number ofindividuols)
Gender:
number{%)

]9 (S6)

23 (50)

3 (30)

Ages (in years):
mOllll (range)

21.6
(6.5-36.6)

21.0
(0.9-4B.3)

24.7
(15.1·33.1)

Deceased:
(number ofindividuals)

,

6

9

M.l
Ofthe 32 1!ving AS cases, 20 resided al home, nine Were resldenl in group
homes or hostels, and onc each in foster care, an independent home, and 1!vlng
with adoptive parents. The moan nge of individuals living in privole residences
was slgnifiCDI\lly lower ibMIbose in shellered accommodation (20.2 years vs 27.9
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years: t = -2.255, p = 0.032). The majority of people were registered within the
Perth metropolitan regions (90.6%), with the remaining 9.4% living in rural areas.
Members of the PWS group were also mainly resident at home (n = 28) or
in group homes or hostels (n = 6). Once again, there was a significant difference
between the mean ages of individuals living at home and those living in
residential care (20.2 years vs 32.6 years: t = -2.584, p = 0.015). The place of
residence for six individuals was not recorded, and the remaining six were
deceased. The Perth metropolitan regions were home to 70.0% of living PWS
individuals, with a further 17.5% living in rural and remote regional locations
throughout Western Australia.

Five individuals were not in receipt of DSC

services at the time of sampling and therefore were not allocated to a region of
residence.
The residences of the nine surviving PWS-like patients were recorded as
home (n = 7) and group home or hostel (n = 2); three were from the Perth
metropolitan regions, and the remaining six individuals lived in country districts.
There was no significant difference between the mean ages of the cases residing in
private homes compared with sheltered accommodation.

Figure 4.1

Year of birth for the cohort at five year intervals
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4.1.2

Level of intellectual function
The level of intellectual function of the study group varied from ' low

average' to profoundly handicapped, with 4.4% being unspecified, i.e., the
subjects may not have been fonnally tested due to their youth or for other reasons.
The range ofJQ scores reported for the study group are shown in Figure 4.2.

Figure 4.2
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Levels of intellectual function of the study group (n=90)
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4.2

Angelmao syndrome

4.2.1

Prevalence
The prevalence of Angelman syndrome in the study group was

approximately 1 in 40 000 live births. This figure is based on the numbers of
patients with AS identified in the study who were born in WA (n

= 26), and

the

number of births in WA during the 50 years that DSC records have been kept (n =
1.05 million) (Australian Bureau of Statistics, 2003). The remaining members of
the AS group were variously born in other parts of Australia (n

= 6), Canada (n =

1), and England (n = 1).
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4.2.2

Age at diagnosis
The diagnosis of AS was made for members of the study group at a mean

age of 5.8 years (range, 1-27 years).

On average, the deletion cases were

diagnosed at a later age than those with other forms of AS defect (6.9 years and
5.0 years respectively), and females were diagnosed earlier than males (5.2 years
and 6.5 years respectively), although neither difference was statistically
significant. There have been no AS cases registered in WA since 1999, even
though prior to that date the numbers registered per five year period were
gradually increasing, possibly in line with the increasing total population of the
State (Figure 4.3). On the basis of the established clinical criteria, one individual
was originally diagnosed in chiJdhood with PWS, but subsequent methylation
testing confirmed a diagnosis of AS.

Figure 4.3

Date of diagnosis for the study cohort at five-year intervals
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4.2.3

Major AS clinical criteria
Half of the AS patients were assessed with severely affected intellectual

function, with more than a third (38.2%) within the moderate range of disability
(Figure 4.2, p. 53). Developmental motor delay was not universally evident in the
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group

11.';

a wbole,

11.';

shown by the lower boundlllJ' ofth. sitting/walklng nlllge

which fell within the pnramelers for the general population (fahle 4.2).

TabJe4.2

Frequeucies ofthe majordlnlcal ,Igo' ofAngclmau syndrome
withlo the.tudy ....mpl.
Negative (%)

Clinical criteria

PoslUve(%)

MoJordevelopment (age in yOllU"S);
mean (nlllge) (n � 29, n �J3)

sit, l.4y {0.5-4.9y}
'
walk, 4.4y (1.I-9.0y)

No speech orminimal words
(o"'34)

82.4

Some delay
17.6

Atnxia (n -34)

91.0

,..

76.5

23.5

Micnx:cphaly(n � 20}

"'..

15.0

Scb:ures (n� 34)

g8.0

12.0

Abnonnal EEG (n '" 30)

82.0

,..

Inappropriate laughter orsmiling
(n-34 )

*Five subjects had never _lked

o - number ofsubjectsfor whom data WII.'; available for cnch clinical symptom

The majority of AS patients (0 '" 29134) walked at some stage of Clltly
development The pailents who walked comprised 13 orthe IS males (mean age,
3.5 years; nmge, 1.1-9 years), nod 16 or the 19 females (menn age. 5.2 yClll'S;
nmge, 2.2-9 years). This difTcJCm:e in the mean ages at walking of male and
female children was significant (1- -2.052.p '" 0.05) The three females who had
neverwntked were aged 21 years. 6 yenrs, and 6.5 year.; (deceased), wbile the two
non·ombulanl males were aged 11.8 years, and 12.8 yClll'S (deceased) respectivciy.
All of the subjects had delay and/or imulea,uaoy of speech, with the
majority acquiring few, if ""y, words. Ataxia Dnd inappropriate laughter also
were present in most cases. Microcephaly WIlS diagno""d in 44% of 5lIbje<Jls,
although the number ofeases for whom dota were available (n '" 20) was too few
for statistical comparisons to be m.de. A large proportion of eases (88%) wen:

reponed to hove experienoed seizures, with 26% su/fering frequent episodes. In
addition, the majority of mdividuals had at I� on. nbnormal EEG reading
(82%), with only three subjects neVer having been tested (Tnbl. 4.2, p. 55).
4.2.4

MinorASdin/colcrit�rill

Th. lh'"'.::iO"ce or absence of the characteristic facial features such lIS flat
occiput, mandibular "I'IDgnnthin, drooling, mouthing, and tongue thrusting was
rnrely noted in the p,�irnt files (Figure 4.4, p. 57). Strnbismus was recorded in
almost half (47%) of the """'cs, Md hypopigmcnlation in 35%, although
information on these eharactcnSlics was unavailable for significant numbus of
patients.

Few data wen: available On the presence of the mised, flexed arm

position claimed to be chorneterutie of AS, or on sleep disturbMccs. A small
number of subjects (n

� 3)

wcre recorded as having a fascination with water

(Figun: 4.4, p. 57).
4.2.5

OtherclinicalFmdings
A number of additional clinicnl chnrocteristics were frequently reported

within the study group. Most ",,",cs (79%) ofAS were hypotonic, and half ofthe
group were regarded lIS hyperactive. Over 38% were considered obese, and 50%
ofthe group wcn: ofnormal stature. Skin picking II'DSreported in seven patients,
mainly older individWlIs. Scoliosis was present in 33% of all pollents and in 56%
ofthose more than 16 years old. Three ofthe moles had either undescended testes
or a small penis.
<1.2.6

LaimratorydiDgnos/s
acnelie tcstmg was conducted on 88.1% of the cohort, although eight

patients (23.5%) had received only karyotyplng or banding tests (Table 4.3, p.
58), cf which halfwere JIOsitive. Two persons with a delelion, as indIcated by
ohromosomal banding, had relurned normal bifllltl"Jl al methylation tests and were
therefore included in the 'inconclusive' group. Onc IcSl hod heen performed for

UDDA. abnormalities (which wru; negative), but none at all for le defects. afthe
19 methylation tests conducted, I I were positive and eight were negative, and
three ofthe four FISHtests were posItIve. Delctions accounted for 33.3% ofthe
JIOsitive l"CSults, IIl1d UPD for a further 6.7% (Tnble 4.3, p.58).

ss

Figure 4.4

Frequency of the minor clinical signs of Angelman syndrome within the study group (n

Minor clinical criteria

I•

Positive • Negative D Unknown/no data

I

= 34)

Table 4.3

{�etalls ofdlagnOlltic lest(WlCd for Angelmlln !l)'adromeeases
(0"'34)

Typeofmoleo:ularlcits (%)

Moleo:ular test re,ults:
number (% ofthosetested)

4.2.7

Kaxyctypellmnding

".,

FISH

11.8

Methylation

55.9

Unknown/no test

11.8

Deleticn

n � 10 (33.3)

Uniparenta.l disomy

n � 2 (6.7)

Positive (not specified)

n m 2 (6.7)

No abnormality dete<.:ted

n - 1 3 (43.3)

Inconclusive

n = 3 (10.0)

HorpllllladmlsslollS
Individuals witb' AS bad been admitted to hospital on 11 totnl of 301

oe<:aSions, with an average of 8.8 (SO - 8.6) inpatient episoocs. As sbown in
Table 4.4 (p. 59), epilepsy nnd/or seizures were the most common reasons for
admis.sion

(14.3%),

followed

by gastrointcstinlll

tract disorder, (13.0%),

holiday/respite care (I ].3%), dental care (9.6%), and "" piratory. tract disorders
(8.6%). The remaining admissions covered 11 wide variety of reasons, e.g.• eye
abnonnalities, bums, congenital dcfonnities.

Four pwple had no recorded

hospital admissions.
More than h�lf of the individuals with AS were admined one or more
times for dental work (n

=

18), rn.J .Imost as many for epilepsy (n '" 16). A

fuMher 12 indIviduals were hospir.lIsed for f"ilure
delay (rllble 4.4, p. 59).
patients

to

thrive or developmental

Admission for dental work was over-represenLed in

with seVere or profound intellectual disability (62%

of dental

a�,"issions), even though this group comprised less than 53% of the AS

;;;'

pulatlon.
Three individuals were admitted to psychiatric units fer up

to tiuee doys

durati!.'n. The reasons listed for their admIssion were developmental dday (1111

three

persons), and epilep.y (two persons).

Three other AS patients atrended

psychialric outpatient clinics on two, six and eighteen occasions respectively. The
diagnoses reported for these persons were seven: ID, microcephalus, and
psychosocial circumstnnl:CS (unemployment) respectively.

Table4.4

Hospital admissions for Ibe ADgellnan syDdrome gronp
of

Rouon foradmlssion

Numberof

I
I

oHotal

Dental

29 (9.6)

Respiratory disorders

16 (8.6)

10

Ear pmblems

IS (5.0)

7

18

Skin disorders

]5 (5.0)

4

Open wound, various sites

13 (4.3)

•

Failure to thrive/feeding dimculties

]2 (4.0)

12

Foreign body Inserted, Ymous sites

9 (3.0)

,

Congenilal anomaly

8 (2.7)

,

Urinary tract disorders

6 (l.0)

4

Fructured bone ± complications

5 (].7)

4

Other causes (various)

47(15.6)

19

4.28

M0r1111ity
There had been two deaths within the group of 34 AS patients.

One

person died of $/QIV3 epllcpllcw; al the age of 12 years 10 months, and the other
p,tienl wosaged 6 years 6 months atdeath from pneumonia.
4.3.

Prader-WnU..yndrome

4.3.1

Prevalence
A birth prevalence of [ in approximately 29,500 was calculated on the

bosis of the number of PWS cnscs identified for this study who well: born in

'"

Western Australia {n c 31} and the number ofbirths were registered In WA over
the lust 50 years (n � 1.05 million) (AustraliDll Bureau of Statistics, 2003). Ton
Olher memben of the PWS group had been born in other parts of Australia, and
one each in Hong Kong, Scolllllld, Soullt Africa and Spain. The remaining
individual had no record of counlly ofbirth In the rclcvllIltDSC files.

The avemge age at diagnosis of PWS was 5.3 year,;, willt 34.8% of lite
entire PWS group diagnosed before lite age orone year. Within the subset of 1 1
individuals who were added to the database a!ler 1998, the mean age at diagnosis
was

1.1 years (l'IIIlge, 0.1-6.0 years), while the 3S individuals who were included

prior to 1998 had a mean age at diagnosis of 6.6 years (range, 0.2-17.0 years).
This difference WIIS highly significant (I g -3.5, p a 0.001). Deletion taSCS WCre
diagnosed at a slightly earlier but SIlItlstically non-significant "ge than those
without a deletion (mean, 4.5 years and 5.9 years respectively; 1 = -0.90, nls), and
males curlierthWl temales (mean, 4.6 years and 6.0 years respectively; I g -1.015,
nls). The numbers of PWS cases diagnosed were appreciably higber in the five_
year periods of 1980-84 (n - 12) IUId 1995_99 (n � 13) than during any other time
perioo (Figure4.3, p. 54).

Mojor PWS cllnlcol alierlo

M.J

As indicated in Toble 4.5 (p. 61), the majority of PWS

cases

repolled

hypotonia (96%), infantile feeding preblems (85%). nnd rapid weight gain at an
early age, followed by obesity (87"10). HyperphagIa

11'85

described less often

(61%). Repolling oftbe characteristic facinl features was poor, with over 90% of
case files

without mention oflhis feature. H)IpOgonodism and/or c!),ptorchidism

were present in two--thirds (67%) ofPWS patip;ots, i.e., 91% ofmales ofa!1 ages.
and 58% of females OVer IS yearn.

t.il

of the adult female patients with a

""nfinned deletion had ubsc:nt oT delayed menses. but this feature was reported in
only 300/ooffcmules ofthesame age in the group ofpatients without IIlI identified

deletion. MOlOr devclopml:llwl delay WlIS found in many caseS (n -20), but there
were some patients (n

�

18) who did not show any marked delay in rcucbing

physical milestones by comparison with the general population (fable4.5, p. 61).
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Table 4.5

Frcquucle!l ortbe major diuital sign" ofPmde....WilLi

syndrome"':\Ibiu tbe study sample

Negative (o,.\. of

CLiuic.oi criteria

Positive (% ofgroup)

Hypotonia (o -46)

95.7

4.3

Feeding problems{n-43)

84.8

'.3

Exeessivewcighl gain (n

86.9

l3.1

Ch"",eteris!ic facies (n ,. 2)

4.3

0

Hypogon�dism (n -41)

67.4

21.1

Hyperpi1agia (n g 33)

60.9

"l

Mo!ordcvcicpmcnl (nge in years):
mean (range) (n �34, n '" 39)

sit, l.Oy (0.5-2.5y)
walk,2.8y{I-IOy)

group)

10.9
I subjc<:t unable
10 sit or walk at
0."

n ,. number of subjecl! for whom data was available fer each clinical symplom

4.3.4

MlonrPWS clinical criterln
Figure 4.5

(p.

62) Shows that more thllll halfofthc study subjects (57%)

had exhibited some orthe charne!.ri,tie bchavioul'III patterns lISS""ialed with PWS
(tem;>er Irultrums IIlld violen! oulbursts), IIlld 72% were short in stature compared

to fnmily member.;. Individuals who hod received growUl hormone th"ropy (n"
4) were recorded lIS short, regordlcss oftheir current height Ocular abnormalities
were reported in bolf of cases, IIlld a large percentage of PWS paliem.3 (85%)
suffered from delayed speech development lIlld/or articulalion dcfecl!. Many of
the remaining minor clinical signs were under_reported. with fewer thIlll 40'" of
individuals having specific features record"" in their files; i.e., decreased Iclal
movement (23%), sleep diSturbances (13%), size and sh';>e ofbandslfeel (3)%),
pmenee ofthiok soIiva (O%) , IIlld skin picking behaviour.; (37%).

'"

Figure 4.5

Frequencies of the minor clinical signs of Prader-Willi syndrome within the study sample (n

= 46)
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4.J,5

Oilierdlnlcalfintllngs
Scoliosis was reported in I I ofthc 30 subjects (37%) who were aged I S

y= Or more, but in none ofthose aged less than [ 5 years. Two individuals with
scoliosis had received corrective surgery for the condirion.

Osteoporosis Was

identified in one female, aged 32 years.
Al lcasI one episode ofepilcpsy or convulsions was reported in 28.3% of
cases. Of the

13 persons who had an epileptic episode, five showed n deletion,

One was diagnosed as UPD, four had nC'lCf been tested, nnd four had no genetic
mechanism identified.

Diabetes was reported in four adults, with no data

available for the other 30 adult members ofthe PWS cohort.

4J,6

Llrhofll/ory tllagnofis
Tahle 4.6 shows that geJIetic testing was performed on 84.8% ofthe PWS

cases.

Almost n third of these people received only kruyotyping or handing,

There were no lests for

le defects.

All of the FISH and methylation tests Were

positiVe, Le., unipnrental, as the patients with bipare!ltnl methylation had

been

removed pre-annlysis 10 form the PWS-like group. A deletion was identified in
43.6% ofle5k:d cases, and UPD in 10.2%. No genelic mechanism was identified
in 23,1% of those tested, and the remainder had returned unspecified 'positive' or
inconclusive tests,

Table4.6

Diagno
..ictests for Prader-' l1i syndrome""""" (0 - 46)
.

Mean age al diagnosis (range)

5.3y (0.1_17y)
KllI)'otypelbanding

Type ofmolecul.. tests (%)

Mole""l.. lest re,ults;
number (% oftbose tested)

30.5

FISH

17.4

Methylation

36.9

Unlmownfno tcs\

15.2

D.letion

n � 17 (43.6)

Uniparental disomy

n � 4 (IO.2)

Posilive (nol specified)

n - 6 (15,4)

No nbnonnality detecled

n = 9 (23.1)

In,,,,nelusive

n - 3 (7.7}

62

4.3.7

Hospital admis�lo/1<

As shown

in Table 4.7, PWS patients had been hO);pitalised on n total of

328 occasions (mean, 7.4; SO, 6.9). with respiratory truet infections accounting
for the 11I1'S.st number of admissions (7.6%), followed by breathing difficulties
(7.3%), dental = (6.4%). nndescended lestes (5.8%), gastrointestlnal disorders
(5.5%) and

an unspecified congenital wlOmaly

(5.5%). In addition, a large and

varied number ofreasons were listed in the pallents' files for their Ddmis.sion to
hospital.

These Included ceUulitis, musculoskeletal discrders, congenital

deformities, Md ingestion of toxic subst<mces.

Nearly 37% of individuals

sutTered from ut lellS! one respiratory infection, and 1 4 individuals ..ch had been
admitted to hospital for dental work Or with breathing difficulties (Table 4.7).
Table4.7

Hospital admissions for tbe Prader_Witti syndrome cases
witbin Ibe sludy group
Total n llmber of

Reason for admwioD

admissions (% oftotal
admlMioDll)

Numberor
Individual!
admllled

Respiratory infections

25 (7.6)

Breathing difficulties

24 (7.3)

14

Epilepsy

15 (4.6)

9

Gastrointestinal disorders

18 (5.5)

•

Holiday care

3 (0.9)

"'""'

21 (6.4)

Congenital anomaly

18 (5.5)

10

Undescended testes

19 (5.8)

9

Eat problems

11 (3.4)

,

Skin disorders

5(1.5)

,

fructured bone," compIicotions

16(4.9)

•

Failure ID thrive/feeding difficulties

1 1 (3.4)

6

Urinary tract disorders

II (3.4)

9

Foreign body inserted, various sites

2(0.6)

,

Complications ofpregnancy/childbirth

9(2.7)

Open wound, various sites

2(0.6)

Other causes (various)

118 (35.9)

17

04
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Silt patients had been admitted to psychiatric units for an averng� of 24.S

�

days (range, 2.96 days), on the groUllds of l , developmental >:!day or, in one
CIISC, nonoOrganic psychosis. One male PWS case, who recorded 1162 psychioWc

outpatient visits, attended group theJllPY sessions for mixed disturban<:e of
conduct and emotions over a period ofnln. years, ut an avemge of 10 visits per
month. Further outpatient visits to psychiatric units wen: made by three persons,
with the tolnl number of visits per person I'8IIging from 3

to

12.

ID,

developmental delay and disturbance of conduct Were the moin rellSons for
attendance.

Two individuals with PWS attended both as inpatients and

outpatients (one personeach with mod.mIC ID and schizophrenia).

Three individuals had neoplasms roported

in their files. One patient had

been diagnosed with a benign tumour of an endoorlne gland, another had a
molignant melanoma removed at 16 years of age, and the third person hod a
thyroidectomy for malIgnancy at uge 35 year.;. The only onc of these

Urree

patients who was deceascd had survived for 20 years ofl.r removal of the
melanoma and then died ofcnrdinc failure, aged 36 years. Only one ofthese cases
was listed in the Cancer Registry, lIS the other two persons had been diagnosed
before the Registry WIL< ""mmeneed.

�.3.8

Mortality
Of the silt deceased PWS

cases,

two had died from cardiac

am:stI

myoonnlia! infan:tion, onc from pneumonia, and in the remaining three cases the
CaUSe of death w... not recorde�.
referred

to

The case noles for onc individUIII had been

the Coroner, but nO notifiention had been received by the Deaths

Registry at the date of dol.!! Hnuge. The other two people were not listed In the
Deaths Registry, and nod.ta wcre inoluded in their DSC file!. Theiragcsat de.th
rnnged from 2.3 years to 36.5 yeW'S.
4.4

Metbylatlon Donnal 'PWS-like' group

4.4.1

Oln/ca/flndlngs
As previously describod (Section 3.5), this group comprised 10 people

with a clinioal diagnosis ofPWS but who showed biparental methylation patterns
(Toble4.I, p. SI). TheiravCnlgc age Was 24.1years (range, 15.1·33.1 years). As
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can be Seen from Figure 4.2 (p. 53), the level of ID reportod was mild (0 D 6),
borderline (n '"' 2), modemte

(n '"' I) nnd ,evere (n = 1). Moan age ot dingnosi,

was 10.6 years (range, 0.9-25 yClU"S). However, the age for two cases was
l1I\JeCorded, and ,oth. dnte of first contaot with DSC was used as the upper limit

oftheage at dj.gIln,i, for those individllOl,.
Half ofthe ,ubJects were reJlOrted 10 have hypotonia, and five individuals
eJ<hibited feeding problems in infancy. Eight were obese, one was of normal
weight nnd .w.lure, and one bad no dntn on body habitu,. Their uVrnlge age ot
sitting was 0.8 y= (range, 0.7·],0 years), and it WlIS 1.6 years (range, 1.1·2.1
yeur,) for walking. Ofthe ,even males, five were hypogonadal, whereas only one

of the three femal.. hOO no menses. HypOIJlhogio

was

re(>Orted

os present in

,even ofthe subjecls, and speech delay or defects in nine cases (Table 4.8). Half

ofthe group Were either of normal .w.1ure or were Inll. Skin picking behaviour
was evident in two ;ndividUl!I,.

None of the other features regarded

as

chorneteri";. ofPWS (Table 2.3, p. 28) were recorded with ,umc;ent frequency
' :'

to enable a valid ELlSCssmcnt. Fourofthe group had reported at least one epileptic
episode.
Table 4.8

Frequendell ofvarious dhlical cbaracteristitll In the PWS-like
subgroup (n = 10)

Clinical criteria

Poslll�e (Dumber)

Negatlve(aumber)

Hypotonia (n � 8)

4

4

Feedi�g problems(n- 8)

,

3

Excessive weightgaln (n � 9)

•

Hypogonndism{n - 10)

•

4

Motor development (nge in yenn;);
mean (range) (n �7, n = 8)

si� 0.8 (0.7-1.0)
walk, 1.6 ( l .t-2.7)

I subjedncver
walked

Hyperphagia(" - 10)

7

3

shortm4
Stature compared torelatives (n � 9)
tall�1
Speech dclay/def,cts(n - 10)

9

Skin picking (n � 10)

,

normal =4

n - number ofsubjel'ts for whom daln was available for each clinical symptom

.,

4.".2

H"rpIlJladmks/om

Members ofthe I'WS-like group were admitted to hospital on a tolal of70
occasions (rnenn, 7.0; SO, 10.3), but with a large proportion of these visits
(32.9%) for epilepsy and ""ovulsions in a single individual. Re:;piralOry tract
infeotions and gaslrolntcstin.l tract disorders accounted for ten (14.3%) and eight
(1 1.4%) admissions respectively.

Individuals (n � 4) were more commonly

hospitalised ror sustrointes\inal disorders than for My other rellSOn within this
group ofpatients (Table 4.9).
As with the AS and PWS cases, there were vruious other reasons recorded
ror hospital admission, including syncopc und collapse, disorders of the
ligDlIUmUmuscie, and virnVChlamydiol infection. Four (>001'1. from the PWS-likc
group accounted for one day ofinpalicnl llIld six visits to outpatient psychiatric
services, ID, stress/ftI]xicLy disomers and infantile ccrebml palsy were I'I:cordcd as
the main Teasons for Ibese ollClldOllces. One womon died at age 17.9 Y""". but no
informalion on her caUse ofdealb was available from the Deaths Rcgisuy.

Table4.9

Ho'pltal admission, ror the PWS-JJkc alses within iD tbe 'tudy
group

R....Dn for admwloD

Number of
Totalnumberof
admission. (% "flotal Individuals
admllted
admissions)

RespiIatory disordcn

10 (14.3)

3

Epilepsy

27 (38.6)

3

Gasuolntestinnl disorders

8 (11.4)

,

"'""'

1 (1.4)

Congenital anomaly

I (1.4)

Ear problems

1 (1.4)

Skin disorders

1 (1.4)

Frnclurcd bone ± complications

2 (2.9)

Failure to thrivelfeedingdifficutics

1 (1.4)

Urinary !met disorders

3 (4.3)

Olber causes (various)

15 (21.5)

3
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DISCUSSION

,.

A numb.... of diverse demographic, clinical, gelletic and technical factors
need to be considered when ossessing the ovemll findings ofthe study,

5.1

Potealial limitallno. of Ihe study

5.1.1

ellSe IlScu(alnmenr
Onc disadvantage ofusing the DSC database for case ascertainment is the

Commission's requirement that a specific level orlD is idC'lltificd before a client
is acccplCd for rcgistrntlon. This hus particullll" relevllIlCil for individuals with
PWS, because an estimated
inlelligence (ClISoidy

27-40% an:

et 01., 2000;

thought

Cimke el

to

have at leas! low-avcmgc

al., 2002).

Therefore PWS

individuals who have nonnaI or borderline intelligence arc unlikely \0 be
regi!rtercd at DSC.

In addition, a recent study of ID in WA found that a

significant number of children with ID wen: identified either through the
Department of Eduoalion, Catholic Education or the Association of indcp<mdent
�chools, rather than vi. DSC (Leomml

et al., 2003).

Globally, the majority of

pefSOll5 with ID fall within the mild/moderate mngcs of functional limillltion
(ChristiWlson

et al., 2002;

leonnrd

et al., 2003).

Hence it is possible that

additional people with AS Or PWS DrC living nndingnosed in lbe community Md
could perhaps be identified if 1I1""e educatiolllll agencies were used as souroes of
lISCCJlIiI nmenL
The orgMisation

known as Irrnbccn.. which

la!er became the Disability

Servi""s Commission, was a centre originally eSlllbHshed by the Slow learning
Children's Group (now the A"liv foundation) in 1954. The centre, which was
used for the testing and diagnosis of ID, became the responsibility of the Menwl
H..lth Depllrtment of WA in 1964. Over those years of foundation Md change
1I1cre were a number ofdifferent physicl!lllS involved in rccord·kccping, and mIIior
chEUlgcs in public attitudes to ID occurred (GilIgrcn, 1996).
The initial descriptions of PWS in 1956 und AS in 1965 were published
during 1I1is period of development in the provision of services for lbe ID
population in Western Australia. By 1I1c lime the consensus diagnostic criteria
were published (Holm

et al., 1993;

WiIliams

et al., 1995),

a majority of the

individuals in the present study cohort hod been dingnosed by the swffot DSC or

by another Medical Practitioner. The "",!iest rocorded diagnosis of AS at DSC
wns in 1966, and that ofPWS 'Has in 1968. In some cases the Heber code WIIS
ndded reIrospectivoIy to the patient's file, and 1Ilere WIIS no way ofascenaining at
whill precise date the coding hnd been perfonned. There also was no gunrantee
that all cases of PWS Or AS hnd been identified from the registered client
population and hurl the requisite Heber code appended to their file.
Linknge of the GSWA records to 011 registered DSC clients ensured that
all persons with 10 who had undergone cytogenetic testing of chromosome 15 in
Western Australian public tabomtories were considered for inclusion in the study,
thllS ensuring the creation of 0 databo.sc comprising most of the known cases in
WA. By cleflllition, those cases identified ut GSWA butwho were not registered
with DSC could not be induded in the study, IlS no clinical data were available on
thest.: individuals. However, only three individuols who were identified through
GSWA IlS having PWS or AS were not included in the DSC files, so it is unlikely
tIlat a signifiCllltl number of caseS were missed bc<:ause of this limitatioo. It is
known that at an early stage ofthe development ofGSWA SOme individu.als had
sumples for testing sent to Inbomlories in other Statesof Austratin. Unfortunately,
it WIlS not possible to access tile records of these labomlOries tn get confinnotio"
oflest results.
It wns difficult 10 estimate the number of people with PWS or AS in the
WA resident population who were not registered on the DSC databnsc. Given that
some 1.05 million people were born in WA between 1950 and 2003 (Australian
Bureau of Statistics, 2003), Md previous prevalence mtes for both AS and PWS
bave been estimated at I in IO,OQ()"25,QQO births, it initially was expccted that
between 84 and 210 people would be Identified as having one or other syndrome.
As demonstrated in Section 3.5, 80 pcrsons born before 2003 were identified from
the DSC database. However, only 57 ofthese people (26 with AS, and 31 with
PWS) were born in WA. This leads to the possibility that at least 27 nod perhaps
as many as 153 individUllls born in WA with either syndrome may not bave been
diagnosed.

If correct, several potenti"1 contributory cireumstances can be

identified:
I.

The birth incidences for both syndromes are lower in WA than would
seem probable from estimates derived for other population••
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2.

A sizeable proportion ofpeople with PWS or AS hnd migmted from WA
before they were diagnosed.

3.

A slgnlficnnt number ofJ'WS or AS cases remnin undlagno!lCd In the
general population.

4.

Indi�id\Ulls with one or other of the syndromes died before a diagnosis
and/or""n!net with DSCwas made.
Ofthcse four possible oulcomes, numbers 3 and 4 would ...em to be the

most feasible. Worldwide then: appears to becompa!lllively liltle variation in the
reported inddenre rotes for AS and PWS, therefore it is difficult to suppose
credible grounds for their apparent low prevalrnce in this SlIIte (Hou 0/ al., 1998;
Stromme, 2000; Whittington el 01., 2QOI; SmIth cl 01., 2003). In addition, the
population of WA is considered to be demographically quite stable, with vCI)'
limited permanent migration from the State (HotrnWl elol., ]999; Trewin, 2003),
SO it is

unlikely that many peo�le have moved out ofWA before being diagoosed

wllh either syndrome. As 23 suhjects were born outside WA. there appears 10

�

l ave been n medy rate omet inward migr.>lion over the last 50 years (Trewin,
2(103). It is acknowledged that the diagnoslic services offered by GSWA arc both
comprehensive and of high quality, bu� no; was noled above, then: have beeJ\
periods when genetic tests were conducled In the laboratories of other Austrolian
States, and the results were nol always availab]e i n the cllcnt files.
There remains the possibility that n ,ubsUUltial number ofindividuals with
ID nre registered nt DSC bul have not had a diagnosis of AS or PWS recorded.
Over the lasl lS years there bas been n greater empbasls on community care for
people wllh ID,

'0

thut mOre oft;:n palien!S arc seen by a Geneml Practitioner

talher than by the s[JeCialisl physioians at DSC (Stella, 1996). In these cases there
probably is lillle chance that the individual, would have returned to DSC to have n
retrospective dlagnosis recorded in their filos, eS!",cinlly iftheir level of ID Was
borderline or mild.
AS patients arc difficult 10 diagnose in the first fcw years of life, before
the chlU'8Ctcristic patterns of developmontal delay and epilepsy bave become
manifes� and some cases ofPWS are nol diagnosed until chlldbood areven tater.
It i! therefore enlirely possible that some individuals in WA with either syndrome
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have nol yet been identified. Du. to the relatively =nt development (post1995) of specific diagnostic laborolOry tesls for both syndromes, it seems likely
that a number of older people with AS or PWS have nol i>ee'l recognised as
having dther syndrome.

In the Netherlands, for example, two middle-aged

I"'tienls with PWS or AS WCre identified during a retrospective study of the
residenls of a single l,mg-slny in;litution

(VI1rl

Buggenhout er �I., 2001).

Similarly, fouredult AS cases wen: diagnosed after screening n sub-section ofthe
population ofa large Dcvclopmenlnl Centre in the U.SA (J.oobsen ., al., 1998).
The large-scale deinstitutionalisation of the inlcltcctUlllly disabled pop"I,;!;"n in
WA since

th� 1970s

makes it unlikely thut many of these putative PWS or AS

cases will ever be specifically diagnosed (Stellll, 1996).

5.1.2

Dalll avllilabUIIy
Specific restrictions were effectively imposed on the study by the dala

oollection meih<KI employed. As there was no direct or indirect palient or ClllCr
oonlnCl, the daln ool1ected were wholly dependent 011 the quality and quantity of
infonnntion recorded in the various datablo.Scs IUld in the client hard mpy files.
These records have been compiled and mainlnined by a rel.tively small number of
Medical Pnu:titioners, with the consequent expectation that they would b.
internally t(lnsistent.

Howcvor, under-reporting of mMY of the recommeroded

diugnost!c sigm for both disorders WEtS apparent
early patiCllt

files,

in

a suoolnntial numlJ.er of the

possibly du" to the relatively nxcnt specification of the

diagnostic clinical criteria for the \Wo syndromes, allied tothe retrospectiVe nature
ofsome ofthe diagnoses.
The volume of data contnined in eneh

m<l also depended on the degree of

utilisatio" of DSC assistancc IUld resources by individual clients. Some people
were rarely in contnl:1 with DSC, especially those with a milder phenotype or
whose pnrenl!;/canlJS mny have had more resourees available to them.

In the

ea:rlier years ofwhat wm to becomethe Disability Ser;joes Commission there was
considemble distrust of the 'professionals' expressed by some parents, and it was
also difficult for clients who lived in more remote regions of the Slat. to access
DSC services (GilIgren, 1996). The overall result was tluIt the records of certain
indi�idua!s t(lntained relatively liUle information.

In

these cases,

the

supplementary data acccssed from the othel WCSlcm Australian dntabases w�re of
plUticular value in establishing the morbidilY pallCtns ofthe patients.
The del/clopmen!l\Ild use of record sheets specifically for AS or PWS has
greatly aided th� collection of data pertaining to the major clinical signs of both
disorders (Appendices IX &

X).

Howel/er, in the absence of professional help,

the record sheets can only be completed with a level ofaccuracy dependent on the
memory and opinions of the parents or <:arers of Ihe patients.

Tenns such as

'fceding difficulties' are often subjective and vague, nnd they may elicil a wide
variation in response, dependen! on the perceplion ofth� meaning ofth. phrase on
the part ofthe respondent [n addition, SOme oftbe characteristics, Le., hypotonia
and weak cry in PWS, and feeding difficulties in either syndrome, are generally
confined 10 infancy Md may not be rccnUed at a loter dale. Conversely, short
slalure and hyperphagia in PWS IlfC normally fClllures ofthe olderchUd and adult,
mther than the infant.

5.2

Prevalence estimates

5.1.1

InlelleCf��fdis�bility find flhnlc origins
A study from Western Australia covering the period

estimated that

(10.611000)

1983 to 1992

14.3 persons per 1000 births In WA had "" ID, with the mojorily

showing mild/modemte ID (le<.>nnrtl et

female mlio Was J.�:I, and there was

0

01., 2003).

The male

10

disproportionately high number of

[ndigenous AustraliM clients, with 2.3 Indigenous cases to each non-Indigenous
patienl (Lconnrtl er al., 2003), even tllOUgh Indigenous people only comprise 3%
ofthe Slate popUlation (Aust",H"" Bureau of Statistics,

2002).

The gender ",tio

Was similar to that recently calculated for a rural South African population, but the
ovemll prevolencc in South Africn was much higher at

35.6 persons per 1000

births, ofwhorn 29.1 per 1000 were mildly disabled (ChristillllSOn elo1., 2002).
The presence of high mtes of specific morbidities in mothers, e.g.,
diabetes, hypertension and chronic rennl disease, or in the child, e.g., fetal alcohol
syndrome, postnalal lcad poisoning, malnutrition and infanlile Maemia, may be
implicaled in the increased occum:nce oflD nmong both Indigenous AustrnliMs
and Indigenous So�th Africans, as these disorders IlfC indicative of the lower
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socio-economic standing of many indi�idunls in �)CSC two populations
(Grossman, 1983: Christillll50n el al., 2002; Leonard el aI., 2003).
As mentioned previously (Section 5.1.1), in WA more children wilh mild
ID Were identified through lhe Department of Education, CDlholic Education Md
'the Association of Independent Schools lhM from DSC (Leonard cl al., 2003).

n,.

preVlllence of severe 10 profound [0 vlllies widely across studies Ilfld

populations, llIIIglng from 0.64 per 1000 to [4.4 per 1000, ollhough some oflhesc
figures refer 10 binb incidence while olh.rs signify prevalence in a surviving
cohort, so thnt no over.l1l comp=ive conclusions can be rendily drown (Durkin

., aI., 2000; Christinnson el al., 2002: Arvio & SiIIllflpaa, 2003; LeonDId el aI.,
2003).
5.2.2

Angel""'n syndrome
The relalively low prevalence mte for Angelmnn syndrome suggested by

the data from the present study group could ..flect the problems in ensuring an
ac:eumte clinical dlagnos[s of AS, especially in infancy, "Ilhough it is difficult 10
understand why this would be more relevanl in WA thM in other I�gions of
AustrnUa or intemotion.lly. The comparatively sleady rate of migration into the
Stale would indicate thot there can be little ground for supposing n founder effect
is opemtive, especially in the light ofthe ever-increasing ethnic diversity found in
the migrant population.

The apparent reduced incidence of the disorder is

reflected in the obscnce of individuals diagnosed with AS within the losl five
years, eVen though the various eytogenClic Md DNA_based diagnostic laborulory
tests ha�e been available throughout this lime-period (WilIiwns ., al., 1995:
Sailoh el al., 1996; Glenn cl aI., 1991).
It would seem that there hos been a laok of di"gnostie testing in Weslem
Aus\nllilll\ cytogenetic and moleculnr genetic labcratories for IC or UBE3A
deft<:is, which were identir.ed os �i&llj(jCllltl causative mechanisms of AS in 1996
nnd [991, respectively.

Addition,,!y, the tests thnt were used proved 10 be

uninfOlTllltive
l
for many patients, .Ilggcs\ing that a number of AS ca:;es rem"in
undiagnosed in WA. For example, ancr a negative bllIlding test or kW)'otype, in
the pasl individuals may have been listed either as nol having AS or been
allocated some other diagnostic code (e.g., 'other unkllown prenatal influence';

n

Hel>er 6900). lfso, they would nol�ave been selected forthe study from the DSC
dalllbase.

Ncvcrthele",

there were four people who

had °

negntive

karyotypeibanding test but who were still considered 10 have Angelman syndrome
based on clinical assessment, and were recorded as such.
To date, there has been no reported voriation in prevalence ofeither PWS
Or AS which could be attributed to membership of any specific ethnic group.
Therefore, the absence of Indigenous Australians from Ihe AS co�ort could be
i�dicalive of a lack of opportunity

for

idenlification due 10 remotene"

SCl'Viccs, Or of communilY'specific beliefs and aUitudes (Morgan

el

01.,

from

1997).

Aboriginal people often prefer 10 care for individUElls with n disability within the
community, ralher thWl seeking outside help (Brown. 2001). This means Ihat,
despilc ovcr·represenmtion of the Indigenous communily

(7.4% of cases)

in the

records of DSC (Glasson .' 01., !n !'re,,). there still mny h e . significant number
of individuals who have nol been given a causative diagnosis for their intcllcctunl
disability. AI the sa!ne time, as [ndisenous Australians comprise just 3.5% ofthe
lotal Western Au,tralian populalion, small number effects may also provide a
part-e:<plEll1alion (AustraliEll1 Bureau ofStntistics, 2002).

5.2.3

Prader_WllIIsyndrome
In a similar m""ner to Ihe AS group, il was vITj difficult to estimate the

birth incidenccofPWS in WA from the dam collected as part of the current sludy.
E�clusion from the DSC n:coms of persons with no or minimal lD would have
meant that some PWS individuals with borderline ID were almost ccrtllinly
missing from the study.

The possibility of ov.r-<lia�nosis wru; also a

consideralion since, ru; previously discussed in Section 2.3.3.5, there is a range of
condilions that superficially resemble PWS if elinicnl crilena are used as the only
basis for assessment.

This was onc of Ihe reasons for removing methyl.lion·

nonnal individuals from Ihe main study cohort (Section 3.5), as there is a high
probability thnt few of these people have PWS, despite their clinical presentntion
being consi,lent with the symptoms of the syndrome.
Most previous sludies have reported no gender bias amon� people with
PWS, although females ore ollen under·represented in the groups investignted
(Orecnswag, 1987; Akcfeldt & GilIbcrg,

1999; Couper & Couper, 2000; Fridman

el al., 2000b). [t has been suggested that the probability of miHliagnosing PWS
in females i� inrn:ased by the difficulty of identil}'ing female genital hypoplasia
(Akef.ldt & Qil1berg, 1999; CriDO el 0/., 2003). In this study, then: wen: equal
numbers ofmales and females with either a strong clinical Or a confurned genetic
diagnosis of PWS, and the mean age nt diag�osis did nOI differ significantly
between mal.,. and females.

5.3

Denlnpmeotal characterislics

5J.l

Angdmansymlro=
Although seven: or profound ID was common (S2.9%) in the AS study

group, the frequency was nol a< high as ha< been suggested in other reports (Lnan

.,al.,

[996; Leilner & Smith, (996). h would be expected that most people with

severe ID in the Slnte would be included in the records of DSC, as one of the
primary functions of the CommIssion is to provide support for individuals with
inldI.ctual difficulties.

Thus there is no obvious explanation for the relalive

paucity ofpl:ople with Seven: ID in the study. Both ofthe AS patients identified
with UPD had moderate ID, which may be indicative ofthe less scverophenotype
prevIously described in this su1H:las, ofAS patient (Monela et 0/., 1999b; lossi.
el al., 2001).
Table 5.1 (p. 76) provides a comparison between the frequencies of a
number of dingnostic features found in the presenl sIIldy and those ..ported by
other authorn. A Ir.ljority of the observed rates of cIiniCIII f""tures did not vary
greatly from those previously r,"oted, olti10ugh some minor discn:paneies were
noted. Leilncr and Smith (19'!6) found rn�t males were mo.. likely 10 become
independently ambulant, Md :\[ an ealiii( age, than females. This was supported
, .
In the prcsenlstudy,where thcinean og'� �fjndcpendent watking wassignilicnntty

greater for females (5.2 years) than for mnles (3.5 years) (Section 4.2.3). Th�
average oge or walking ror the whole group (4.4 years) was in close agreement
with figum reported by other authors {wn cl a/., 19990; Moneln et 0/" 1999b}.

AS

Literatare

.�·\7mth

,I,

walk�53mth

(Bunlinx.,�I� 1995; Smith et�I 1996: !..aan " "J.• 1999; Moncl." "J.• 19990;
w.lk�33·72rnth Mo"cla" al� 1999b)

"

�'OO

(BUllri"" et al� 1995; MonclReI"J 1999.)

Ab",ntlmiolmol.peech (%)
(n -34)

12_2Omth

.•

.•

Atnxia (%)(n a 34)

"

�,

(!lUll!i""" al.• 1995: Smith ,I "J., 1996; LiIIIll el"J.• 1999; Sod!mg<I al., 2004)

Beha>iotlr(%} (n -34)

,.

77_100

(Suntinx el"J.• 199�; Smilh <I"J.• 1996: !..aan <I aI., 1999; Monclo<1 "J.• 1999.)

MicrocopholY (%) (n · 20)

M

62-93

(!lunlinx tI01., 199;; Monol. eI <J1� 19990; Mon'Ia""J� 1999b)

Epilepsy (%) (n a 34)

..

79_8S

(Buntirn: <Ial 1995; !.eim", & Smith, 1996; Mi....l. ... " al.• 1998;
Monclaer al� 1999a; Clayton·Smith & LIIIIn, 200J)

Abn<JmUII E E G (%) (n c 27)

"

�,oo

(!luntinx<1 al., 1995; Leit",,< & Smith, 1996: Moncl. <I<>1� \999n)

Fe<ding diffiOlllli.. (%)

"

21_77

(SmIth, "al.• 1996; Mond.<I"J; 1999n)

Sln!bi",,", (%) (n • 27)

"

2 1_57

(Bunlinx <I01.. 1995; L... et al. 1996; Sond""","." <>1. 1997;
Monol.<Ial.• 1999.)

Hypoplgm=ion (%)
(n- 17)

"

".

(Bunl;"" <1<>1, 1995; Moncl. <I<>1� 1999a; Moncl." cl.• 1mb)
(Buntirn: et"J, 1995; Smith <I al� 1996)

(n �25)

"

Rcfcreac""

CbaraderisUc

Oo:v<lopmOllIlll delli)':
(n�29;n�28)

Hypotoni. (%) (n � 34)

"

48-{;3

Salli",i,!",.)
(> 15)" n � D)

M

25_10

Obesity (%) (n � 34)

"

IS_SO

.•

(!luntin",' cl, 1995;!..aan <Ial. 1996; 5"",IOIo
I m <IaI� 1991;
Moncl." 01, 1mb; CloyWn-Smith, 200I}
(Smi!h <Ial.• 1996; Monel• •,ai, 19990; M<IIl<I. <IaI� 1mb;
Clll)'loo-Smlth & l=n, 2(03)

The majority ofindividuols willl AS never acquire more llIan n few words
ofspe«h (Buntinx eta/., 1995; Monela et ai" 1999h: Alldersen ctal., 2001), IlIId
most ofIll. AS cases studied had cilller no ability 10 speak, or had only a very fcw
words in their vocabulary. Many individuals from llIe AS cohort were reported 10
be able 10 underslnIld some verbal communication from olllers. Commonly, AS
cases

arc

reported to have a higher degree of speech comprchClIBion llIan of

expression (Buntinx N al., 1995; Monela el al., 1999b). In 0 Norwegian study
(Andcrscn cl al., 20tH), llIe median cognitive age for AS patients between the
ages of two and 14 years was estimated to be [(} months (runge, 7.23 months).
This cognitive oge corresponds to Slage 4 of the sensorimotor period of
development as described by Piagel (CllIIIpbell, 1976), and onc of the
characteristics of this singe of developmen� defined as 'pre-Iangunge', is that
llIerc is a recognised ability to underslnnd verbal commUlliCDtion and show
intelligentbehaviours (Campbell, 1976).
S.3.2

Proder·W/II/syndmme

The I'WS study group conlnined n much smaller percenlnge of nonnal or
berderline intellectually disebled individuals than would be expected, i.e., <9% by
comparison with the 3040% reported by other researchers (Cassidy & Schwnnz,
1998: Wcbb Cl al., 2002).

As previonsly indicated {Section 5.t.1}, ilia case

asccrtoinm.nt method used in the present study was effectively biased to exclude
those with a borderline level of ID. Unfortunately, the study design and ethical
considerations precluded the use of the educational Sources described in Section
5.1.1. as a mODnS of identifying additional cases. The number of PWS cases
falling into the severe or profound ID categories (4.4%) did not differ
significantly from that Eiven in most oilier reports (Slnte & Dykens, 2000;
Clayton-Smilll, 2001), although one study did indicate that 18.8% of their group
functioned nt lQ <50 {C!nrke et aI, 2002}. Therefore, it seems probable that most
ofthe more severely affecled PWS patients in WA havebeen identified.

"

TableS.2

ComparUoD oftbe Prailer-Wil1i gTOopwitb tbe literature

Cbaraderistic

,ws

Literature

Hl'l"'tOtlia(%)(n m46)

96

liJ-l00
81_100

Weigh'�IIin{%)(n=46)

"'

HYl"'&"nadiom{%)
(nmI5:nm I9)
D<>,:opm""al del")'

Rerereuces
(Oill<»<tl_K"""b<tch., al., 1995; fridmBn., al., 2OOOb;
Webb., al., 2002; Whittingtoo.1 al., 2(02)
(Giltwen-K...b<tch tI al., 1995: FridmBn e/ al., 2OOOb;
w.bb.t al., 2002)

73-93

(GilI.<=I-)(u"b<tch .. al., 1995: Gun,y-Aygun tI al., 2001:
Whittinglon., al., 2002)

mole-94_Ioo
f<mol.-60-100

(GiU"".".Kaesboch tIal., 1995: w.bb <I al., 2002;
Wh<ttingtml., al., 2(02)

,it - 12mth
w.!lkm2'\_29mih

(Oillwen-K...ba<h ., �I.• 1995; W.bb., al.. 2(02)

(n-34:n-39)

,it - 12mU.
walk�31m!l>

Hyperphagia (%}(nm33)

85

(fridmm etal.• 2000b: Whittington., al., 2(02)

Short ,tnI\ll'e (%) (n = 39)

TJ.

(Oill....,,·K...boch et �I., 1995: FridmBn., al.• 2OOOl>;
Whittington"al., 20(2)

Hypopigm."laIfun (%) (n" 20)

75

(GiU==-K...ba<h.,aI., 1995; OWidy ok Schwartz. 1998:
WhittlngtD!l"al., 2002)
S8_77

(Gillcss""·K...bach,,al., 1995: Fridman <I al., 2OOOl>;
BUll"" al., 2002; Ylhinington tIal., 2002)

32-75

(La"""", ,, al.. 1981: B.,I.,.., al.• :!OO2; Whinington "al., 2002)

(Oill=en-K...ba<h "al., 1995: Whittington <I al., 2002)
Sooliosi, (%) (n _ 30)
Epilep!i)' (%) (n =46)

"

14-46

(OiU=en-K=ba<h <I al., 1995: FridmBn <I al., 2000b:

Butl.... al.,2002)

The frequencies ofselecled clinical fcalures within the PWS group were
compared with previously published papers, and the results summarised in Table
5.2 (p. 78). Speech artieulalion problems or delayed acquisition of specch lire
listed as minor clinical signs ofPWS (Holm .' al., 1993), however, in the currenl
study 85.7% ofPWS cases suffered from speech dcfccts. According to data from
the U.SA., speech articulation defects and some of the other minor features
appear la be more sensitive lIS diogno.<tic tools than many of the major criteria
such lIS characteristic facie. (Ounuy-Aygun e/ al., 2001).
This more recent rcscarch has produced additional infonnation On the wide
runge ofphc:notypie variation found in p""ple diagnosed with PWS, and for this
reason it has been SIlggestcd thot the existing clinical crite'!'ia may n=1to be
revised (Ounay-Aygun " al., 2001). 11 has also been recommended that specilic
features ofPWS should be differentially weighted as diagnostic tools

ot different

singes of life. Fore>tample, during infancy, hypotonia and feeding difficulties DrC
the most reliable indicators ofthe syndrome, and it is only after the

first two or

three years of life thol hypcrphngin, global developmental delay nnd obesity
become prominenl diagnostic traits (Gunny_Aygon el al., 2001; Whittington el al.,

2002).
5.4

Physical charactcristlCII

5.4.1

Angelmnnsynd,ame
The compll/lltively high pro]HIrtion of AS cases with hy]HItonia in this

study (Table 5.1, p. 76) may be a conscquence of clinicians hecoming
Increasingly aware of the value Df "]HIrting such clinical delails.

Truncal

hypotonia and limb hypertonia have previously been described as wlde"Pread in
AS (Lnnn ela/., 19%; Smith el al., 1996; Cassidy & Schwnrtz, 1998). As this
fcatufl: was not included in the diagnostic criteria, it seems improbable that all
physicians would have recognised the benefit of including the specific 1<,,:at;on of
any hypotonia nnd hypertonia in client files. At the present time, however, the
DSe "Pccialist disability clinicians routinely include this type of detailed
infonnation in their re]HIrts.
Earlier reports have suggested frequencies ofobesity in AS p.lticnts of I S

SO%,

and individuals with

UBEJA

mutations are usually

reported

to be more
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prone \0 becoming overweight than those with other AS di= genotypes {Laan

cl al., 1996; Monclad a/., 19998; Monela e/ aI., 1999b). More Lhan one-third of
the AS tohort in the present study wcre obese at some period prior to the time of
sampling (Tuble S.I. p. 76). which was within the expected nmge for AS
populations. There Was onc individual with AS who was originally thought to
have PWS due toobesity and hyperphagia, but who had no ataxia or inappropriate
laughter. This was similar \0 0 potieT1t described by Dupont el a/. (l999), who
showed also features ofboth AS and PWS and had, In addition \0 paternal UPO, a
SMC 15 which was lotated outside the PWSIAS crilital region.
Up \0 64% of adults Md 26% of adoles«nts with ID

ilIC

obese

or

overweight (Beang. & Lennox, 1998; Fisher, 2004), and 0 study from the U.K.
described 4.S-6.8% ofadults with ID as severely obese (Cooper, 1998b). Obesity
Is estimated to lessen the life-span by 6-7 y= at oge 40. Hypertension, Type 11
diabetes, coronary heart di=. dyslipidacmla, and gaU bladder disease
malO COmmOn in thuse who are obese, compared

\0

ore

all

people with 0 nonnal body

mass index, regardlcSi of their level of Intellectual function (Cooper, 1998b:
Labib, 2003; Marshall e/ aI., 2003; St-Onge & Hcymsfield, 2003). This means
tho\ Ihe obese and overweight members of the AS group would benefit from
regular physical nsscssment with the aim ofminimising the risk ofthese adverse
health effects ns they become older.
Strabismus (47%) was present in the study cohort at a similar rIIIe to other
AS patient groups (Buntilll( el al., 1995: Lann el al., 1996; SlUldlUlatn �t al.,
1997), and the frcqueT1cy was much higher thlUl the 1 1-13% noted for the geneml
populotion ofpeople wWt lD (Roid & Ballingcr, 1995:Thompson & Reid, 2002).
An cslimated 25-70% of AS patients have been described

lIS

presenting

with scoliosis (Laan et a/., 1996; Sandanam elal.• 1997; Monela et al., 19990;
Cloyton-Smith, 200l), and the perccntnge of sooliosis cases in this study (43.5%
of thos e :>I S years old) fell within this range (Table 5.1. p. 76). None of thi,
cohort ofpalicnli had received surgery fOT scoliosis prior to the collection ofdata,
Wld none were reoolded lIS having scvere scoliosis. Follow_up at a laterdate may
Indicate that the level of severity inorcases in ""me cases, leading to possible
surgical intervention.
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Rates of osteoporosis i�=ase with age in both the ID population IIIld the
general population,

IIIld

the condition oflen loads to

increased frequencies of

fractures in people with ID (Beangc & Lcnnox, 1998; Center./ al.,
of the AS

1998).

cases Were reported to have osteoporosis, even though

None

individuals

receiving anli-epileplic medicalion arc at 0 higher risk ofdeveloping osteoporosis,
due

10

1997).

abnormalities

in

(MurchiSlln e/ at.,

bone mClllbollsm

1975; Prestwood,

An investigation into the correlation between epilepsy nnd bone frnctures

WIlong people with ID showed thot 26% o f the epileptic ID population suffered
from one or more frncturc, but only 15%

of those

without epilepsy (Jancar &

Jancar, 1998). Among Ibe AS patients in this study, 17% ofthose with n history
ofepilepsy bad bone flllClures, but then: Were no reports of fractures in the four
individuals wilD had no ""izurcs. The sample sizes were \00 small

for any

finn

""nelusions to be drown, bal the direction of the correlation was in keeping with

previous reports.
PnuIe".Wili/ $Ji/fdrom�

5.4.2

of

Then: was stronS similarity between the frequencies

phy..lcal

eh"",cteristics found in the PWS group nnd the literature, with the exception
the relBtively high numberofpntients (n =

of

15) with hypopigmcntation (fable 5.2,

p. 78) among the 20 cases in whom this feature was recorded. There is, bowever,
considerable

disparity in the

prevalence

of hypopigmentation reported by other

authors as the trait is asscs""d in a subjective manner, IIlId comparison with family
members may be influenoed by the commonly ob!ierved darkening
skin which tends to OCCUr lIS children age. In sevCIlII studies it was

of hair IIlId

noted thul the

hair colour of both AS and PWS children with hypnpigmentntion be<.:ame darker
as they aged (Bu ntinx el 01., 1995; Sandllllam el al., 1997).
The very high rate ofobesity in the PWS patients WIIS as expected (Table
5.2, p. 78). There was
overweight or

obese

a

distinct

age difference between

and those whu were not (23.5

compnred with 4.3 years for non...,bese cases:
that younger potionts generally

fell

individuals who were

years for

overweigb�

/ � -4.033, P � 0.001), indicating

within the normal weight range.

The

administration of growth hormone therapy to four children with PWS may IISsi,t
the retention

of a

normal weight range into adolescence in these individWlIs, lIS

has been repol1ed elsewhere (Lindgren & Ritzen, 1999; Carrel 01 al., 2002;
Hoybye cl aI., 2003; l'lI!CJSon & Donaldson, 2003).
In general, people wIth ID \end to be signifieanlly less II.I,ltivc, eVen when
able·bodied, thon pe<lple in the wider popul.lion, which may contribute to U1C
weight problems exhibited by so mnny ID individuals (Rober1SOn ot al., 2ill10;
Fisher, 20M).

Their increasing obesity levels In rum lend to increase the

incidence of secondary conditions such

Il.'i

Type 11 diabetes and Clll'diovascular

disease (Turner & Moss, 1996; van SchrojcnSlCin Lantman-dc Valkelo1., t997).
Comparable health problems are likely to beset overweight PWS p�tienLS,
especially lIS they become older, In the U.S.A� rates ofobe'ity for the general
population have been increasing over the lll.'it 50 years. The proportion of adults
who wereobese in 1960.62 Wll.'i 13.4%. however by 1999·2000, itwllS 30.9% (St·
Onge & Heymsfield, 2003). It is estimated that the direct cost of obesity in the
United States is 3·8% of the total health cxpaldirure ond, worldwide, there Is
considerable loss of productivity due 10 sickness or =Iy denth wnong the obe,e
population (Labib, 2003). Similarly, obese PWS patlenlS arc likely to require
greater level. of health care for weight.related morbidities.
. Scolio,is hllS becn repol1ed in 32.75% ofPWS subjects aged 15 year,; or
older (laurancc el al, 1981: But!crel 0/" 2002; Whittinglon .1 01., 2002). Some
37% of the PWS subjects older than 15 years in this study showed signs of

scoliosis, and

IWO

had been surgically treated for the problem. There were,

how....er, 40%ofthe ,tudy group forwhom no data on scoliosis were available, so
that no finn estimate ofits pn:valencc could be mad. for the study Sllmple (Table

S.2, p. 78). 11 is possible that scoliosis will become less of a problem In those
individuals who are treated with growth honnonc, lIS the lenn body to fat mll5s
ratio and the degree of weight control move closer 10 the nonnal range, thus
pl.cing les, strain on the developing ,pine.
Relatively high mtes ofosteoporo'is (21%) nnd 05toopo""lo (58%), i.e., a
bene mass density ofbelWcen ·1.0 and ·2.5 SO, have been found In PWS patients
(Hoybye �I m., 2002). However, only two of the 30 PWS cases OVcT IS years of
age were repol1ed to have astooporosis. AJ; noted in Section 5.4.1, osteoporo,is
may be associated with the relatively high numbers of fnl(;\ures reported in the
PWS and/o, 10 population,

as

a single 5tandard deviation decrease in bone
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mineral density is estimated to increase the risk ofbrcaking a bone by n fnclor of
two (Marshall el al., [996; Center el al., 1998; Butler el aI., 2002).

Not

surprisingly, females are more likely 10 experience m.ctures at some time of life,
11$ young women gencrnlly reach n lower peak bone mass than men

(Prestwood,

1997). After menopause, changes 10 honnomil leve!s cause an increase in the rate
of bone density loss, leading to higher mtes ofosteoporosis (Ahlborg cl al., 200l).
The reduced level ofphysical exercise and [imiled mobility which are bQth more
common in PWS patients tend 10 decrense bone density (Bennge & Lennol(,

1998), thus placing persons of either gender with PWS

at sreater risk of

oslooporosis and bone frncture.
Among the PWS p"pulotion studied by Butler el al. (2002), approximately
30% had sustained one or more fmetured bones, with n comparable figure of 2 [%

omong those loilS than 1 8 years of uge.

The number of PWS patients with

fractures was significantly lower in this study group, i.e., 14% overall, and 4%
among those persons less than 18 years old. However, the data on froctures Were
only derived from dota linkage 10 the Hospital Morbidity system. Hence any
fractures that did not require hospital admission were nol recorded, andthere may
have oo.n more instances thot were trealed at an outpatient department or by

General Practitioner.;.

Given Ihe small numl>er of patienlS with osteoporosis

recorded in the study, the low incidence ofbroK(n bones may not be unusual.

As in previous studies, cryptorchism/genital hYP"plnsia WIlS present in a
majority or males (9[%) from this cohort (CllS.Sidy & Schwmtt, 1998; NichoUs el

al., 1998; CllS.Sidy cl al., 2000; Fridmllll el al., 2000b; Slate & Dykens,

2000).

However female genital hypoplll$ia, as evidenced by absent or delayed menses,
was reported in only 58% ofth. 19 female subject.s over 15 years old (Table 5.2,
p. 78). ThIs was significantly lower than figures from the U.K. which ranged
between 76-100"/0 (Lnurance el al., 1981; Webb el al., 2002: Whittington et al.,

2002; Crinu el al., 2003).
Within the su\>.group ofadull female cases from the present study with an
identified deletion, 011 had absent or delayed menses. The remaining eight female
subjects, none of whom had confirmed genital hypoplasia, were compo;ed offonr
cases with nonnal menses (including unc who had three children), three who
exhibited precocious puberty with early meoses, and One for whom no relevant

data hod been recorded. None of the eighl individllJlls hwl received a genelic
confl1nUlllon of PWS. therefore stallslics rel810d to these CIISeS should be
interpreted with appropriale caulion.

However, both precocious puberty and

fertility have bCl:n reported in Individuals with ge:nelica1ly-confirmed PWS
(Akefeldl et al.• 1999; Schulzc er al., 2001: Crino cl al., 2003). 50 lbal diagnosis
ofPWS cannot be excluded for llIIy of the eight women discussed above.

S.S

Bebavloural ...pocb
Up 10 69% of intelleclually discbled individuals aged over 65 years

experiencc a comorbid psychi"tri� disordcr (Cooper, 1998.; Bowley & Km,
2000).

Of these cases, 40% have been described as suffering from seVere

emotional or behavioural disturbancc (King er al.. 1997). 11 has been suggested
that the challenging behaviours often shown by people with ID may be related \0
the nbnormally high anxiety levels they experience in situations which would nOI
be perecivcd as stressful by persons with normal lnlellectual funclion (Jansscn er

01" 2002). The limited social networks and poor so1f-estecm frequently exhibited
by people with inlellectual disabilities can also havc a neg81ive imp,cl on their
behaviour and menllll health (Walsh, 2002). In edditton, the presence ofcpUepsy

has been linked 10 a variety of psychiatric disorders, maladuptive bebn.viours, and
sleep disturbances, although il is not clear if epilepsy cnuses these conditions or is
D """morbid feature (Bowlcy &Kerr, 2000).

SS.1

Ang�/""'n :;yndf(J�
The majority of AS subjects were reported In bave the chamcll:rislic bappy

disposilion associated with the syndrome, although S<lme individuals occasionally
had II:mpcr tantrums or periods of withdrawal.

It seems probable that these

episodes may have been relaled 10 the frustration ol\cn experienced
who arc unnble

10

communicate their wants or

.10-00;\;

effectively.

by persons
The rew

individuals from the cohort who hod attended psychiatric clinics wen: not
recorded as having specific psychiatric disorders; rather their admissions were "
consequence ofthe devclopmcntnl delay and inlellectual disability associated wid1
the syndrome. There Were only limill:d data on theprcscm:. ofsl".,p distnrbances
among the AS group, which previously had been described as a minor
consequence of the syndrome.

"

5.5.2

Pnule,..WlIlJ syndrome

Although no member of the srudy ""hort wns over 51} years old, eight
individuals (l7.4%) had some level of contact witJo the State p5)'chiatric servIces

by the time of dota collecllon. Seven of these people were over 15 years old, IIlId
onc was 12 yC/ll'S si� months at fif!t contact with p5)'chinlric services. The adult
patient who had attended mor: than one thousand outpatient sessions suffered
from !1 combinnlion ofbchavioUnll lll1d emotional disordcrs (Section 4.3.7). The
majority of the

cases

were being nssessed IIlId treated by the menial h""lth

specialists for ID er developmental delay. rather thlll1 for psychotic episodes.
The behnvlourIll traits exhibited by the PWS study group proved to be
particu1arly problematic in tcnns ofthe administration of routine care. Temper
tantrums, violent outbursts III1d stealing, commonly of food or money to buy food,
were reported for a number of the PWS individual!. However, the diagnostic
criteria require that five or more of the ehnructeriS'N behaviour symptoms

ore

present before they un: accepted as a significant diagnostic feature (Holm ., al.,
199�).

On this basis, there was insufficient informallon to state the real

prevole�ce ofthe characteristic bchoviourIll real\rres in the study sample.
5.6

Neurolngicnl findings

5.6./

Angelmansyndro1ll4

Seiwrcs were reported at some stageoflife for 88% orth. AS cases in the
study. This was ""mpamble to the prevalence statistics given In other srudles
(rabIc 5.1, p. 76}, lIlId almost double the mean frequency of seizures present in
the wider ID population (Rdd & Bollinger, t995; Leitner & Smith. 1996; Smith et
aI., 1996; Clayton·Smith & Lnan. 21}1}3). Seizures and epilepsy arc more frequent

in people with intcllccrunl disabilities compared to the general popUlation, and the
presence of seiwre disorders tends to correlate positively with the degree of
intellectual hlll1dicap. vlU)'ing from 14% of individuals with mild 10 to 44% of
those with severe 10 (McQrother el al., 1996; Beange &; l.cnno1<, 1998; Bowley &;
Kcrr. 2000; van SchrojcnSlein Lantman·De Yolk el 01., 2000; Fisher. 2004).
Some previous reports have stated that epilepsy In AS decreases in
frequency and severity with advancing agll (Buntinx ., 01., 1995). However, there
WII.'i

little evidence of any reduction in the OCCUrmlce of seizures within the AS

..

study group.

A sampl� of 100 individuals with seVere or profound ID were

fonowed by researchers in the U.K. over n 26_yenr period, and similar proportions
ofthe group were epileptic at all data collection times (2&-32%), indicative ofthe
persistence of seizure nctivity throughout the lifc-coursc of many individuals
(Reid & Ballinger, 1995; Thompson & Rcid, 2002). Conversely, the incidence of
epitepsy h"" been reported to decline among older intellectually disabled people
in The Netherlands and the U.K. when compared to younger adults. This finding
Is possibly a sign of the healthy survivor effect, since the presence of seizures
significantly lowers life expectancy (van Schrojenstcln Lnnlmnn-de Valk el al.,
1997; Chnney & EymWl, 2000: Patjael al., 21100: Morgnn et al., 2001).
Around n quarter (26%) ofthe seizure activity among the AS study group
was reported to be difficult to control andlor of frequent occurrence, lJUlking
epllepS)' onc of the mo51 significant health problems for indivldll!lls with AS and
their families on1 enrers (Bowley & KelT, 2000).

The eldenslve EUTlount of

hospital care needed for treatment of epilepsy attests to the severity of the
condition within this group (Table 4.4, p. 59). In nddition, one of the two deaths
in the AS group was attributed to epilepsy.
Tho majority ofAS patients have specific abuonnal EEG patterns (Leill1er
& Smith, 1996, Smith el al., 1996, Monela el al., 1999a; Clayton-Smith & LtIIUl,
2003).

Among the AS cohort, abnonnalities were evident in 25 of the 27

individuals who had at least one EEG perfonned (TDble 4.2, p. S5).

Of the

individuals tested, three hrul no recorded epileptic episodes, even though two of
these

three people demonstrnted the chorneteristic EEG

patterns of AS. It has

been proposcd that the presence of suggestive EEG pallems, cven in the nbscnce
ofseizure IICtivity, could be used to assist in differentiating between AS and some
mimicking conditions, ond forthe eonfinnation ofAS in those individuals lacking
an identifiable genetic mcchlll1ism (Yalente el al., 2003).

The results of the

present study provide elenr support for the potential application of this proposal.

5.6.2

Prade,...WlIIIIf/lldro_
Epilepsy bas be"" previonsly reported in n significant proportion (34-42%)

ofPWS cases (Butler.' al., 2002), which is n slightly higher mte than the 21%
given for the oVClllll intellcctuulIy dis"bled populntion (Reid & Bnllinger, 1995,
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Coopc:r, 1998b: Thompson &. Rdd, 2002). Approximately 28% of the present
cohort had nt least one episode of epilepsy or convulsions throughout life (Table
5.2, p. 78). In fact, at 4.3% of total admissions, epilepsy was one of the more
common rea5Oll5 for hospital admission within the PWS group (Toble 4.7, p. 67).
It Is possible thot hnploinsufficiency, i.e., low dosage due to the lo,s ofone allele
ofa gcne Or genes within the PWSIAS critit:II.' region, moy COIU.., the development
ofcpUcpsy in patients with PWS, although the ,�izuros were genernUy in n milder
fonn than those ruffere<! by individuals with AS.
5.7

Laboratory diagnosis
There appeared to be some lack of effective testing to dctennine the

specific ge:netic mcchanism(,) in�oIved in the aetiology of AS in a con,idernble
number of cases. More thon a third orth. AS group had either n klU)'otype or
banding test only, orno diagnostic test at all. 10 addition, 111= had becn no tests
undertake:n for le defocts, and only one (which was negntive) for an UBEJA
mutation, even though eight of the 34 subjects showed biparental methylation
(Table 4.2, p. 55).

Many of the patients had been offered the most recent

laboratory diagnostic tests os they became nnilable, but the take-up rate wo>
exceptionally low. Further qualitative research would be needed to invcstigote the
mtionale for this apparent reluctance to take advantage of the newest diagnostic
ICchniques, although much ofth. lack of motivation may be simnar to that related

to the limited use ofscrccning tests by ID persons in the U.K., and the lowcrrntes
of mammography �; conducted on women with 10 compared to 1110 general
population in WA (Pearson el al., 1998; Djuretic el aI., 1999; Whitmore, 1999;
Sullivan el al., 2003).
There seems to be a perception by some physicians and/or carors that such
tests are UDIlecesswy, or that tile patients will be markedly upset by the procedure.
This �iew i!! supported by the fact 1I1at severely ID individuals may become
cxcessi�ely "gilnted when undergoing phlebotomy or oth�r mcdical procedures
(pearson <I al" 1998; Asprny el aI., 1999; Djuretlc elal., 1999; Whitmore, 1999).
Monetnry comiderutions may also play a role in the unwillingness of fwoilies and
carcrs to agree to comprohen,i�e genetic testing, and almosl20% of1l1e cases in

tIlis study li�ed in more romote region!! of the State wb= SIIlIlpling is more
difficult to IImIIlge. In addition, infonnation about the new testsmay not be freely

available, er, In some cases, comprehensible te many laY·p"rscns. These could
well beadditional factors affecting the poor uptnkc ef laboralory tests.
It ls apparent that the avcrngc age at diagnosis for AS is continuing to fall.
following al. inc""",ed understanding and appreciation of the phenotype Md
improved genetictesting (Leitner&. Smith. 1996; Loan 0/ al., 1999a; Smith 0/ ,,/.,
2003). The absence ofumunbiguous clinioal signs in young AS patients may be
the major reason for the meDII age ofdiagnosis for the study group remaining III 5
or 6 years, even though there has been u rise in the numbers ofAS cases identified
before the age of2 years during the COIUSC ofthe IllS! decode. As with most ether
reports, no gender bias was IlPJl'lf"nt in the group of AS patients (Leilner &. �mith,
1996; Smith et ,,/., 1997). The numbers of AS cases diagnosed per five-year

period rose steadily until 1995, but there had been no individuals diagnosed with
AS and registered with DSC after that time.
Substantial

numbers of PWS patients also had not undertaken

comprehensive diagnostic testing. However, nil but one ofthe 14 cases added to
DSC files since ]993 had a positive geneticdiagnosis. The smg]e indiv!dll!ll who
had not nndergone genetic testing was clinically diagnosed al 6 months ofage and
wllS only 1 I months old DI the time ofdata analysis. Therefore. it seems probable
that the requisite genetic tests had yet to be conducted. OfL�e 32 clients added to
the mes prior to 1994. six had not been tested, five had a karyotype examination
enly. nine were tested by banding. and the remainder were positive on FISH or
melbylation testing.
As was Ihe case with AIlgelman s}'Ildromc, the issue ofdiagnostic tesling
for established clients is interesting in that, although specific new tests have
[,.o-r,o!nc available over the course of the last decade. there are still mllIly
indi',idunls who have nol partidpated in genetic an.lyses which could provide
confirmation of their genetic abnormality. Ifparental Or carer inertia is the main
reason For lbe lack ofdiagnostic testing. then a campaign efieltelS IUld inter;iews
may be �ffective in helping te procure consent for these procedures. This strategy
would need to explain the importance to future generalions of improving lbe
understanding ofthe mechanisms involved in the development of the syndrome.
and the =0. risks within thd families concerned.
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The presence oftwo distinct peak5 in Ihe rate of di�snosis of PWS

per

live-year period Is an interesting p�enomcnon (Figure 4.3, p. 54). The fir.;! peak,
in 1980-19&4, coincided with the movement oflD in�iYidunls from Swanboumc
Hospilal lo either I'yr!on Trnining Centre or to one of the new hostels for people
with ID. DUMg the movement process, each person WIIS reassessed at Jrrabecnn,
which may have resulted in the larger number.; of diagnoS<ls during thot time
period (SI.Iin, 1996).
1999, could be

The ,eccod peak, which oc:culrod over the yews ]995·

nssoc;nl!:d

with the prior publication of the clinical criteria in

1993, and the development of l�borntcry \ests fOT genetic diagnosis.

It

is,

however, difficull to understand why no complll1lblc peaks were ob,::n'cd in the
diagnosis ofAS.

n•• definitive identification ofPWS has become ....ieT in the last decade
since the devclopml.'llt of a comprehensive I1lIlge of laboratory tests and, lIS

n

"" ult, Ihe age at diagnosis has been falling oonslstenlly. OYer the I!I.<I four years.
nine of the elevCII PWS cases added 10 the DSC database wen: diagnosed before
the age of onC year. This was similar 10 the results of 11/1 Austrnlasill/1 survey that
found 71% ofnew diagnoSC5 were being made before the firsl birthday (Smith el

nl.• 2003). These figures an: in shatp oonlrasl lo 11/1 earlier report in whieh 36% of
PWS cases were nOI diagnosed unlil afler 16 years of age (G",enswag. 1987).
The oldest age al which a memher of Ihe preSC1lI study group Was diagnosed was
17 years (in 1982).

5.8

Morbidity

S.B.l

Angl!lmansyndrome
Epilepsy, ",spirlltory inH:clio!l5, Helicobaclerpylori Infections, Md gastric

renux, all of which can I..,d

10

oe:;ophagcal disease Md/or "",,,phagcnl

c:nn:inomas, !!<:Cur ot higher frequencies among peopl.

with

intellectual

disnbilities thDll in the general populalian (Turner & Moss, 1996). In this study,
respiratory system disorders oomprised a significanl proportion of the primary
grounds for hospitaliUllion (Toble 4.4. p. 59). Oesophagitis was a'so found In a
significant number ofthose admitted for gastroinlestinal prohlems, similar to the
results observed by ClaytOn-Smith (lOOI), who dcscriboo oc"'phageal ",nux as
one nfth. main mooicn! problems found in 28 individuals with AS (aged 16-40
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years). Epilepsy was also onc ofthe most cemmen reasons for hespi"'l admissIon
among theprcsentstudy group (T"bl.4.4, p. 59).
As summarised in Section 4.1.7, " disproportion"te numbor of the total
hospital admissions for dentnl work were for AS cases with severclprofound ID.
Much of the dental work cenducted on the AS patients involved tooth filling.
cleMing and scaling, which an:: normally cen.lidered to bo minor procedures
within the geneml population. However, many pcrs!!ns with severe ID require a
general Ma""thetic 10 a!low any inll1lSlve medical procedure to bo CWTied out,
including venesection, injections, end dental work

(Bujok &

KnDpik, 2004),

which would explain the high rotes ofhospito.lization for these procedures.
People with intcllectual disabilities huve a higher prevalence of particular
health problems thllll the genernl popuMion.

These include thyroid diseases,

visual and hCllling abnonnalities. deficiencies in oml heatth, Md cardiovascular
disease (Beange & Lcnnox, ]998; KDpcll
Fisher,

10(4).

el 01..

1998; How]ey & KelT, 2000;

nU of which an:: especially prevalent in

Down syndrome patienls

(Pmsher, ]996; VM Sehrojenstoin l..antman·de Valk el al., 1997; Saxena, 200]).
Almost halfof the AS group had visu,] problems, mesl]y strnbismus, but there
was very lil\le information available on the presencc of thyroId diseasc. h.,..ing
difficulties, or eordlovascular disease.

5.8.2

Pratltr-Willl syntlrolnl!!
Re:;piratory disorders were prevlous]y noted in 46% of PWS patients

(Butler el 01.. 2002), and in the p=t study a similar propor1ion of.ubject.! had
boen diagnosed with "t ]east o�e �pisode of I15thmll, pneumonia or respiratory
di.ease over their lifetime (Table 4.7, p.

64).

Many of these illnesses required

hospilll]ization, making rcspimtory problems the mo,t COmmOn primwy reaso� for
hospital admission within the patient group, RespimlOry diseases arc /lmong the
most frequent Ciluses ofdcath for peop]e with My form of inteUoctual disability
(Beans. & LennOx, 1998; Janicki
infcetior.5, hepatitis

et m.,

]999; Patja el al., 2001). R�,pimtory

B, C IrIld D, and tubereulosis arc also found mOre often in

institutionalised POPUllllion, (Turner & Moss, 1996), and Illere were two PWS
pntients in this study wbo had tontrncted bepatitls at some stage oftheir life.
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As with Angelman syndrome, many ofthe PWS JIlItients attended hospilal
for denial procedures (n � 14), and a significant numbe:rofthe males (n - 9) also
required lfealment for undescendod tcsles (foble4.7, p. 64). The former problem
was probably associated with their intcllectUIII disability, while the 1.ller disorder
is more specific to l'rlIder-Wil1l syndrome.
Three carcinomas were rerorded for the PWS Stoup.
malignant, but nil were treatod successfully.

Two were

Althougb the reported rates of

cancer.; ore relatively low, carcinomas may present a UIlique threat to those with
intellectual disability, as there have been reports from the U.K. and Australla of a
poor uptake of the nvailable screening programs by individuals with ID, chiefiy
women (P=n el al., 1998; Aspray et 01., 1999: Djuretic el dl., 1999: Whibnore,
1999: Pntja el a/., 2001: Sullivan

el 01., 2003).

There appear to be: n variety of

ralionales for this under-utmsntion ofl/>� available programs. Some membc:rs of
the target groups may be dismissed by their doctor as not needing the tests, due to
a presumption that there arc fewer environmental risk factorn associated "'ith the
lifestyles of the ID population, Or to the assumption th.t people with ID an: nol
sexually active (in the tII5C ofcervical smears). Some individuals arc difficult to
\cst because of behavioural or cooperation problems, and yet othCTS refuse

consent, or have consent refuscd on their behalfby care.-:", for unidentified reasons
(pearson el 0/., 1998; Djuretic el 01., 1999; Hall & Ward, 1999; Whitmore, 1999).
Although two ofthe Cl!.SCs ofcarcinoma had been made before the inception ofthe
Cancer Regist:y, the pruticulars of the diagnoses Md tn:alment were available
through the DSC JIlIJICl" files, which strengthenod the likelihood that nil the data
pertaining to CfII1Cers within thi. group Were IICccssiblc.
The positive heulth consequences of screening tall be eonsldemble, as was
found in New Zealand when: compreneru;ive health screening of most oHlle ID
populatiou in a single region resulted in almost thrcc:-quartcrs ofthe people tcsled
requiring furlller actions, e.g., vaccinations, optical work, blood tests, dental work,
and ear, nose and throat consultations. If these interventions had not taken place
the quality of life of the individuals may have been greatly impaired (Webb &
Rog=. 1999).

Other researchern have nlso found relatively high rates of

unsuspected but treatable disorders among those with ID (Sutherland et al., 2002).

90

s,�

PWS-lIke dl!order coml'utd 10 true PWS
Ccmpari�cn cf the phomotypic featun:5 of the small group of PWS-likc

palients with Ihe PWS group re'/caled some features that were common 10 or
differed between the two groups (Tohle 4_5, p. 61; Table 4.8, p. 66).

The

Incidence of obesity, hypogonadism, hyperphagia, and speech defects was not
significantly different between the two groups.
developmental delay.

Neither was the level of

However, feeding difficulties, short stature, and skin

pIcking were 011 no\.Qbly less prevalent In the PWS-like group than in the PWS
group_ Epilep:;y was reported somewhat more frequently in this group (4U%) than
in those with PWS (28%), although the small sample size meant that 'he
differencc was not statisticaUy significanL There was no discernable pottem 10
theyeors in which thediagnoses ofPWS were made for the people in this group.
'
In gem'l'lIl, the PWS-likC group showed many of the characteristics
,
reported in a U.K. stu�y of individuals who hod a supertlumermy inverse
duplication(15) mnrker chromosome (Wcbb et al., 1998). In that study, 011 ten
probands who ellhibited a maternally-derived inverse duplicate SMCI5 had some
level of phcnotypic abnormality.

All showed de'/clopmenllll delay, hypotonia,

and ID, and most had SOme history of seizure activity, autistic charncteristi",
undlor behavioural abnormalily (Webb el al., 1998). TherewllS nO record that any
of the present PWS-like study gmup hod been tested for autism. Six of the ten
pntients in the U.K_ SMC study had three rr more copies ofthe DlJSll locu. on
the mnrker chromosome, and all of them possessed four oopies or the PWSIAS
critical region (Figure 2.1, p_ 20). Ifth. D1JS/J site is present on aSMC, then on
abnolillal phenotype, nOI m,ecssarily PWS or AS, generally results (Cotter e/ aI.,

J<}99).
It could be helpful if cnscs with clini""Uy diDgIlosed PWS but nonn.1
methylation patterns were reviewed, with special attention paid to the presenc<: or
nbscnc<: of mnrker chromosomes.

Where no chrl5qll-q13 mutotion is found

associated with the PWS-type phenotype, several other disorders could be
considered as potenlial explanations for the clinical profile ofthe PWS-like group
(Sec:tion 2.3.3.5).
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5.10

MGrtalUy
In

the pllSl, the mGl1IIlity ",tes for institutionalised persons with ID were

cornidembly higher than those: found In the gcnCI'D1 population.
mortality TIlt. for people

with ID

in a Greek institution

For instanoe, the

between 1965 and 1995

equated to 59.2 d""thsllOOO JICI'SOn-years, whioh WIlS 20-150 times hicher than
age/sex-specific

for the rest of Greece at that time (J'emkis d 0/" 1995).

rotes

0-,.... the thirty-year

study period,

22%

of patienLS

died within One year of

admIssion to the institution. The dcnth mte WM marc f""lucnt in the a!;c range

1-

4 years than for older pcople in the study, possibly due 10 the pnrticulur need of
children with ID for high levels ofCDJ"e, which Were unmel in those circumstances

(Pernki. er 0/" 1995).
In Finlnnd, disease mortality mtes for people with ID have fa!!en 10 similur
levels to Ihose in the gen=l population

after the age of 411 years, but they still

tend 10 be somewhal higher prior 10 that ll8c, suggestive of the healthy survivor
effect (Palja eta/., 20()[); Poljad 01., 20(1). A study in the U.S.A. fOUlld thal men
with ID who survived

10

90 y= or older arc likely 10 hove higher levd, of

cognilive funclion than either middle-aged ID men or ID women, which WM
accepted II.'i further evidence of the differenlinl survivnl of less severely affe::led
individuals (Perls cl 01., 1993).
The presence ofepilepsy al any lim� oflife hos been shown 10 incrcnse the

relallve riskofdeath 10 My person, irrespective ofthe level oflD ofthe Individual
(Palja e/ a/., 2000).

However, Dutch ohildren who fU/lctioned within the normal

range of IQ had no incrcnscd mortality ratc in conneotion 10 epilepsy (Collenb.ch
e/ 01., 2001). Epilepsy increases !he standardised mortaE�J' ratio (SMR) of those
wIll!

ID

from 1.6 times the mte for the general population la 5.0 times,

cerebral palsy

increases the SMR

lID!!

S.4·fold (Slrauss e/ 0/., [999; MOrgM e/ 0/.,

2001). Antistic individuals nonnally have lID overall SMR of 2.4, but autistic
people who

olso suffer from epilepsy hove a SMR of 33-38, OS the combination of

the two disordel3 seems 10 greatly magnify the adverse effects ofboth conditions
(Shavellee/al.,2001),
Among individuals with ID,

deaths from cpil'psy M a

primary or

secondary cnus<: are found to occur at yonnger agcs (mean age at death � 29.8
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year,;) than those who die from causes other lhIIn epilepsy (m",," age at death >50

years) (Potjo el al., 2001). However, over the last half century there has been n
d� in the proportion of [0 individuals who die from slaJlLJ epilepliCU.J, as

improved medication has increased the degree ofconlro! oftheir seizures (Chaney
& Eyman, 2000; O'Cal[agilan el al., 2004). Only one AS patient from the present
study cohort had died ofepi[eJ1'Y. In Au,trn[ia, individuals with severe cerebml

palsy are much more likely to also have severc ID and epilepsy, both ofwhich are
associated with greatly increased mortality, �omparcd to those with a modernte or
mild phenotype (Strnuss el al., 1999; Reddihough el al., 2001; Camficld el 0/.,

2002). This i. particularly evident in persons from younger age groups.

Respiratory complaints are regarded as significant prinl.llry cauSes ofdeath
among individual5 with ID, lIS are diseases ofth. circulatory system (Beangc &
Lenno", 1998; lnnioki el 0/., 1999; Strnuss el al., 1999; Chnney & Eyman, 2000;
Potjo el a/., 2001; Reddihough el al., 2001). One person with PWS nnd one with
AS from the present study cohort had died of pneumonia, nnd two PWS
individuals died from cardiovascular failure. Both a Finnish nnd a U.S.A. ,tudy
have found that CW'diovascular disord= arc the mo,t frequent caUse of death
among pcoplewith ID in those countries (lnnicki el al., 1999; Patja ela/., 2001).
The same rcsoarch groups found thot cancers ofall types are slightly less

likely to be the primary causc of de.th in poople with ID, regnrdless of .ge or
level ofhandicap, than in the general population (lanicki cl a/., 1999; Potjo Cla/.,

2001).

This is

in concurrence

with the present study in whieh

none of the

Individuals died from Cilm:er, with at! three ""rdoom.... being successfully treated.
However, 15% of 4028 people with cercbml palsy in a Californian study died
from carcinoma, often in infancy or adolescence, and cancers mised the SMRs of
auti,ti" individuals in the """,e stnte to 1.9-2.9 times th.t ofthe genernl population
(Strnuss cl al., 1999; Shavelle et a/., 2001). Older cerebral palsy patients in the

Californian study population appeared not to have any incrensed susceptibility to
canccrs, which may be a rellection of the lifestyles of poople with ID, who are
expected to have lower levels of exposurc 10 carcinogenic agents over their
lifetimes than the general

population. For e)(l!J1lplc, both

consumption are much less widespread

smoking and 81collol

among individuols with ID, and

wcrkplaccs for those with ID are less likely to contain chemicals, dust or other

cardnogens (Robertson e/ al., 2000). Some carcinomas an: not associated with
home- or wolk-based carcinogenic agents. Then:ron:, then: may be some degree
of unde.-.diagnosis of cancers in th� ID populat!on due to lack of =nlng, as
5IIggestcd by SUlliVM el 01. (2003).

PrevloU.!lly reported low rates or cancers

could also have been influenced by the reduced life-span of ID individual, in
earlier generations.

FUTURE ni'RECTlONS

••

The study has seJ'\'ed [0 highlight different genetic and clillical 8Spct:ts of
Angclman syndrome, Prad.,..WilIi s}'Il<irome, and the Pnulcr-WilIi.likc disorder
diagnosed in a minority of the patients investigated. In this concluding section,
direction.s for rubIn: work will be considered.

ellre requlremfnts

6.1

The runS!! of physical, neurological and behnvioul'IIi problems experienced

by

individuals with

ID

suggest thnt the vast majority need some degre. of

supervision or carer attendance. The extent ofcnrer involvement is varied !lIld
dependi On many facton;, e.g"

level of

ID,

physical health, mental health,

adeptive skill level, Md degree of sooialisalion (McGrotbcr e/

nl., 1996).

Individuals who have relalively high functional nbility may not require continuous
supervision, but there is likely 10 be some need for occasional help with non
stnndanl matters, such as financial or legal business.

Fonn.! guardillll5hip

arrangements also may be ncceSSlll)' lIS the person age:;, or if they become
incapable of managing their own affairs and no appropriate family member is
available (Milano & Nanba, 2003).
The majority of Individual� In the present study were living in home
envlronmenls. However, the averageagc ofthe individuals in residential care Wll.'i
much higher than that ofpaticnls staying at home. Thus it must be supposed that
there will be an increased need for sheltered accommodation when parents or
other CDrers become unable to provide home care through age or other incapacity.
Thiswill increase the burden On the State Disability Services budget IIIld available
I'llsources. In addition, currently there Drc limited numbers ofthe h'lIlned support
staff who would be needed to equip the greater future numbers of hostels Md
group homes (Megahc/, 1996).

MIIIlY

health issues Drc specific to the elderly, even those within the

nonnlll range of intellectual function, and lIS individuals nge they oflen become
mOI'll reliant on carerS for a number of functions. The need for assistance with
medication management is very common, and an estimated

82% of persons of

avelllge intellectual capacity living in a personal care environment, Le., n level of
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care between living at home and a nursing home, need this type ofaid (Quinn el
0/" 1999). Other = where support Is often required arc: personal hygiene
(69%), viSlllIl (42%) Md hearing (60%) impairment, arthritis and rheumatism
(43%). Incontinence (42%), mental health conditions (43%), mobility limitations
(39%), and hypertension (30"10). Most ofthese difficulties require assistance from
carers to prevent further deterio!'lllion ofthe health of the patient (Quinn el al.•
1999).

As these conditions

arc

found at similar

or

higher !'lIles in the ID

population (Reid & Ballinger, 1995; Thompson & Reid, 2002), the consequent
need for""'" assistance is even greater among the disabled.
Hearing Md visual impairments are liable to be under-dingnoscd in the
Intellectually disabled populalion, of\cn due 10 the failure of the individual andfor
their = to recognise the signs of impairment. Unusual l>ehovlours, such lIS
imu:tivity, irritability, self-injury, Or autism-like symploms may be indicative of
sensory impairmenl (Nngalzmun & Vink, 1998).

Up

to

half

of

all Down

syndrome individuals have been fOUIld, 10 have SOme degree of h=ing
impairment, and many also sufTer from visual disorders (Kapell et Ill., 1998;
S!lXenll, 2001; Harvey, 2004). In lhe U_K., 1 1 -13% oflD pcople followed over a
26-ycar period were visually impaired. The numbers of individllllls from this
study who were hearing impaired, incontinent, andlor had mobility problems all
Increased overtime (Rcid & Bollinger, 1995; Cooper, 1998b; Thompson & Reid,
2002).
Progressive loss of mobility with lIgeing i!l common to both the gencml
populalion and those with ID, lIS are incontinence and chronic constipation
(Evenhuis. 1997). In addition, lIS individunls grow older they are likely to recover
mOre slowly and less completely from freclures, resulting in permanent loss of
mobility in many cases and a concomilllnl increase in the level of care required
(Beange & LennoK, 1998; Centerel al., 1998).
Although 11 range of mental health problems are common in the elderly,
dementia is found in less than 6% of the generel population over 65 years old,
however it is present in ppproximnlely 25% ofpemms who nn: between 80 and 85
years old. In individualo; with ID. 15%ofthosc aged belween 65 and 74 years and
70% of those older than 85 yearn have been reported to have signs of dementia
(Cooper, 1997; van Scruojenstcin Lantman-de Valk el 0/" 1997; Cooper, 1998a).
"

When compDred to those without dcmentlD, Individuals with dementia arc more
likely to be older, female, non-smokers, with poorly controlled epilepsy, andlor
.with a higher number of additional

physical disorders (Coop"r,

]9980). Down

syndrome CllITies 0 disproportionate risk for early OIl5C! dementia, especially
AlUJelmcr's disease (van Schrojenstein Lnnbnnn-dcYalk et 0/., 1997; Beange &
Lenno)(, 1998; BillIes & Glasson, 201>4).
None ofthe present study group had evidence of dementia.

However, the

oldest member of the cohort was 48 years 4 months cfage, which prob.bly wns

not old enough for elItly onset dementi. to become manife,';L There were no
reports

in

the patient files of increased

individuals with either Prader_Wil!i or

rutes

of early onset

dementia in the

AnBelman syndrome, such as

is found

in

p"ople with Down syndrome.
6.2

Where to from bere?
As discussed previously (Section S.2) there Were . number of limitations

associated with the data

collection

quantity of data recorded

for this study,

in particulll1"

in many potienls' file,';. To produce

th� quality and

a comprehensive

overview of the phenotypes and ageing charoc\eristics of individuals with AS or
PWS, it would be necessary to expnnd the scope of the projcctto include access to
Medical Practitioners' files, Medicare dali!, and hospital outpatientrecords.

As noted by Hollt1llJl el 0/. (1999), General PnlCtitioner re<:ords and
MedIcare details are held by the Australian Commonwealth Govemment, and
during the study
Linlrnge VniL

period

il wns not possible \0

link

the.. data to the WA

Data

The Hnlmge ofWA residents with the Medl= Benefils Schedule

(MBS) and the Pharmaceutical Benefils Schedule (PBS) was approved in mid·
2004. Any

future project clUImining

from this odditional data
specialist physicians, and

the two syndromes would benefit grently

lin1rngc, a9 all visits to Geneml PIlICtitioners and

all mediClltions prescribed (since 1984 for the MBS, and

1990 for the PBS) will be recorded in these datasels, thus allowing a significant
expansion of

detailed information on the

morbidllies assocIated with each

syndrome.

The usc of comprehensive questionnaires and/or interviews,

aimed

al the

familie,'; and carers or the clienls themselves, would also be n valuable ancillary
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resource to extend the /'!illge of information available On individuals with AS or
PWS.

Specific instroments such

Children or WeeFIM (Msall

lIS the Functional

Independence Me= for

.1 al., 1 994), the Food-Related Problems

Questionnaire (Russell & Olivel, 2003), and the Quolily of Life Questionnaire
(Schalock el al., 2002) could be use; to lIS5ess pnrticulnr aspects of the lifestyle
""d care needs �fper.ons with Angelman or Proder-Willi syndromes. There nre
also questionnaires designed to elicit information on levels of carer stress Md the
elTeels, both positive and negative, ofhaving a fll/llily memberwith an ID, such as
the Fnmily Stress and Coping Interview (Nnchshen e/ al., 2003), the Cnrers
Assessment ofDifficul!ies Index (Nolan cl 01., 1990) , and the Carer.; Assessment
ofSatisfaction Index (Grant .,al., 1998).
Specific dalll on the influence of a pnrticulnr genotype on the preSCIlting
phenotype would requir'! that the majorily of AS and PWS patients undergo
comprehensive genetic testing.

At prosent there are substantial numbers of

patients who have not pnrtidpated in this testing, and so their status with regnrd to
spedfic mutations within ehrlSqll..q13 ,lmnins unknown. Personal approaches,
including home visits, stressing the benefits to the family in terms of accurate
recurrence forecasting, nnd

to the

individuals with respect to morbidities which

might be avoided or mitigated by early intervention, could encourage groater
participation in the testing process. There is also some evidence that diagnostic
certaInty is ofpsychological benefit to mothers ofcbildren with Down syndrome,
enabling better use of coping strategies and improved emotionol stress levels
(l.enhard er al., 2004). Future cases could also potentinlly benefit via neonatal
thC/Dpy or other early treatment to alleviate the variOll.'i manifesllltions of the
syndromes.
The abilily to gain access 10 lndividunls who !!l"e not registered with DSC.
partloularly intellectually able persons with PWS, would broaden the =
ascertainment and give a more accurate picture ofthe complete phenolypic range
of beth syndromes.

The relcvnnt AS nnd PWS Support Ass""i"tio"" both

Nationnl and SllIte, are excellent potential sollrCes of case ascertainment, ru; are
the WA Educntlon Department, Catholic Education and the Association of
Independent Schools (l.eonard cl al., 2003).
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Western Australian n'ld intersl.1lc moiecular and cytogenetic lobcmtorie.l

CIluld similarly be ofassistance in identifYing people who had undergone gCIletic
tests

for chromosome 15 abnormolities, regnrdh:ss ofthe outcome. The ability to

track DSC cl!ents who had moved out ofWA would nssist the extension of the
database, especially In tenns ofinformation on deaths and morbidities, but this is

no! currently nvailable. In addition to the continuing enlargement ofthe database
as records become nvailable, any .!<Ira

information from such sources would be

very nelpful in providing a clearer and more CIlmpreilcnsive per:spective on the
phenotypic variation and ageing issues associated with Pmdcr-Willi or Angelman
syndromes In Western Australia.

"
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Skin lesions/skin picking

Presence/degree ofsooliosis
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Temper/aggression

Epilepsy

ControlofepUepsy

EEG

Ataxia

La�ghlcT/5miJing

Hypr.:IlIc1ivity

Family history

Medical information

Genem! notes

Number ofhospital admissiOll5

DIagnoses on admission

Furthcrdiagnose, on admission

Psych outpatient number visits

Psych outpatient diagnosis

Psych admissioll3 no. days

Psych admissions diagnosis

Hospirnl procc:dures

"
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Record Iheet for AS clinical crileriB

App"odll: IX:

ANGELMAN SYNDROME
N=,
Fileno

DO.
MO

Region
DIAGNOSTIC FEATURES
l'sycholDolor dcveloplOenl
Feeding prohlems In Infancy

YES {NO I DON'T KNOW

Delayed psychomotor development
Sat unsupported __ months

YES INO I DON'T KNOW

Able to walk withoul ps,i,tance
Walked alone
months

YES INOI DON'T KNOW

Absent speech or use of<6 words

YES INOI DON'T KNOW

Able to use sign language

YES/NOlDON'TKNOW

Severe mental retardalion
_
IQ (ifknown> _
_

YES/NO /DON'TKNOW

Regression (Io,s ofacquircd skills)

YES I NO I DON'T KNOW

Neurological features I movelOeol dlsordel!l
Seizures

YES I NO I DON'T KNOW

Truncal ataxia I hypotonia

YES I NO I DON'TKNOW

Limb hJIPCnonia

YES I NO I DON'TKNOW

Jelky I ntaxic movement

YES I NO I DON'TKNOW

Tongue thrusting

YES I NO I DON'TKNOW

Hand /lapping

YES I NO I DON'TKNOW

Bebavionr
Happy disposition

YES I NO I DON'T KNOW

Easily provoked I Inappropriate laughter

YES I NO I DON'T KNOW

Pby.icai fenCores
Osymorphic focles

Promincnljaw I mandible

YES/NO/DON'TKNOW

Widely spaced tec:th

YES/NO/DON'TKNOW

Largemouth

YES I NO I DON'T KNOW

'"

Deep se! eyes

YESINO/DON'TKNOW

Small bead (<25'" percentile)

YES/NO/DON'T KNOW

HypopigmentntiGn (foirhair I ,kin ccmpUCd

to other family mcmbcrll)

YES INO I DON'T KNOW

OTI:lER STUDIES IRESULTS
YESINOI DON'T KNOW

EEG
_
_
_
_
_
_
Rcsult'_
_

Cyto&enetic st udies
Daleoft..,t

I I
Laboratory wheret.iSi)ierfonned'-________
Test result:
"",.""
FISH studies
Molec ular studies
Methylation studies
Uniparental disomy

Otberlovestlgallons ______________
Additional commcnb or information (including ..,I""aol family bllitory)

ISO

Appelldll:X:

Record .hoe! for PWS cllnlcal criteria

PRADER-WJLLISYNDROME
N�.
File No_
DOB
Region

MO

CLASSICAL FEATURES

YES {NO I DON'T KNOW

Infantile feeding problems:

YES {NOI DON'T KNOW

tuOOfed
•

I point each

Infantile hypotonia

YES/NOIOON'TKNOW

Hypogonadism:

YES/NO/DON'TKNOW

genilal hypoplnsinlpubertal deficiency
•

Rapid weighl gain

1-6 year.;

-" --

YES I NO I DON'T KNOW

percentile

Characteristic focial features

YES I NO I DON'T KNOW

Developmental delay I intolloelu,,! disability YES I NO I DON'T KNOW
.g, --

MILD IMODERATE I SEVERE

y,point each

MINOR CRITERIA
Decreased felnl movements

YES I NO I DON'T KNOW

Typieal behaviour problems

YESINOIDDN'TKNOW

Sleep dislUrbll1lce I sleep apnoea
Shortstature for family by age

", --

15

YESINO/DON'TKNOW
YESINO/DON'TKNOW

percentile

•

Hypopigmcnllllion

YESINO/OON'TKNQW

•

Characteristic fol di,tribulion

YES/NO/DON'TKNOW

•

Small hands and reet for height & age

YES/NO/OON'TKNOW

-g'-Narrow hands wiLh straight ulnar border

YES I NO I DON'T KNOW

EstroplaI myopia

YES/NO/OON'TKNOW

Thick viscous saliva

YES/NOIDON'TKNOW

Specch IllIiculation derecls

YESfNOIDON'TKNOW

Skin picking

YES fNO I OON'T KNOW

Supportivecriteria
High pain Lhroshold, decreased vomiting, temperature control problems,
scoiiOBiSikyphosis, early adrcnDrChe, ostoeporosis, unusual skill with jigsaws,
normal neuromuscular studies.
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Poor motor eoordinDlion
Head size

I1

YESlNOIDON'T KNOW
M1CROCEPHALY/NORMAUMACROCEPHALY

Head circumference __ ." __ pcrocnti!e__
Seizures

YESlWOIOON'TKNOW

"".
DIAGNOSTIC TESTS
Cytogenetics

Perfomed

Standard kaJyotypc

YES/NO

Exp8J\dr.:d kaJyotype

YES/NO

FISH

YES/NO

Rcsults,

Mol..n"'r
Uniparental disomy

YES/NO

Expression /methylation

YES/NO

"

